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Zusammenfassung 
Schon lange ist eine erhöhte Prävalenz von Frauen für Schilddrüsen- (SD) 
Funktionsstörungen wie einer Über- oder Unterfunktion bekannt. Allerdings sind die 
Auswirkungen einer SD-Fehlfunktion im menschlichen Organismus kaum 
geschlechtsspezifisch charakterisiert. Zudem steigt die Rate an SD-
Funktionsstörungen mit dem Alter an und auch hierbei ist bislang nur unzureichend 
bekannt, ob eine Über- oder Unterfunktion bei älteren Frauen im Vergleich zu 
Männern ähnliche Konsequenzen hat im Hinblick auf z.B. das kardiovaskuläre 
System, den Energiestoffwechsel oder das Verhalten.  
Um diese klinischen Fragestellungen in einem in vivo Mausmodell nachzustellen, 
wurden zunächst Protokolle für eine chronische Überfunktion in männlichen und 
weiblichen Tieren etabliert. Im Anschluss erfolgte eine Charakterisierung von 
geschlechtsspezifischen Eigenschaften einer Über- und Unterfunktion in 
verschiedenen Lebensabschnitten bei jungen, erwachsenen und alten Mäusen sowie 
Analysen zur organspezifischen SD-Hormon (SDH) Wirkung. 
Im Vergleich der jungen Tiere zeigte sich, dass das Geschlecht eine wichtige Rolle 
bei SDH-abhängigen Veränderungen des Körpergewichts, der Körpertemperatur, der 
Futter- und Wasseraufnahme, den SDH-Serumkonzentrationen und neuro-
muskulären Eigenschaften spielt. Im Vergleich von erwachsenen und älteren Tieren 
wurde sowohl eine gleichbleibende (für Körpertemperatur, SDH-Serum-
konzentrationen, Aktivität) als auch verstärkte (für Körpergewicht, Muskelfunktion) 
geschlechtsabhängige SDH-Wirkung beobachtet. Interessanterweise ließen sich in 
allen drei Altersgruppen keine Unterschiede zwischen Männchen und Weibchen in 
der Herzfrequenz bei einer Über- und Unterfunktion beobachten. In der Analyse der 
organspezifischen SDH-Wirkung zeigte sich, dass die SDH-abhängige 
Genexpression im Herzen die geringsten geschlechtsspezifischen Unterschiede 
aufweist, während im braunen Fettgewebe und noch deutlicher in der Leber 
ausgeprägte geschlechts- und SDH-spezifische Transkriptänderungen auftraten. In 
weiteren Analysen konnte eine geschlechts- und SDH-abhängige Regulation von 
Claudin-1 in der Leber nachgewiesen werden, welche wahrscheinlich eine Relevanz 
für die Gallensäure Homeostase hat und einen möglichen Pathomechanismus für 
geschlechtsabhängige Cholelithiasis bei SD-Funktionsstörungen darstellen könnte.  
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Zusammenfassend sind dies die ersten Arbeiten, welche geschlechtsspezifische 
Aspekte einer SD-Über- oder Unterfunktion in verschiedenen Lebensaltern im 
Mausmodell abbilden. Diese Ergebnisse dienen als Grundlage, um die molekularen 
Mechanismen auf organischer und Zellebene zu verstehen. Dies kann helfen, 
translational zukünftig am Menschen Komorbiditäten einhergehend mir einer SD-
Fehlfunktion bei Männern und Frauen besser vorzubeugen und zu therapieren. 
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Summary 
It is well known, that the clinical situation of thyroid dysfunctions (TDs), hyper- and 
hypothyroidism have an increased preponderance in women than men. In contrast, a 
sex-specific outcome of hyper- and hypothyroidism has not been characterized yet. 
Moreover, the prevalence of TDs increase with age, with unknown sex-specific 
consequences for the cardiovascular system, energy metabolism and behaviour.  
To mimic the clinical situation, first an in vivo mouse model for chronic 
hyperthyroidism in male and female mice was established, followed by induction of 
chronic hyper- and hypothyroidism of both sexes in young, adult and old aged mice. 
This allowed a comprehensive characterization of the interplay between sex and age 
on phenotypical traits of TD at different life stages and enabled the analysis of organ-
specific thyroid hormone (TH) effects. 
Metabolic parameters of body weight change, food and water intake, TH serum 
concentrations, heart rate, body temperature, muscle function and activity were 
assessed. In young mice a distinct sex impact on TH-dependent alterations was 
identified for body weight, body temperature, nutrient intake, TH serum 
concentrations and neuromuscular features. In comparison to adult and old age 
groups sex-effects were persistent (for body temperature, TH serum concentrations, 
activity) and exaggerated (for body weight and muscle function), whereas no TH-
dependent differences between male and female mice were noted for heart rate at 
any age. Molecular investigations showed less sex influence on TH-dependent gene 
expression in heart, whereas in brown adipose tissue and even more significant 
alterations in liver were detected. Further analysis of a sex and TH-dependent 
regulation of Claudin-1 in livers of mice indicated relevance in an altered biliary 
homeostasis and a possible pathophysiological role for TH-dependent change of sex-
dependency in cholelithiasis.  
To conclude, these studies allow a comprehensive analysis of sex influence on 
phenotypical and molecular traits of hyper- and hypothyroidism at different life stages 
in mice for the first time and enable the subsequent analysis of the underlying 
mechanisms in an organ and cell-specific manner. This will help to improve our 
understanding of possible sex impact on complications of TD in women and men and 
implicate a sex-specific prevention and treatment of patients. 
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protein-bound to thyroxine-binding globulin (TBG), transthyretin (TTR) or albumin. Figures of 
hypothalamus, pituitary, thyroid gland and blood vessel provided by mindthegraph.com. 
Uptake of T4 and T3 across the plasma membrane of cells is mediated by specific 
TH transporters, as amongst others by monocarboxylate transporter 8/10 (MCT8, 
MCT10) or organic anion-transporting polypeptide 1C1 (OATP1C1; Hennemann et 
al., 2001; Visser et al., 2008; Visser et al., 2011) as a prerequisite for intracellular TH 
action. Within the cell T3 proceeds to the nucleus to canonically mediate repression 
or induction of gene expression. In the nucleus T3 binds to TH receptors (TRα or 
TRβ), which can already be prebound to a TH response element (TRE). TREs act as 
enhancer elements on the DNA and are located in promoter regions of responsive 
genes. To stabilize binding of the complex of T3/TR at the DNA an additional 
receptor, e.g. retinoid X receptor (RXR) is needed to form a heterodimer and enable 
induction or repression of gene transcription (Fig. 2, Yen, 2001). 
TRs as ligand-dependent transcription factors exist as two isoforms, TRα and TRβ, 
which are differently expressed among all organs (Flamant and Gauthier, 2013). The 
TRα isoform is highly expressed in the heart, muscle, brain and adipose tissue, 
whereas TRβ is the predominant isoform in the liver (Schwartz et al., 1992, Bookout 
et al., 2006). 
Another alternative intracellular T3 pathway has been described in form of a 
cytoplasmatic complex of TR and phosphoinositide 3-kinase (Pi3K). Binding of T3 
results in a rapid phosphorylation of Pi3K and activation of down-stream targets (Fig. 
2; Moeller and Broecker-Preuss, 2011). In addition, extracellular TH signalling has 
been postulated in vitro to occur via T3 and T4 binding to plasma membrane 
receptors integrin αvβ3, thereby initiating intracellular response on e.g. gene 
expression by activation of Pi3K or extracellular signal-related kinases 1/2 (Fig. 2; 
Moeller and Broecker-Preuss, 2011; Davis et al., 2015, Davis et al., 2016).  
In conclusion, by upregulation or repression of genes THs influence diverse 
metabolic functions and are highly important for the development and proper function 
of the brain, bones, muscles, fertility, as well as regulation of heart rate, glucose and 
lipid metabolism and energy homeostasis (Yen, 2001).  
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hyperthyroidism is characterized by decreased TSH and elevated FT4 and/or FT3 
serum concentrations (Staub et al., 1992; Khandelwal and Tandon, 2012).  
The major cause of hypothyroidism worldwide is still environmental iodine deficiency, 
however in areas of iodine sufficiency chronic autoimmune thyroiditis (Hashimoto’s 
thyroiditis) is the most common cause for hypothyroidism. Hashimoto’s thyroiditis can 
be associated with a thyroid enlargement (goiter) or with thyroid atrophy. Less 
frequent are other causes as thyroid surgery, radioiodine treatment, thyroid cancer or 
other non-thyroid-related head and neck malignancies, as well as secondary to 
pituitary and hypothalamic diseases or drug-induced hypothyroidism (Garber et al., 
2012).  
Graves´ disease as a second known autoimmune thyroid disease (AITD) accounts 
for the majority of hyperthyroid patients worldwide (Bahn et al., 2011). In AITDs the 
thyrocytes are infiltrated with sensitized T lymphocytes, which serologically result in 
circulating anti-thyroid antibodies. An inherited defect in immune surveillance is 
believed to cause AITD, by leading to an abnormal immune responsiveness and 
alteration of presenting antigen in the thyroid (Ban et al., 2008, Menconi et al., 2008). 
Thus, antibodies against thyroglobulin (TGAb), thyroid-peroxidase (TPOAb) and TSH 
receptor (TSHRAb) are known to be found in patients with AITD (Garber et al., 2012). 
TSHRAb are most prominent thyroid autoantibodies in Graves´ disease and are able 
to mimic TSH signalling resulting in increased TH production (Bahn et al., 2011). 
TGAb and TPOAb are distributed among the population and occur with a frequency 
of 75% in patients of AITD, but were also detected in ~10% of disease-free 
population. Thus, antibody concentrations should always be evaluated in context with 
other thyroid function parameters (Garber et al., 2012). 
Furthermore, hyperthyroidism frequently occurs from toxic multinodular goiter or toxic 
adenoma as a result of constitutively active TSH signalling. Other rare cases include 
acute or painless thyroiditis and drug or human chorionic gonadotrophin induced 
hyperthyroidism (Bahn et al., 2011).  
All previously mentioned causes may lead to overt hypo- or hyperthyroidism, 
however there is a gradual change between subclinical and overt forms in terms of 
clinical symptoms and morbidities (Vaidya and Pearce, 2008).  
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Due to the variety of functions that THs exert on many organs, alteration in TH status 
and or action may cause diverse and wide spread symptoms affecting the whole 
organism (Table 1). These include organ-specific signs, as e.g. of the skin (dryness, 
sweating), heart (palpitation, atrial fibrillation, bradycardia), brain and nervous system 
(depression, lack of concentration, anxiety, nervousness), muscles (lack of energy, 
weakness, aches and pains) and digestive system (weight loss, weight gain, loss of 
appetite, increased bowel movement).  
Table 1: Symptoms and signs of hyperthyroidism and hypothyroidism (Crooks et al.,1959; 
Billewitz et al., 1969; Boelaert et al., 2010; Bahn et al., 2011). 
symptoms and signs of thyroid dysfunctions 
hypothyroidism hyperthyroidism 
lack of energy irritability  
puffy face nervousness, tremor 
dry hair lack of energy, muscular weakness 
dry skin weight loss 
constipation sweating 
aches and pains osteoporosis 
parasthesiae palpitation, atrial fibrillation 
cold intolerance  heat intolerance 
poor memory anxiety 
lack of concentration shortness of breath 
depression neck enlargement 
heart failure increased frequency of bowel movement 
weight gain eye symptoms 
loss of appetite heart failure 
growth delay in children impaired fertility 
lowered heart rate difficulty of falling asleep 
impaired fertility accelerated growth in children 
 
If hyper- or hypothyroidism remains untreated, morbidities may occur and this is most 
likely with increasing age. Cardiac events and heart failure are among the most 
frequent complication of hyper- and hypothyroidism in the elderly population (Table 2, 
Surks et al., 2004). Thus, a correlation between increased mortality and both TDs 
hyper- and hypothyroidism could have been shown recently in an elderly population 
(Grossmann et al., 2016). 
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Table 2: The most prominent morbidities of hyperthyroid and hypothyroid patients (Surks et 
al., 2004). 
Morbidities 
hypothyroidism hyperthyroidism 
cardiac dysfunction atrial fibrillation  
adverse cardiac end points adverse cardiac end points 
artherosclerosis cardiac dysfunction 
elevation in total and LDL-cholesterol systemic and neuropsychiatric symptoms 
neuropsychiatric symptoms reduced bone mineral density and fractures 
 
1.3 Prevalence and background of sex-specificity in thyroid dysfunctions 
Sex-specific characteristics of hypothyroidism 
A sex-dependent distribution is well known for hypothyroidism. Large studies in 
different countries have shown a higher prevalence in women than men. In Europe 
the ratio of affected women/men with hypothyroidism varied between 1.7 to 6.8 
(Table 3). In other countries the female to male ratio varied from 1.7 (in US 
population, Hollowell et al., 2002), 2.4 (in Brazil, Camargo et al., 2008), 2.0 (in 
Australia, O'Leary et al., 2006) to 4.6 (in Japan, Konno et al., 1993; Table 3).  
Interestingly, little is known whether symptoms and complication of hypothyroidism 
differ between women and men. A recent study which focused on treatment and 
treatment outcome of hypothyroidism, reported a sex-dependent symptom 
presentation. Thus, symptom presence or absence were better predictors for overt 
hypothyroidism in men than women, as women reported significantly more symptoms 
after replacement therapy than men (Carlé et al., 2015). Moreover, a tendency for 
overtreatment of women in comparison to men was associated with increased risk of 
atrial fibrillation and reduced bone mineral density in female patients (Mammen et al., 
2015). 
Furthermore, a small study in Finland reported an association between subclinical 
hypothyroidism and hypertension in women, though male patients were not included 
in the analysis (Luboshitzky et al., 2002). However, the findings of the Finish study 
were confirmed later in a Chinese study where subclinical hypothyroidism was shown 
to be a significant predictor for increased systolic blood pressure and an elevated 
pulse pressure in females. Serum TSH was significantly higher in the hypertensive 
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female group compared to the normotensive group. In contrast subclinical 
hypothyroidism and blood pressure did not correlated in male participants, 
suggesting that thyroid function could influence blood pressure to a greater extent in 
women compared to men (Duan et al., 2009). Surprisingly, an association of 
hypertension with subclinical hypothyroidism could not have been shown in an 
Australian and a Japanese study for any gender, which indicates a need for 
additional studies to understand the influence of sex and hypothyroidism in regulation 
of blood pressure (Walsh et al., 2006; Takashima et al., 2007). Furthermore, a 
Danish study showed an association between subclinical hypothyroidism and 
development of cardiovascular disease with a possible role of triglycerides and C 
reactive protein levels in males below 50 years of age (Kvetny et al., 2004). Hereby, 
these findings however were not confirmed so far as population studies may be 
influenced by ethnicity and age of participants, different experimental desings and 
assays applied.  
Sex-dependent traits of hyperthyroidism 
Hyperthyroidism as a result of a TH excess occurs more frequently in women than 
men. In Europe the ratio of affected women/men varies between 2.5 and 11.7 (Table 
4). In other countries, the female to male ratio ranged from 1.6 (in Brazil, Camargo et 
al., 2008) 2.4 (in US population, Hollowell et al., 2002) and 8.6 (in Australia, O'Leary 
et al., 2006; Table 4).  
If this situation is also related to sex-dependent disease characteristics or outcomes 
has been rarely addressed. Apparently, description of symptoms of hyperthyroidism 
had majority of signs in common in women and men. Interestingly, some were 
associated with female sex, e.g. weight gain, palpitation and neck enlargement. 
Moreover, women were less affected by atrial fibrillation, whereas males were 
independently associated with higher risk of atrial fibrillation (Boelaert et al., 2010). 
The outcome of hyperthyroidism on bones has a distinct impact on postmenopausal 
women as described in several studies. Thus, a significant increase in bone turnover 
markers and a decrease in bone mass were diagnosed in women affected by 
endogenous subclinical hyperthyroidism, additionally being greater in early 
postmenopausal patients (Tauchmanovà et al., 2004). Reduced bone mineral density 
was found in hyperthyroid post-, but not premenopausal women or men (Uzzan et al., 
1996). Moreover, this may cause serious consequences as the association with an 
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increased risk of fractures (Bauer et al., 2001; Blum et al., 2015). Furthermore, 
overtreatment of hypothyroid women with L-thyroxine has been shown to increase 
fracture risk in a longitudinal study (Ko et al., 2014; Bassett and Williams, 2016). 
 
 
 
  
 
 
 
 
B
ac
kg
ro
un
d 
 
 
  
 
 
 
 
 
 
21
 
T
ab
le
 3
: P
re
va
le
nc
e 
of
 h
yp
ot
hy
ro
id
is
m
 a
nd
 g
en
de
r d
is
tri
bu
tio
n 
re
po
rte
d 
in
 s
tu
di
es
 in
 d
iff
er
en
t c
ou
nt
rie
s 
an
d 
co
nt
in
en
ts
. 
au
th
or
 
ye
ar
 
co
un
tr
y 
to
ta
l p
op
ul
at
io
n 
h
yp
ot
h
yr
oi
d 
(%
) 
w
om
en
 (%
) 
m
en
 (%
) 
ra
tio
 
T
un
br
id
ge
 e
t a
l. 
19
77
 
G
re
at
 B
rit
ai
n 
3,
53
8 
1.
10
 
7.
50
 
2.
80
 
2.
70
 
K
on
no
 e
t a
l. 
19
93
 
Ja
pa
n 
4,
11
0 
n.
a.
 
3.
13
 
0.
68
 
4.
60
 
V
an
de
rp
um
p 
et
 a
l. 
19
95
 
G
re
at
 B
rit
ai
n 
1,
87
7 
n.
a.
 
4.
10
 
0.
60
 
6.
80
 
K
nu
ds
en
 e
t a
l. 
19
99
 
D
en
m
ar
k 
2,
65
6 
1.
00
 
1.
70
 
0.
40
 
4.
30
 
B
jo
ro
 e
t a
l. 
20
00
 
N
or
w
ay
 
94
,0
09
 
n.
a.
 
4.
80
 
0.
90
 
5.
40
 
H
ol
lo
w
el
l e
t a
l. 
20
02
 
U
S
 
17
,3
53
 
4.
60
 
5.
80
 
3.
40
 
1.
70
 
H
oo
ge
nd
or
n 
et
 a
l. 
20
06
 
N
et
he
rla
nd
s 
6,
43
4 
4.
40
 
5.
50
 
3.
20
 
1.
70
 
O
´L
ea
ry
 e
t a
l. 
20
06
 
A
us
tra
lia
 
2,
11
5 
5.
64
 
3.
64
 
1.
80
 
2.
00
 
C
am
ar
go
 e
t a
l. 
20
08
 
B
ra
si
l 
67
8 
6.
54
 
8.
40
 
3.
43
 
2.
40
 
Le
es
e 
et
 a
l. 
20
08
 
S
co
tla
nd
 
38
8,
75
0 
n.
a.
 
5.
14
 
0.
88
 
5.
80
 
M
ei
si
ng
er
 e
t a
l. 
(K
O
R
A
) 
20
12
 
G
er
m
an
y 
2,
31
6 
4.
10
 
16
.1
0 
12
.3
0 
1.
30
 
M
ei
si
ng
er
 e
t a
l. 
(S
H
IP
) 
20
12
 
G
er
m
an
y 
2,
50
5 
1.
50
 
4.
50
 
4.
20
 
1.
10
 
 
 
  
 
 
 
 
B
ac
kg
ro
un
d 
 
 
  
 
 
 
 
 
 
22
 
T
ab
le
 4
: P
re
va
le
nc
e 
of
 h
yp
er
th
yr
oi
di
sm
 a
nd
 g
en
de
r d
is
tri
bu
tio
n 
re
po
rte
d 
in
 s
tu
di
es
 in
 d
iff
er
en
t c
ou
nt
rie
s 
an
d 
co
nt
in
en
ts
.  
au
th
or
 
ye
ar
 
co
un
tr
y 
to
ta
l p
op
ul
at
io
n 
h
yp
er
th
yr
oi
d 
(%
) 
w
om
en
 (%
) 
m
en
 (%
) 
ra
tio
 
T
un
br
id
ge
 e
t a
l. 
19
77
 
G
re
at
 B
rit
ai
n 
3,
53
8 
1.
60
 
2.
70
 
0.
23
 
11
.7
0 
K
nu
ds
en
 e
t a
l. 
19
99
 
D
en
m
ar
k 
2,
65
6 
1.
90
 
2.
80
 
1.
10
 
2.
50
 
B
jo
ro
 e
t a
l. 
20
00
 
N
or
w
ay
 
94
,0
09
 
n.
a.
 
2.
50
 
0.
60
 
4.
20
 
H
ol
lo
w
el
l e
t a
l. 
20
02
 
U
S
 
17
,3
53
 
3.
20
 
4.
40
 
1.
80
 
2.
40
 
H
oo
ge
nd
or
n 
et
 a
l. 
20
06
 
N
et
he
rla
nd
s 
6,
43
4 
1.
20
 
1.
80
 
0.
60
 
3.
00
 
O
´L
ea
ry
 e
t a
l. 
20
06
 
A
us
tra
lia
 
2,
11
5 
0.
44
 
0.
43
 
0.
05
 
8.
60
 
C
am
ar
go
 e
t a
l. 
20
08
 
B
ra
si
l 
67
8 
3.
34
 
3.
83
 
2.
46
 
1.
60
 
Le
es
e 
et
 a
l. 
20
08
 
S
co
tla
nd
 
38
8,
75
0 
0.
78
 
1.
26
 
0.
24
 
5.
30
 
M
ei
si
ng
er
 e
t a
l. 
(K
O
R
A
 ) 
20
12
 
G
er
m
an
y 
2,
31
6 
2.
00
 
1.
70
 
1.
70
 
1.
00
 
M
ei
si
ng
er
 e
t a
l. 
(S
H
IP
 ) 
20
12
 
G
er
m
an
y 
2,
50
5 
5.
20
 
3.
50
 
4.
20
 
0.
80
 
______  Background 
  23 
1.4 Is thyroid function sex-specific?  
During the last 5 decades many population studies investigated the reference range 
of TH serum concentrations in humans, but a consistency for a sex-dependent 
impact could not have been defined. In some studies the TSH concentration was 
shown to be higher in women than men (Hollowell et al., 2002; Bjoro et al., 2000; 
Tunbridge et al., 1977), while other studies reported no difference (Aghini-Lombardi 
et al., 1999; Kapelari et al., 2008; Roelfsema et al., 2009) or in contrast even men 
having a higher TSH concentration than women (Hadlow et al., 2013).  
Moreover, TSH concentrations varied age-dependently in women but only if studies 
consisted of probands below 50 years of age (Roelfsema et al., 2009; Tunbridge et 
al., 1977). In subjects of older age the TSH concentration range increased in both 
gender with age consistently (Canaris et al., 2000; Bjoro et al., 2000) or decreased 
with age in women and men (Hoogendoorn et al., 2006). For the FT4 and FT3 serum 
concentrations no significant gender-dependent difference was shown so far (Ahmed 
et al., 2009, Dika et al., 2010). However, these findings do not preclude that similar 
TH concentrations or similar alteration of THs in pathophysiological states will have 
the same effect in a male or female organism since serum thyroid state is not 
necessarily reflecting tissue state.  
Along this line, recent findings by Porcu et al. in 2013 in a genome-wide study to 
identify common genetic variants associated with altered serum TSH and FT4 
concentrations showed sex-specific differences in some loci. At the loci 
phosphodiesterase type 8B (PDE8B), phosphodiesterase type 10A (PDE10A) and v-
maf musculoaponeurotic fibrosarcoma oncogene homolog/LOC440389 the TSH-
elevating alleles showed significantly stronger genetic impact on pituitary-thyroid 
function in males compared to females. Interestingly, in a sex-specific meta-analysis, 
alleles that are associated with higher FT4 concentrations, showed one female-
specific locus and one male-specific locus which both did not appeared in the whole 
meta-analysis study before. The female-specific locus is located on chromosome 
18q22 near gene neuropilin and tolloid -like 1 550 kb upstream and F-box only 
protein 15 500 kb downstream. The male-specific locus is located on chromosome 
16q12.2 in intron 11 of the lysophosphatidylcholine acyltransferase 2 gene near 
calpain, small subunit 2 (CAPNS2; Porcu et al., 2013). This might implicate sex-
specific gene regulation in proper TH function. However, if these loci are clinically or 
mechanistically relevant has not been proven so far. 
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1.5 Interaction of sex and thyroid hormones 
Basic research on the interaction of sex hormones, in particular female sex 
hormones and THs dates back to the 1950´s. In 1956 the effect of diethylstilbestrol (a 
synthetic nonsteroidal estrogen) on the binding of T4 in serum was described. 
Diethylstilbestrol that was administered to various patients with endocrinopathies in a 
dosage of 30 mg daily for periods of four to eight weeks induced increase in 
thyroxine-binding by TBG comparable to the observed changes during pregnancy. 
Moreover, this effect was not dependent of normal functioning of the thyropituitary 
axis (Dowling et al., 1956).  
In 1958 Engbring and Engstrom studied the effect of estrogen on circulating THs in 
humans. When administering estrogen to athyreotic patients they found the following 
results: Estrogen increased the thyroxine-binding capacity of serum, the 
concentration of serum total T4 and increased secretion of TSH at pituitary level, as 
well as thyroidal activity. Additionally, estrogen administration decreased the basal 
metabolic rate (Engbring and Engstrom, 1958). Later these findings were confirmed 
in vitro and showed that estrogen-induced serum TBG elevation may not be 
mediated through an increase of synthesis (Ain et al., 1988). Furthermore, T4 
turnover was determined during estrogenic therapy at different time spans. In all 
subjects, estrogen induced an increase in the binding avidity of TBG and a marked 
retardation of the fractional rate of peripheral turnover of T4 (Dowling et al., 1960). 
These early pioneer studies demonstrated that estrogen and it´s derivatives are 
important modifiers of TH action in serum and thyroidal activity. 
Conversely, THs affect reproduction ability and menstrual cycle in women, as women 
with TSH values outside the reference range were more likely to report shorter or 
longer menstrual periods than women within that range (Sowers et al., 2008). Around 
21.5 % of untreated thyrotoxic patients experience cycle abnormalities even though 
most thyrotoxic women remain ovulatory. In hypothyroid women menstrual 
disturbance is reported in around 23.4 % and negatively influences fertility of women 
(Krassas, 2000). Thus severe hypothyroidism is associated with failure of ovulation 
or serious problems during pregnancy with occurring abortions, stillbirths or 
prematurity (Krassas, 2000). The menstrual pattern is influenced by THs directly 
through impact on the ovaries and indirectly through impact on sex-hormone binding 
globulin, prolactin and gonadotropin-releasing hormone secretion and coagulation 
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factors (Poppe et al., 2007). These findings show the interplay between sex 
hormones on THs and reveal TH influence on gonadal system.  
 
1.6 Thyroid hormone action studies in mice  
Distinct rodent models for studies of thyroid function have been developed over the 
last decades to increase the knowledge about the thyroid gland and TH action in an 
organism. The American Thyroid Association (ATA) summarized in 2014 a series of 
recommendations related to the study of TH economy and action in rodent models, 
as well as in cell models to improve reproducibility of experiments and tests (Bianco 
et al., 2014). Although extensive work has been done on this topic, the majority of 
studies were performed in male mice only and remarkably fewer in female mice only. 
Thereby, sex effects within TD have not been addressed directly so far, but were 
reported mainly if recognized by chance or during characterization of a mouse strain. 
Defining the TH status of several mouse strains, a sex-dependent difference in 
serum TSH concentrations in untreated mice was reported of either two-fold higher 
(Yeager et al., 2007; Vella et al., 2014) or even four-fold higher TSH concentrations 
in male compared to female mice (Pohlenz et al., 1999). Thus, mice in contrast to 
humans appear to differ in their normal thyroid function between both sexes. 
Furthermore, functional assessment of components of TH metabolism, e.g. Dio1 
showed a sexual dimorphic activity in kidney and liver of young (8 weeks) euthyroid 
mice. Hepatic Dio1 activity was higher in male than female mice, while renal Dio1 
activity was higher in female than male mice (Riese et al., 2006). Moreover, this 
effect was age-dependent, as sexual dimorphism for hepatic Dio1 activity vanished, 
but for renal Dio1 activity was preserved in adult (12 months) mice (Schomburg et al., 
2007).  
In another crucial TH target organ, the brain, an effect of TH excess on glial 
morphology and function was described to be sex-dependent. Whereas T4 induced 
morphological change and activation of microglia and astrocytes, as well as 
microglial phagocytosis in male mice, no such effect was noted for female mice 
(Noda et al., 2016).  
Interestingly, in 1968 a higher uptake of T4 in the thyroid gland in female compared 
to male mice was found when mice were treated with desiccated thyroid or 
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subcutaneous injections of T4 (Schreiberova O. and Kapitola J., 1968), indicating 
already a sex dependent response to THs in mice. However, this topic was not 
followed up for a long time, until in 2014 a difference in response to T3 was noted. T3 
treatment resulted in a two-fold higher increase of T3 serum concentrations in female 
mice, while only a 1.5-fold increase was observed in males (da Silveira et al., 2014). 
Other studies have found sexual dimorphism in thyroid cancer. Thus the incidence of 
different thyroid cancer types in mice shows a sex-dependent distribution, not 
dissimilar to the human situation. Thyrocyte-specific loss of phosphatase and tensin 
homolog resulted in the development of follicular adenomas by the age of 10 months 
preferably in female mice, whereas males were not affected (Yeager et al., 2007). 
Furthermore, the laboratory mouse strain B6C3F1 which is commonly used in long-
term toxicity studies developed thyroid tumors in 1-10 % of the female compared with 
0.8 % of male mice (Charles River Laboratories, USA) by the age of 24 months. 
Although not in relation to a sex difference, TH action in mice has been studied for a 
long time and the prominent influence of TH on bones, brain and behaviour, heart 
function and energy homeostasis are well described (Schneider et al., 2001; 
Dillmann, 2002; Shin and Osborne, 2003; Schneider et al., 2006; Coppola et al., 
2007; Trajkovic et al., 2007; Pierpaoli and Lesnikov, 2011; Lin et al., 2012; Hübner et 
al., 2014; da Silveira et al., 2014; Zhang et al., 2015; Bassett and Williams, 2016). 
TH influences adult bone homeostasis in male mice as hyperthyroidism was found to 
be associated with reduced trabecular and cortical bone density, cortical thickness 
and high bone turnover. In contrast increased trabecular bone density and low bone 
turnover has been noted for hypothyroidism (Bassett and Williams, 2016).  
Cardiac outcome of TH excess was associated with increased heart rate and heart to 
body weight ratio (Dillmann, 2002; Bachman et al., 2004; Suarez et al., 2010). 
Furthermore, functional left ventricular analysis showed a declined ejection fraction, 
wall thickening, systolic index and fractional shortening of hyperthyroid mice, but was 
partly reversible after TH cessation in young, but not in adult females (Hübner et al., 
2014). In contrast, propylthiouracil induced hypothyroidism in mice reduced heart rate 
and weight, lowered the ejection fraction and capillary density, suggesting cardiac 
microvascular impairment and increased sensitivity to angiogenic growth factors. 
Finally, one year of treatment even induced heart failure (Chen et al., 2012).  
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Brain is known to be TH responsive, as TH excess and deprivation resulted in 
alterations of gene expression (Hernandez et al., 2012). Furthermore, proper TH 
function is a prerequisite for development of pyramidal cells of the neocortex and 
Purkinje cells of the cerebellum, which is impaired under hypothyroidism (Bernal et 
al., 2003). Moreover, hypothyroidism results in a major impact on the striatum of 
adult mice, which were described to result in motor behaviour modifications 
(Vallortigara et al., 2008). A clear influence of TH status could be shown in a 
behavioural study of hypothyroid, euthyroid and hypothyroid mice supplemented with 
TH. Graded difference of anxiety, with TH serum concentrations was noted as adult 
onset of hypothyroidism in male mice induced mild anxiety which was reversible by 
TH-supplementation and euthyroid mice were inbetween both treatment groups 
(Buras et al., 2014).  
THs are essential for metabolic processes, thus TH excess results in hypermetabolic 
syndrome with increased resting and total energy expenditure, food intake (Klieverik 
et al., 2009), reduced cholesterol levels (Lin et al., 2012), increased lipolysis, and 
gluconeogenesis (Mullur et al., 2014), decreased hepatic glycogen stores and 
increased body temperature (Yao et al., 2014; Alvarez-Crespo et al., 2016). TH 
deficiency in turn is accompanied by hypometabolism characterized by reduced 
resting energy expenditure, increased cholesterol levels, reduced lipolysis, and 
increased hepatic glycogen stores (Ueta et al., 2011; Yao et al., 2014). 
Currently in vivo TH action is based on findings in mainly male organisms and is a 
bias to clinical situation of far more women being affected by TD than men. Thus, a 
prerequisite is to dissect the contribution of sex on TH action in a healthy or diseased 
organism by evaluation of male and female animals. Moreover, for a translation of 
experimental data it is mandatory to understand whether and to what extend sex 
influences TH action. Furthermore, since patients are affected at different life stages, 
with increased prevalence of hyper- and hypothyroidism at older age, a 
comprehensive analysis for sex dependent TH action also needs to consider mouse 
organisms of different ages.  
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To this aim, the focus of this work is based on the following questions:  
1. What is an appropriate protocol for chronic hyperthyroidism in males and females? 
2. Do males and females differ in signs and symptoms of hypo- and hyperthyroidism? 
3. Is this sex difference age-dependent and thereby possibly sex hormone related? 
4. Is there an organ difference in sex-specificity of hypo- and hyperthyroidism? 
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2.1 Abstract  
Purpose: Protocols for induction of hyperthyroidism in mice are highly variable and 
mostly involve short-term thyroid hormone (TH) treatment. In addition, little is known 
about a possible influence of sex on experimental TH manipulation. Here we 
analyzed the efficacy of intraperitoneal (ip) vs. oral levothyroxine administration to 
induce chronic hyperthyroidism in male and female mice and asked which thyroxine 
dosing intervals are required to achieve stable organ thyrotoxicosis. 
Methods: Thyroxine was administered ip or orally over a period of 6/7 weeks. 
Assessment included monitoring of body weight, TH serum concentrations, serial 
quantitative TH target gene expression analysis in liver and heart. 
Results: Our results show that both intraperitoneal and oral thyroxine treatment are 
reliable methods for induction of chronic hyperthyroidism in mice. Thereby thyroxine 
injection intervals should not exceed 48h and oral levothyroxine should be 
administered continuously during experiments and up to sacrifice, to ensure a 
hyperthyroid organ state. Furthermore, we found a sex-dependent variation in T4-
induced TH serum state, with significantly higher T4 concentrations in female mice, 
while expression of investigated classical TH responsive genes in liver and heart did 
not vary with animal’s sex.  
Conclusions: In summary, our study shows that common approaches for rendering 
rodents thyrotoxic can also be used for induction of chronic hyperthyroidism in male 
and female mice. Thereby T4 dosing intervals are critical as are read-out parameters 
to verify a chronic thyrotoxic organ state. 
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2.2 Introduction  
Hyperthyroidism is a pathological state characterized by excessive thyroid hormone 
(TH) action in the body and is associated with significant morbidity and mortality, 
mainly from cardiovascular and cerebrovascular disease [1–3]. Women are more 
frequently affected and in the general population, 1.7-11.7% of women and 1.2-7.6% 
of men are suffering from subclinical or overt hyperthyroidism [4, 5]. The most 
common causes of hyperthyroidism include Graves’ disease, thyroid autonomy, and 
over-dosage of levothyroxine [5]. 
Animals serve as useful models to study TH action in vivo. This is also reflected in 
the 2014 guidelines of the American Thyroid Association (ATA), which comment on 
experimental settings to investigate TH economy and action in rodent and cell 
models [6]. The spectrum of potentially involved players has become increasingly 
complex and comprises distinct TH and TH derivatives, transmembrane transporters 
and other putative membrane targets of TH, in addition to intracellular TH metabolism 
and classical nuclear vs. non-genomic TH action [7]. 
With the aim to study molecular aspects of chronic hyperthyroidism in mice, we 
searched the literature for established protocols. We found, besides a preference of 
rats vs. mice, a great variety of protocols including application of different 
iodothyronines and dosages, different modes of TH administration and treatment 
duration as well as variable tools, endpoints and markers for monitoring 
thyrotoxicosis in vivo. Furthermore, data on female mice are lacking so far and little is 
known on sex-dependent molecular TH action in mice. In this context, the Endocrine 
Society has recently highlighted that sex is an important variable that needs to be 
considered in basic science as well as clinical research [8]. 
With this reasoning and in light of lack of standardized protocols for induction of 
chronic hyperthyroidism, we tested the efficacy of long-term intraperitoneal (ip) and 
oral thyroxine (T4) administration in male mice. In addition, we compared effects on 
serum TH and tissue thyroid status in male and female mice. Furthermore, we 
investigated the sustainability of ip and oral T4 supply on organ TH status to 
determine which T4 dosing intervals ensure stable tissue hyperthyroidism during 
experiments and at organ sacrifice.  
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2.3 Materials and Methods  
Animals and treatment 
For study 1 two to three months old male and female C57BL/6NTac mice (Taconic 
Europe A/S, Denmark) were randomly assigned to ip T4 treatment (n=6 
mice/sex/treatment) or control treatment (n=3 mice/sex/treatment). For study 2 four to 
eight months old wild-type male mice with C57BL/6 background (Zentrales Tierlabor, 
University Hospital Essen) were randomly assigned to oral T4 treatment (n=12) or 
control treatment (n=3). After 3 weeks of T4 treatment the oral group was divided into 
2 subgroups and the dosage of T4 reduced. One group (n=6) received continuous T4 
treatment, while a second group (n=6) was given a recovery time of one week until 
T4 supply continued (Fig. 1). 
Animals were housed in temperature- (23 ±1°C) and light-controlled (inverse 12:12 
hour light-dark cycle) conditions two weeks prior to the start of the experiments and 
until all experiments were finished. Food and water were provided ad libitum. All 
animal experiments were performed in accordance with the German regulations for 
Laboratory Animal Science (GVSOLAS) and the European Health Law of the 
Federation of Laboratory Animal Science Associations (FELASA). The protocols for 
animal studies were approved by the Landesamt für Natur, Umwelt und 
Verbraucherschutz Nordrhein-Westfalen (LANUV-NRW, Germany).  
In the ip treatment group, animals received ip injections of 1 µg/g body weight 
levothyroxine (T4; Sigma-Aldrich (T2376), St. Louis, USA; stock-solution: 2 mg/mL 
T4 dissolved in 0.01 M NaOH, 0.1% BSA (Albumin from bovine serum, Sigma-Aldrich 
(A7906), St. Louis, USA); injection solution: stock-solution diluted 1:10 with PBS) or 
PBS (control males: 150 µl PBS; control females: 100 µl PBS) every 48h. T4 
solutions (stock and injection) were prepared freshly every two weeks and were kept 
protected from light at 4°C.  
In the oral treatment group, T4 was continuously supplemented in the drinking water 
containing 5 µg/mL or 1 µg/mL T4 (stock-solution: 100 µg/mL T4 dissolved in 40 mM 
NaOH, 0.1% BSA (Albumin from bovine serum, Sigma-Aldrich (A7906), St. Louis, 
USA) in tap water; solution was kept frozen at -20°C and freshly thawed before 
dilution) in black drinking bottles (Tecniplast, Hohenpeißenberg, Germany). Control 
animals received no treatment. T4 supplemented water was prepared freshly three 
times a week. The treatment period was six weeks for ip and seven weeks for oral 
mice.  
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T4 supply (ip or oral) was stopped after six/seven weeks and all animals were placed 
on tap water without change in food supply. For analysis of TH tissue status and T4 
ip/oral dosing intervals, animals were sacrificed at time points 24h, 48h, 72h and 
144h after last ip T4 injection or oral T4 treatment (Fig. 1).  
TH measurements 
Blood samples were collected from the retrobulbar venous plexus every other week 
at 24h after T4 injection. To allow for weekly assessment of serum TH 
concentrations, ip and oral T4 groups were divided so that blood was drawn from 
three animals/sex/treatment per week. FT3, FT4 and TT4 concentrations in serum of 
mice were measured using commercial ELISA kits according to the manufacturer's 
instructions (DRG Instruments GmbH, Marburg, Germany; FT3: EIA-2385; FT4: EIA-
2386; TT4: EIA-1781). Serum samples with known TH concentrations were used as 
standards. According to the manufacturer's instructions, the minimum detectable TH 
concentration is 0.5 µg/dL for TT4, 0.05 ng/dL for FT4 and 0.05 pg/mL for FT3. 
Collection of TH target organs 
For tissue collection, mice were perfused with heparinized saline through a needle 
placed in the left ventricle. Tissues were shock frozen in liquid nitrogen, and stored at 
-80°C until further processing. 
Quantitative real-time PCR 
Total RNA from liver and heart was isolated using RNeasy Kit (Qiagen, Hilden, 
Germany) and stored at -80°C. 2 µg of total RNA were reverse transcribed into cDNA 
with SuperScriptIII (Life Technologies, Darmstadt, Germany) and random hexamer 
primers. Quantitative real-time PCR was performed using Roche SYBR Green I 
master mix (Roche, Mannheim, Germany). The primer sequences are provided in 
Supplementary Table 2 (PCR conditions are available upon request). In compliance 
with the MIQE guidelines for RT-PCR [9], we used a set of 2 to 4 reference genes 
per tissue to assure accurate normalization and calculation (liver: Rn18s, Ppia, 
Rpl13a, β-Actin in ip treated and Rn18s, Ppia in oral treated group; heart: Rn18s, 
Polr2a, Rpl32 in ip treated and Rn18s, Rpl32 in oral treated group). Analysis and 
calculation of the fold-change in gene expression were done on Ct-values ≤35 using 
the efficiency-corrected ΔΔCt method [10]. 
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Statistical analysis  
Calculation and plotting was done with GraphPad Prism 6 software (GraphPad, San 
Diego, USA). Statistical analysis was performed using two-way ANOVA followed by a 
Tukey's multiple comparisons test or using the unpaired two-tailed t-test, as 
indicated. Fold expression of RT-PCR was statistically analyzed on anti-logarithmic 
data.  
 
Fig. 1: Schematic illustration of the approach for comparison of ip and oral T4 supply 
and analysis of the sustainability of chronic T4 treatment on organ thyroid state.  
Study 1: Mice received T4 intraperitoneal (ip T4, 1 µg/g BW T4 every 48h) over a period of 6 
weeks (6 wks, (n=6 mice/sex). PBS treated mice served as controls (ctrl, (n=3 mice/sex). 
Treatment was stopped and mice were sacrificed for tissue collection at 24h, 48h, 72h and 
144h after the last T4 administration to investigate TH tissue status in target organs (liver, 
heart).  
Study 2: Male mice received oral T4 treatment (5 µg/mL T4 first 3 treatment weeks, n=12) or 
no treatment (n=3). After 3 weeks of T4 treatment the group was divided and one subgroup 
received continuous T4 treatment (1 µg/mL T4 last 4 treatment weeks, n=6), while a second 
subgroup was allowed a recovery time of one week until T4 supply continued (1 µg/mL T4 
last 2 treatment weeks, n=6). Treatment was stopped and mice were sacrificed for tissue 
collection at 24h, 48h, 72h and 144h after the last T4 administration to investigate TH tissue 
status in target organs (liver, heart). 
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2.4 Results  
Intraperitoneal and oral T4 treatment are suitable to induce chronic 
hyperthyroidism in male mice  
Intraperitoneal T4 treatment (Fig. 1) resulted in marked increase in serum total 
thyroxine (TT4 up to 6-fold), free thyroxine (FT4 up to 3-fold) and free triiodothyronine 
(FT3 up to 2.5-fold) concentrations with time and was thus successful in inducing 
chronic serum thyrotoxicosis in the mice (Fig. 2). Intraperitoneal T4 treatment was 
well tolerated in all animals and as expected was accompanied by increased body 
weight gain compared to PBS treated controls (Fig. 4a).  
In the oral T4 group, a higher T4 dosage/body weight (5 µg/mL) was used in the 
beginning with the rationale that the uptake would be ±65% of the oral T4 dosage in 
mice similarly to humans [11]. However, sequential analysis of serum TH showed 
that mice became severely thyrotoxic (Fig. 3) and this was also mirrored in impaired 
animal well-being and loss of body weight gain (Fig. 4b). Hence, at week 3 treatment 
was stopped for 1 week in half of the oral T4 treated mice or was continued at a 
much lower dosage (1 µg/mL). Both approaches resulted in complete recovery of 
animal well-being and comparable TT4, FT4 and FT3 serum concentrations at the 
end of experiment in the oral and the ip treatment group (Fig. 3). This shows that oral 
T4 is well absorbed in mice and that serum TH concentrations can be titrated by the 
oral T4 dosage (Fig. 3). No significant changes in TH serum status were observed in 
control animals during the entire experimental period (Fig. 2, 3).  
 
 
Fig. 2: Serum concentrations of thyroid hormones TT4, FT4 and FT3 in male and 
female mice with ip T4 treatment compared to sham treated controls. Time course of 
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changes in TH concentrations (a) total thyroxine (TT4), (b) free thyroxine (FT4) and (c) free 
triiodothyronine (FT3) determined by ELISA in sera of male (M) and female (F) mice. Mice 
were subjected to intraperitoneal T4 (ip T4, 1 µg/g BW ip T4 every 48h) over 6 weeks. 
Controls received ip PBS injections (ip ctrl every 48h) over 6 weeks. From week 2 to 3, a 
change in housing conditions took place (change from conventional cages to individually 
ventilated cages for all groups). This resulted in a temporary decrease in thyroid hormone 
serum concentrations in almost all animals. Data are presented as mean ±SEM, unpaired 
two-tailed t-test: *p<0.05, **p<0.01, ***p<0.001, #p<0.0001 (n=6 mice/sex for ip T4 treatment; 
n=3 mice/sex as controls). 
 
Fig. 3: Serum concentrations of thyroid hormones TT4, FT4 and FT3 in male mice with 
oral T4 treatment. Time course of changes in TH concentrations (a) total thyroxine (TT4), 
(b) free thyroxine (FT4) and (c) free triiodothyronine (FT3) determined by ELISA in sera of 
male mice (n=12) with or without (w/o) recovery after 3 weeks treatment. Mice were 
subjected to oral T4 (5 µg/mL T4) over 3 weeks and due to severe thyrotoxicosis the dosage 
of T4 had to be reduced (1 µg/mL T4). One group (n=6) received continuous T4 treatment 
(w/o recovery), while a second group (n=6) was given a recovery time of one week until T4 
supply continued (recovery). Control mice (n=3) received no treatment. Data are presented 
as mean ±SEM; unpaired two-tailed t-test: *p<0.05, (n=6 time-point/treatment). 
 
T4 treatment results in higher TT4/FT4 concentrations in female than male mice 
As a separate aspect of our study we analysed whether sex impacts the efficacy of 
T4 treatment. This was only studied for the ip mouse group (study 1). Here we 
observed that ip T4 treatment over 6 weeks resulted in significantly higher serum TT4 
(p<0.001) and FT4 (p<0.05) concentrations in female compared to male mice (Fig. 
2). This was also mirrored in sex-dependent difference in weight gain. Thus in female 
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mice, body weight (BW) increased by 21.0% from baseline (p<0.0001) and in male 
mice by 13.7% from baseline (p<0.0001) compared to female and male controls (Fig. 
4a, Supplementary Table 1). Importantly, while baseline body weight was higher in 
male compared to female mice (Supplementary Table 1), no sex-differences in 
serum TT4, FT4 and FT3 concentrations were found at baseline and in the control 
group throughout the experiment (Fig. 2). Body weight changes in control animals 
were in agreement with C57BL/6 wild-type mouse growth charts published by the 
suppliers.  
 
Fig. 4: Change in body weight in mice with ip and oral T4 treatment. Time course of the 
average body weight (BW) taken in the middle of each treatment week (wk) from (a) ip T4 
treated and (b) oral T4 treated groups, as indicated, represented as the percent of baseline. 
Intraperitoneal T4 (ip T4, 1 µg/g BW ip T4 every 48h over 6 weeks) treatment was performed 
in male (M) and female (F) mice and oral T4 was supplied to male mice (oral T4, 5 µg/mL T4 
in Millipore water containing 0.1% BSA continuously over first 3 weeks and 1 µg/mL over last 
4 weeks). Controls received ip PBS injections (ip ctrl). In ip groups from week 2 to 3, a 
change in housing conditions took place in ip treated groups (change from conventional 
cages to individually ventilated cages for all groups). This resulted in a temporary decrease 
in BW in almost all animals. Data are presented as mean ±SEM, unpaired two-tailed t-test: 
*p<0.05, **p<0.01, ***p<0.001, #p<0.0001 (n=6 mice/sex for oral or ip T4 treatment; n=3 
mice/sex as controls). 
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Gene expression in target tissues liver and heart confirms chronic 
hyperthyroid state and shows differences between ip and oral T4 
administration in male mice 
Changes in TH responsive genes [6, 12–16] in liver and heart of animals sacrificed at 
different time points after last ip or oral T4 treatment were analysed and compared to 
ip PBS treated controls (see Fig. 1 for experimental approach, and Supplementary 
Table 2 for all analyzed genes in study 1).  
Changes in TH target gene expression indicating hyperthyroid state in liver and heart 
tissue were consistently found in ip and oral T4 treated animals at 24h after last T4 
supply. Thus, in the ip group significant down-regulation of Tbg (0.014 fold of 
controls, p<0.0001) and up-regulation of Dio1 (5.87 fold of controls, p<0.0001), 
Spot14 (3.11 fold of controls, p<0.05) and Me1 (2.81 fold of controls, p<0.0001) was 
found in liver tissue (Fig. 5a) and significant down-regulation of Myh7 (0.062 fold of 
controls, p<0.0001) and up-regulation of Hcn2 (3.771 fold of controls, p<0.0001) was 
detected in heart (Fig. 5b). Notably, no changes were found for several proposed TH 
target genes including Atp2a2 and Myh6 in heart, illustrating that these genes do not 
quality as markers of chronic thyrotoxicosis (Supplementary Table 3). 
Comparison of liver and heart transcript levels in ip and oral T4 treated male mice 
showed that ip T4 treatment resulted in more pronounced effects on TH target gene 
expression in liver and heart compared to oral T4 treatment (Fig. 5 and 6), including 
up-regulation of Spot14 and Me1 in liver, and down-regulation of Myh7 in heart, 
which were only found in ip treated mice (Fig. 5 and 6). 
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Fig. 5: Timing of T4 injection to animal sacrifice and its impact on TH responsive gene 
expression in (a) liver and (b) heart. (a) Expression levels of Tbg, Spot14, Me1 and Dio1 
were measured by quantitative real-time PCR in liver tissues of mice treated for 6 weeks with 
intraperitoneal T4 (1 µg/g BW ip T4 every 48h) or PBS injections. Gene expression levels of 
mice sacrificed at 24h (n=8 mice), 48h, 72h and 144h (n=4 mice each) after the last T4 
supply are shown as fold-change to PBS treated mice (ctrl, n=4-8 mice). Rn18s, Ppia, 
Rpl13a and β-Actin were used as reference genes. (b) Expression levels of Atp2a2, Myh6, 
Myh7 and Hcn2 were measured by quantitative real-time PCR in heart tissues of mice 
treated for 6 weeks with intraperitoneal T4 (1 µg/g BW ip T4 every 48h) or PBS injections. 
Gene expression levels in tissues of mice sacrificed at 24h (n=8 mice), 48h, 72h and 144h 
(n=4 mice each) after the last T4 supply are shown as fold-change to PBS treated mice (ctrl, 
n=4-8 mice). Rn18s, Polr2a and Rpl32 were used as reference genes. [Data are presented 
  Chapter 2 
40 
 
as fold-changes (mean ±SEM; efficiency-corrected ΔΔCt method, unpaired two-tailed t-test, 
*p<0.05, **p<0.01, ***p<0.001, #p<0.0001)]. 
 
Fig.6: Timing of oral T4 administration and animal sacrifice and its impact on TH 
responsive gene expression in (a) liver and (b) heart. (a) Expression levels of Tbg, 
Spot14, Me1 and Dio1 were measured by quantitative real-time PCR in liver tissues of mice 
after continuous oral T4 treatment (5 µg/mL for the first 3 weeks and 1 µg/mL for the last 4 
weeks). Gene expression levels of male mice sacrificed at 24h, 48h, 72h and 144h (n=3 mice 
each) after the last T4 supply are shown as fold-change to untreated controls (ctrl, n=3 mice). 
Rn18s and Ppia were used as reference genes. (b) Expression levels of Atp2a2, Myh6, 
Myh7 and Hcn2 were measured by quantitative real-time PCR in heart tissues of mice after 
continuous oral T4 supply (5 µg/mL for the first 3 weeks and 1 µg/mL for the last 4 weeks). 
Gene expression levels of male mice sacrificed at 24h, 48h, 72h and 144h (n=3 mice each) 
after the last T4 supply are shown as fold-change to untreated controls (ctrl, n=3 mice). 
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Rn18s and Rpl32 were used as reference genes. [Data are presented as fold-changes 
(mean ±SEM; efficiency-corrected ΔΔCt method, unpaired two-tailed t-test, *p<0.05, 
**p<0.01, ***p<0.001, #p<0.0001)]. 
 
Sex dependent variation in T4 induced TH serum state is not reflected in target 
gene expression in liver and heart. 
Since we found that ip T4 treatment resulted in significantly larger increases in TT4 
and FT4 serum concentrations in female than male mice, we asked whether this is 
paralleled by sex-variation in transcript levels of identified target genes for chronic 
thyrotoxicosis in liver and heart. While we observed a time dependent sex-variation in 
Spot14, Me1 and Dio1 in liver, no sex difference was found for other investigated 
target genes in liver and heart of ip T4 treated male and female mice (Supplementary 
Table 4).  
Timing of T4 administration influences organ thyroid state  
To analyze the sustainability of chronic ip or oral T4 treatment on organ TH state, we 
performed serial mRNA expression analysis of TH responsive genes in liver and 
heart of mice sacrificed at 24h, 48h, 72h and 144h after cessation of ip or oral T4 
supply and compared them to controls undergoing the same protocol (Fig. 1). This 
aspect was relevant to clarify whether after 6/7 weeks chronic treatment, stringent T4 
administration during experimental assessment (e.g. behavioural testing) and for 
organ sacrifice e.g. before or after a weekend-break was still required.  
Generally, the magnitude of T4 induced changes in target gene expression in liver 
and heart was larger at 24h compared to 48h and larger in ip vs. oral T4 treated mice 
(Fig. 5 and 6). In liver tissue, T4 induced down-regulation of Tbg expression and up-
regulation of Me1 was reversed reaching similar expression levels as in controls at 
144h after ip T4 administration (Fig. 5). In contrast, Dio1 expression, while up-
regulated at 24 h, dropped to 0.39-fold of controls at 72h and was suppressed to 
0.02-fold of controls at 144h after cessation of T4 supply (p<0.001, Fig. 5a). 
Furthermore, significant down-regulation of Spot14 became apparent at 72h 
pertaining to 144h after last T4 supply in ip T4 treated mice (Fig. 5a)  
In heart tissue, T4 induced up-regulation of Hcn2 at 24h and 48h (Fig. 5b) normalized 
to control level at 144h after T4 supply (Fig. 5b). Myh7 expression, which was down-
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regulated at 24h and 48h (Fig. 5b), was increased at 72h (p<0.01), and even further 
at 144h (p<0.0001) after cessation of T4 supply (Fig. 5b).  
Atp2a2 and Myh6 expression in heart, while not affected by T4 treatment (Fig. 5b), 
was significantly down-regulated at 72h (p<0.05 for Atp2a2 and p<0.01 for Myh6 in ip 
and oral T4-treatment) and 144h after cessation of T4 supply (p<0.0001 for Atp2a2 in 
ip and p<0.05 in oral treated mice; p<0.0001 for Myh6/treatment) (Fig. 5 and 6).  
2.5 Discussion 
In the present study we tested the efficacy of intraperitoneal vs. continuous oral T4 
supply for induction of chronic hyperthyroidism. Furthermore we asked whether sex 
has an impact on the efficacy of chronic T4 treatment in mice.  
Based on the available literature, describing ranges from 0.6 µg/g BW T4 [17] to 10 
µg/g BW T4 [18] for longer-term (30 days) or short-term (8 days) treatment, 
respectively, we decided to administer 1 µg/g BW T4 every other day over a period of 
6 weeks to induce and maintain hyperthyroidism in a mouse organism. This dose 
equals approximately 50 fold of daily T4 production rate, assuming that thyroidal 
secretion of T4 in mice is similar to that described for rats (approx. 10 ng/g BW/day) 
[6]. For comparison the dosage for oral T4 supply was calculated based on the 
weekly injected T4 amount in the ip T4 group. Here we initially assumed that the 
biological availability of orally ingested T4 in mice equals that described for humans, 
namely 65% for oral T4 intake [11]. In the literature, similar concentrations of orally 
supplied T4 are depicted for mice and rats, ranging from 2 µg/mL [19] to 12 µg/mL 
[20, 21]. T4 monotherapy was selected over T3 or T4/T3 combination therapy, since 
T4 has been the most widely used iodothyronine in (hyperthyroid) animal 
experiments, and allows for the assessment of T4 to T3 conversion in a living 
organism. Furthermore, levothyroxine is standard in patients requiring TH 
substitution.  
Both ip and oral T4 treatment resulted in induction of hyperthyroidism in mice with 
markedly elevated serum TT4, FT4 and FT3 concentrations after 2 weeks of 
treatment and throughout the entire treatment period. Contrary to our expectations, 
oral T4 supply (5 µg/mL) was well absorbed in mice so that the dosage had to be 
reduced because severe thyrotoxicosis occurred. Discontinuation and/or lowering of 
oral T4 dosage resulted in rapid and proportional adjustment of serum TH 
concentrations in mice illustrating that serum TH state can be tightly manipulated by 
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the oral T4 dose. In summary, 1 µg/g BW T4 injection every 48h or continuous supply 
of 1 µg/mL T4 in drinking water led to comparable TT4, FT4 and FT3 concentrations 
in mice at the end of experiment and both dosages were well tolerated. On the tissue 
level, the magnitude of T4 induced changes in target gene expression in liver and 
heart was larger in ip vs. oral T4 treated mice suggesting more pronounced tissue 
thyrotoxicosis at time of sacrifice in the ip treated animals. For this reason we 
decided to compare the sustainability of tissue thyrotoxicosis in order to ensure 
hyperthyroid state during characterization of mice and for organ sacrifice. To this aim 
we performed sequential analysis of TH target gene expression in liver and heart of 
mice sacrificed at 24h, 48h, 72h and 144h after last ip or oral T4 treatment. We found 
indication for a transient hypothyroid organ state if the ip or oral T4 dosing interval 
exceeded 48h. A likely explanation for this observation could be a suppressed 
pituitary-thyroid axis in mice under chronic T4 treatment. Abrupt cessation of chronic 
T4 supply could hence lead to temporary secondary hypothyroidism. The strength of 
these effects on gene expression in target organs varied between different TH target 
genes in liver and heart. However, from the data it is apparent that ip T4 dosing 
interval in mice should not exceed 24-48h. Furthermore, we are convinced that the 
discontinuation of oral T4 supply prior to animal sacrifice is a likely explanation for the 
reduced magnitude in changes in target gene expression in oral T4 vs ip T4 treated 
mice since in the latter the T4 loading dose is much higher. Hence we strongly 
suggest that continuous T4 supply is mandatory during experimental procedure and 
until organ sacrifice.  
Since sex could potentially impact efficacy of T4 treatment protocols for induction of 
hyperthyroidism, we included male and female mice in our analysis. We found that ip 
T4 treatment resulted in significantly higher TT4 and FT4 concentrations in female 
compared to male mice. We expect that this sex-difference may also hold true for 
oral T4 treatment, which was however not tested. Baseline TH serum status prior to 
start of experiments and TH status in control animals at the end of experiment did not 
differ for male and female mice, suggesting a sex-dependent, most likely estrogen-
dependent difference in metabolism of exogenously supplied T4. Ongoing 
experiments in gonadectomized mice will help to clarify this issue. Of note, the sex-
dependent change in TH serum status with ip T4 treatment did not proportionally 
transfer into TH target gene expression in liver and heart, showing that TH action in a 
living organism is more complex. Thus, besides biochemical assessment of serum 
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TH concentration, further functional and tissue specific markers need to be 
incorporated to assess thyroid state correctly. In this context another finding of our 
study was that several widely proposed TH target genes did not quality as markers of 
chronic organ thyrotoxicosis (Supplementary Table 3) underlining the necessity for 
careful selection of markers that adequately reflect tissue TH action.  
In summary, intraperitoneal and oral T4 administration are reliable, safe and well-
tolerated methods to induce chronic hyperthyroidism reflected by serum T4/T3 
thyrotoxicosis in mice. Thereby ip T4 injection intervals should not exceed 24-48h 
and T4 must be continuously administered to ensure a stable hyperthyroid tissue 
state. Male and female mice show sex-dependent variance in hyperthyroid serum 
status and we propose that this may be linked to estrogen-dependent altered 
metabolism and/or protein binding of exogenously administered T4.   
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Supplemental Tables  
Supplemental Table 1. Mean body weight (BW) in g of ip groups at start of experiments 
(BW start) and after six weeks of T4 or control treatment (BW final).  
Male and female mice were subjected to intraperitoneal T4 (ip T4, 1 µg/g BW ip T4 every 
48h over 6 weeks). Controls received ip PBS injections (ip ctrl) over 6 weeks. Data are 
presented as mean ±SEM. 
treatment ip T4 ip ctrl 
sex male 
(n=6) 
female 
(n=6) 
male 
(n=3) 
female 
(n=3) 
BW start 26.8 ± 0.6 19.3 ± 0.2 26.7 ± 0.2 21.8 ± 1.4 
BW final 30.5 ± 0.7 23.4 ± 0.5 26.9 ± 0.2 24.1 ± 1.1 
BW gain 3.7 ± 0.9 4.1 ± 0.5 0.2 ± 0.3 2.3 ± 1.8 
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Supplemental Table 2. Oligonucleotides used for amplification of house-keeping 
genes and putative TH responsive genes in RT-PCR. 
gene Accession 
number 
forward primer reverse primer 
Rn18s NR_003278.3 CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT 
Ppia NM_008907.7 CTTGGGCCGCGTCTCCTTCG GCGTGTAAAGTCACCACCCTG
GC Rpl13a NM_009438.5 GGGCAGGTTCTGGTATTGGA GGGTTGGTATTCAATCCGCT 
β-Actin NM_007393.3 CTGTCGAGTCGCGTCCA TCATCCATGGCGAACTGGTG 
Polr2a NM_001291068.
1 
CTTTGAGGAAACGGTGGATGTC TCCCTTCATCGGGTCACTCT 
Rpl32 NM_172086.2 CACCAGTGAGACCGATATGTGAA
AA 
TGTTGTCAATGCCTCTGGGTTT 
Tbg NM_177920.5 TGGGCATGTGCTATCATCTTCA GAGTGGCATTTTGTTGGGGC 
Spot14 NM_009381.2 GAGGTGACGCGGAAATACCA TGTCCAGGTCTCGGGTTGAT 
Me1 NM_001198933.
1 
TAAGGGTCGTGCATCTCTCAC TGCAGCAACTCCTATGAGGG 
Dio1 NM_007860.3 GGGCAGGATCTGCTACAAGG CGTGTCTAGGTGGAGTGCAA 
Klf9 NM_010638.4 GAAACACGCCTCCGAAAAGAG AGCGCGAGAACTTTTTAAGGC 
Hif1α NM_010431.2 GTGACCATGAGGAAATGAGAGAA
A 
CACGTTGCTGACTTGATGTTCA 
Fasn NM_007988.3 TGCCCGAGTCAGAGAACCTA TAGAGCCCAGCCTACATCT 
Bcl3 NM_033601.3 CTGAACCTGCCTACTCACCC AGTATTCGGTAGACAGCGGC 
Slc27a
2 
NM_011978.2 GTCACTTTTACCACGCCAGC GCCGTGATTCCACTCGACAT 
Slc2a1 NM_011400.3 TCTTCGAGAAGGCAGGTGTG CGCTCTACAACAAACAGCGAC 
St6gal
1 
NM_145933.4 CCATCCGCCTAGTGAACTCTC TCTGGCTTCTGATACCACTGC 
Igfbp1 NM_008341.4 TGCCAAACTGCAACAAGAATGG CCAGGGATTTTCTTTCCACTCC 
Adrb2 NM_007420.2 ACTTCTGGTGCGAGTTCTGG GCTCTGGTACTTGAAGGGCG 
Pfkl NM_008826.4 ACCTCTCATGGAGTGTGTGC GGTGGGCAAGGAGCTTGTAA 
Rcan2 NM_207649.1 GAAGCCTATCAGCGATGCCA CTGTCACACACATGAACCAC 
Uqcrh NM_025641.3 CTACTCTGGTTGCGCTTGTTG CACTGTTGTTAGGGGGTCCA 
Mlxipl NM_021455.4 GGACAAGATCCGGCTGAACA CAGGTTTCCGGTGCTCATCT 
Atp2a2 NM_001110140.
3 
AACTACCTGGAACAACCCGC TCATGCAGAGGGCTGGTAGA 
Myh6 NM_010856.4 CAGACAGAGATTTCTCCAACCCA GCCTCTAGGCGTTCCTTCTC 
Myh7 NM_080728.2 CACGTTTGAGAATCCAAGGCTC CTCCTTCTCAGACTTCCGCA 
Hcn2 NM_008226.2 CCAGTCCCTGGATTCGTCAC TCACAATCTCCTCACGCAGT 
House-keeping genes: Rn18s: 18S ribosomal RNA; Ppia: peptidylprolyl isomerase A; 
Rpl13a: ribosomal protein L13A; β-Actin: beta-actin; Polr2a: polymerase (RNA) II (DNA 
directed) polypeptide A; Rpl32: ribosomal protein L32; putative TH target genes in liver: 
Tbg: thyroxine binding globulin; Dio1: deiodinase 1; Spot14: thyroid hormone-responsive 
Spot14 homolog; Me1: malic enzyme 1; Klf9: Kruppel-like factor 9; Hif1α: hypoxia-inducible 
factor 1 alpha; Fasn: fatty acid synthase; Bcl3: B cell leukemia/lymphoma 3; Slc27a2: solute 
carrier family 27 (fatty acid transporter) member 2; Slc2a1: solute carrier family 2 (facilitated 
glucose transporter) member 1 (GLUT-1); St6gal1: beta galactoside alpha 2,6 
sialyltransferase 1; Igfbp1: insulin-like growth factor binding protein 1; Adrb2: adrenergic 
receptor; Pfkl: beta 2, phosphofructokinase, liver, B-type; Rcan2: regulator of calcineurin 2; 
Uqcrh: ubiquinol-cytochrome c reductase hinge protein; Mlxipl: MLX interacting protein-like; 
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putative TH target genes in heart: Atp2a2: sarcoplasmic/endoplasmic reticulum Ca 2+ -
ATPase; Myh6: myosin, heavy polypeptide 6; Myh7: myosin, heavy polypeptide 7; Hcn2: 
hyperpolarization-activated, cyclic nucleotide-gated K+ 2. 
 
Supplemental Table 3. Changes in mRNA expression of putative TH responsive genes 
in liver and heart tissues of animals receiving ip T4 treatment compared to controls. 
Animals were sacrificed at 48h after last ip T4 or control treatment. 
organ gene 
fold-change 
ip T4/ 
ip control 
Expected regulation in 
hyperthyroidism 
liver 
Tbg 0.07 ± 0.02 ↓ 
Spot14 1.16 ± 0.05 ↑ 
Me1 1.94 ± 0.06 ↑ 
Dio1 3.48 ± 0.12 ↑ 
Klf9 1.51 ± 0.10 ↑ 
Hif1α 1.30 ± 0.06 ↑ 
Fasn 0.70 ± 0.05 ↑ 
Bcl3 0.96 ± 0.09 ↑ 
Slc27a2 1.34 ± 0.08 ↑ 
Slc2a1 1.33 ± 0.13 ↑ 
St6gal1 0.87 ± 0.06 ↓ 
Igfbp1 3.62 ± 0.53 ↑ 
Adrb2 3.24 ± 1.22 ↑ 
Pfkl 0.95 ± 0.10 ↑ 
Rcan2 1.56 ± 0.17 ↑ 
Uqcrh 0.94 ± 0.05 ↑ 
Mlxipl 0.60 ± 0.04 ↑ 
 
heart 
Atp2a2 0.90 ± 0.02 ↑ 
Myh6 0.84 ± 0.04 ↑ 
Myh7 0.13 ± 0.01 ↓ 
Hcn2 2.93 ± 0.09 ↑ 
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Supplemental Table 4. Changes in mRNA expression of putative TH responsive genes 
in liver and heart tissues of male or female mice with ip T4 treatment (1 µg/g BW T4 
every 48h over 6 weeks) compared to male or female controls (ip PBS injections every 
48h over 6 weeks). Animals were sacrificed at 24h or 48h after last ip T4 treatment, as 
indicated. 
organ gene 
fold-change ip T4 / ip control 
male (n=4) 
24h ip T4 
female (n=4) 
24h ip T4 
male (n=2) 
48h ip T4 
female (n=2) 
48h ip T4 
liver 
Tbg 0.01 ± 0.003 0.02 ± 0.004 0.08 ± 0.01 0.06 ± 0.03 
Spot14 1.83 ± 0.08 5.29 ± 0.25 1.53 ± 0.09 0.90 ± 0.03 
Me1 1.75 ± 0.07 4.50 ± 0.69 2.57 ± 0.13 1.51 ± 0.07 
Dio1 6.02 ± 0.16 5.73 ± 0.25 5.31 ± 0.18 2.81 ± 0.09 
heart 
Atp2a2 0.85 ± 0.02 0.95 ± 0.05 0.92 ± 0.02 0.89 ± 0.03 
Myh6 0.83 ± 0.02 1.02 ± 0.03 0.94 ± 0.05 0.78 ± 0.05 
Myh7 0.08 ± 0.01 0.05 ± 0.005 0.06 ± 0.002 0.27 ± 0.01 
Hcn2 4.42 ± 0.54 3.22 ± 0.41 3.42 ± 0.09 2.56 ± 0.11 
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3.1 Abstract  
Background: Thyroid dysfunction is more common in the female population, 
however the impact of sex on disease characteristics has rarely been addressed. 
Using a murine model, we asked whether sex has an influence on phenotypes, 
thyroid hormone status and thyroid hormone tissue response in hyper- and 
hypothyroidism. 
Methods: Hypo- and hyperthyroidism were induced in 5 months old female and male 
wildtype C57BL/6N mice, by LoI/MMI/ClO4- or T4 ip treatment over 7 weeks, control 
animals underwent sham treatment (N=8 animals/sex/treatment). Animals were 
investigated for impact of sex on body weight, food and water intake, body 
temperature, heart rate, behaviour (locomotor activity, motor coordination and 
strength), liver function, serum thyroid hormone status and cellular TH effects on 
gene expression in brown adipose tissue, heart and liver. 
Results: Male and female mice showed significant differences in behavioural, 
functional, metabolic, biochemical and molecular traits of hyper- and hypothyroidism. 
Hyperthyroidism resulted in increased locomotor activity in female mice, but 
decreased muscle strength and motor coordination preferably in male animals. 
Hypothyroidism led to increased water intake in male but not female mice and 
significantly higher serum cholesterol in male mice. Natural sex-differences in body 
temperature, body weight gain, food and water intake were preserved under 
hyperthyroid conditions. In contrast, natural sex-differences in heart rate disappeared 
with TH excess and deprivation. The variations of hyper- or hypothyroid traits of male 
and female mice were not explained by classical T3/T4 serum state. TH serum 
concentrations were significantly increased in female mice under hyperthyroidism, 
but no sex-differences were found under eu- or hypothyroid conditions. Interestingly, 
analysis of expression of TH target genes and TH transporters revealed little sex-
dependency in heart, while sex-differences in target genes were present in liver and 
brown adipose tissue in line with altered functional and metabolic traits of hyper- and 
hypothyroidism. 
Conclusions: These data demonstrate that the phenotypes of hypo- and 
hyperthyroidism differ between male and female mice and indicate that sex is an 
important modifier of phenotypic manifestations. 
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Keywords: thyroid hormone transport, thyroid hormone action, hyperthyroidism, 
hypothyroidism, sex-difference, sex steroid hormone, mice 
3.2 Background 
Thyroid dysfunction, i.e. hyper- or hypothyroidism, occurs with 2-9 fold higher 
prevalence in women [1], yet besides fertility aspects and bone metabolism, a 
possible impact of gender on disease characteristics has not been well studied, 
neither in the clinical setting nor in epidemiological cohorts.  
Experimental approaches using murine animal models to study thyroid hormone (TH) 
action so far mostly include mice of only one sex or, occasionally, do not even 
specify the mouse sex. A momentum calling for increased awareness of sex-impact 
on manifestation, prognosis and treatment of diseases was published in Nature in 
2014 and was afterwards re-emphasized by the Endocrine Society [2, 3]. 
Furthermore, the “Guide to investigating thyroid hormone economy and action in 
rodent and cell models analysis of TH action“ published by the American Thyroid 
Association in 2013 advised to study male and female rodents separately as the 
response to TH may be sexually dimorphic [4].  
In view of the clinical situation where both women and men are affected by hyper- 
and hypothyroidism and consequences of disease may be gender-specific, we 
decided to employ a murine animal model, in which TH function status can be easily 
manipulated, for a comprehensive characterization of sex-impact on TH action. 
Hence male and female mice were studied for changes in behavioural, functional, 
metabolic and biochemical markers in addition to analysis of cellular TH effects on 
gene expression in selected target organs brown adipose tissue (BAT), heart and 
liver under conditions of TH excess and deprivation.  
 
Fig. 1: Study design for phenotypic characterization of hyper- and hypothyroidism in 
female and male mice. Two weeks were used to study the euthyroid control state of male 
and female mice (run-in period), followed by 3 weeks induction period without experiments 
other than monitoring body weight, food and water intake. After the induction period, male 
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and female mice were analysed under hyper- and hypothyroid conditions over a period of 4 
weeks and compared to sham treated controls.  
  Chapter 3 
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3.3 Materials and Methods 
Animals and study design 
Male and female C57BL/6NTac (N=8/sex/treatment; Taconic Europe A/S, Denmark) 
mice aged 5 months were housed in temperature- (23 ±1°C) and light-controlled 
(inverse 12:12 hour light-dark cycle) conditions. Food and water were provided ad 
libitum. All animal experiments were performed in accordance with the German 
regulations for Laboratory Animal Science (GVSOLAS) and the European Health 
Law of the Federation of Laboratory Animal Science Associations (FELASA). The 
protocols for animal studies were approved by the Landesamt für Natur, Umwelt und 
Verbraucherschutz Nordrhein-Westfalen (LANUV-NRW). All efforts were made to 
minimize suffering. 
The nine-week experimental period was divided into three parts (Fig. 1), consisting of 
a 2-week run-in period prior to manipulation of thyroid status to phenotypically 
characterize each individual mouse (pre-assessment), a 3-week treatment period to 
induce hyper- or hypothyroidism, and a 4-week assessment period to repeat the 
phenotypic characterization of each individual animal under chronic TH manipulation 
or euthyroid control treatment. 
Chronic hyperthyroidism and hypothyroidism were induced as previously described 
[5, 6]. Briefly, for hyperthyroidism i.p. injections of 1 μg/g body weight T4 (Sigma-
Aldrich (T2376), USA) were performed every 48h. For induction of chronic 
hypothyroidism, animals were fed a low-iodine diet (LoI; TD.95007, Harlan 
Laboratories, USA) and received drinking water supplemented with 0.02% 
methimazole (MMI, Sigma-Aldrich (301507), USA), 0.5% sodium perchlorate (ClO4-) 
(Sigma-Aldrich (310514), USA) and 0.3% saccharine as sweetener (Sigma-Aldrich 
(240931), USA) (LoI/MMI/ClO4-). In addition, hypothyroid animals received i.p. 
injections of PBS every 48 hours. Control animals were fed a control diet and 
received i.p. injections of PBS every 48 hours. 
Blood sample collection, serum TH and cholesterol measurements 
Final blood samples were stored 30 min on ice, centrifuged and free triiodothyronine 
(fT3), free thyroxine (fT4) and total T4 (TT4) concentrations in serum of mice were 
measured using commercial ELISA kits according to the manufacturer's instructions 
(DRG Instruments GmbH, Marburg, Germany). Detection limits were 0.5 µg/dL, 
0.05 ng/dL and 0.05 pg/mL for TT4, fT4 and fT3, respectively. Serum TSH was 
measured with a sensitive, heterologous, disequilibrium double-antibody precipitation 
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radioimmunoassay with a detection limit of 10mU/L [7] (kindly performed by the 
laboratory of Prof. Refetoff at the University of Chicago, Chicago, USA). Total 
cholesterol concentrations in serum were detected using an enzymatic cholesterol 
quantitation kit (Sigma-Aldrich (MAK043), USA) according to the manufacturer’s 
instructions. Total triglyceride concentrations in serum were detected using an 
enzymatic serum triglyceride determination kit (Sigma-Aldrich (TR0100), USA) 
according to the manufacturer´s instructions. 
Monitoring of body weight, food and water intake 
Body weight was measured two to three times a week by placing mice on a scale. 
Food consumption was determined once a week by measuring the weight of 
remaining food pellets in the metal cage top. Water intake was controlled by 
weighting of water bottles (for all to the nearest 0.1g) weekly or twice per week in 
control and TH manipulated groups. Male mice were caged individually, while female 
mice were kept in groups of three to four animals. Thereby food and water intake of 
female mice was calculated by dividing the measured intake by the number of 
animals in each cage. 
For each mouse, average daily food and water intake was calculated, and 
adjustments for body weight were derived by dividing average intake by the average 
body weight, and multiplying the result by 40 g. 
Measurement of body temperature 
Body temperature of mice was assessed four times using a cream-covered rectal 
probe (RET-3 rectal probe for mice, Kent Scientific Corporation, USA) connected to a 
thermocouple thermometer (Acorn Temp JKT Thermocouple Meter, Kent Scientific 
Corporation, USA). Mice were placed on the top of the cage and the rectal probe was 
carefully inserted 2 cm into the rectum until a steady temperature was measured, 
which took approximately 8 to 10 sec. 
Measurement of heart rate 
Non-invasive restrained ECG recording was performed using an in-house protocol 
[8]. Conscious mice were placed on a platform with their paws on silver electrodes 
and were restrained by a half-tunnel. Signal was derived, enhanced and digitalized 
(Picoscope 2204, Pico Technology, United Kingdom). ECG was recorded using 
Picoscope 6 Software over 60-90 sec and heart rate was determined by 
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measurements of RR intervals over 8 sec in a stable steady state. Non-invasive 
restrained ECG was recorded 3 times in all animals. 
Collection of organs 
As previously described [5, 6] animals were euthanized 24 hours after the last T4 
treatment or continuous TH deprivation. Liver, heart and BAT were isolated and 
stored at -80 °C until further processing. 
Isolation of RNA, cDNA synthesis and real-time PCR 
RNA extraction was performed as previously described [5, 6]. Briefly, total RNA was 
extracted using RNeasy mini kit (Qiagen, Germany) and reversed transcribed using 
SuperScript III First-Strand Synthesis System for RT-PCR according to instruction 
manuals (Life Technologies, Germany). Exon spanning primers for amplification of 
TH responsive genes (suppl. table 1) were designed using PrimerBlast (NCBI) and 
synthesized by Eurofins (Eurofins MWG Synthesis, Germany). Quantitative real-time 
PCR (qRT-PCR) was performed using LightCycler® DNA Master SYBR Green I and 
the LightCycler®480 System (Roche, Germany). The PCR program consisted of an 
initial denaturation step (5 min at 95 °C) and 40 amplification cycles with 15 sec at 95 
°C, 10 sec at 60 °C, 20 sec at 72 °C.  
For normalization of gene expression reference genes 18S, Ppia (peptidylprolyl 
isomerase A, cyclophilin A) and Rpl13 a (ribosomal protein L13a) for liver, 18S, 
Gapdh (glyceraldehyde-3-phosphate dehydrogenase) and Polr2a (polymerase RNA 
II) for heart and 18S, Ppia and Gapdh for BAT were used. The following genes were 
studied as TH responsive: Dio1 (deiodinase 1), Dio2 (deiodinase 2), Tbg (thyroxine-
binding globulin), Me1 (malic enzyme 1), Myh6 (myosin heavy chain 6), Hcn4 
(hyperpolarization activated cyclic nucleotide gated potassium channel 4), Ucp1 
(uncoupling protein 1) and Pgc1α (peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha) [4, 9-11]. To calculate the relative quantification ratio an 
efficiency corrected calculation model was used [12-14]. 
Behavioural tests 
Rotarod test 
The rotarod test [15] basically consists of five 3 cm diameter cylinders, enabling five 
mice to be tested simultaneously. On the first testing day, mice were allowed to 
acclimate to the rotarod test by letting them walk 6 min on the rotating cylinder with 
constant acceleration from 2-20 rpm. 
  Chapter 3 
58 
 
For each rotarod session mice were subjected to 4 trials, with a minimum resting time 
interval of 6 min between the trials. Rotation mode was switched to constant 
acceleration from 4-50 rpm within 5 min. Maximum time and speed mastered by the 
animal was recorded. Mice that fell off the rod or attained full speed were placed 
back to their home cages. Every animal was subjected to two rotarod sessions (with 
a suspension period of 7 days) each before and after induction of thyroid dysfunction 
(4 sessions with 16 trials in total). Sessions 2 and 4 were used for statistical analysis. 
Chimney test 
The chimney test is constituted of a plastic tube (length 30 cm, diameter 3 cm). Mice 
were placed inside the tube and allowed to reach the other end. Then the tube was 
turned into a vertical position with mice head upside down. The test consisted of 
determining the time taken by mice to climb up to 25 cm of height. Mice were given 
90 sec of time to pass the test [16, 17]. 
Open Field 
Open field consisted of a closed square area made of Plexiglas (50 x 50 cm). The 
area was divided in 4 corners, 4 walls and a center region (16 x 16 cm). Animals 
were tested in the dark phase of their dark/light cycle. Mice were placed in the center 
of the open field and allowed to move freely for 5 min. Movements were monitored 
and digitalized by VideoMot2 software. Software recorded entries in all areas 
including time, frequency, latency and distance. Occurring events of rearing, freezing, 
grooming and jumping were recorded manually by the investigator during the 
experiment. Mice were placed in their home cages after 5 min of exploring the area. 
Statistical analysis 
All data are shown as means ± standard deviation (SD) or standard error of the mean 
(SEM), as indicated. Statistical analysis using GraphPad Prism 6 Software was 
performed. Two-way Anova was used to compare more than two groups, followed by 
the Bonferroni post-hoc analysis. The effects of both thyroid dysfunctions are often 
opposing and inclusion of both treatments would therefore always show a significant 
treatment effect. To prevent false positive results statistical analysis of treatment 
groups were performed separately for hyper- and hypothyroid groups.  Unpaired 
Student´s t-test to compare differences between two groups was applied. Values of 
*p<0.05, **p<0.01, ***p<0.001 were considered statistically significant. 
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3.4 Results 
Sex modifies the impact of TH on body weight, food and water consumption, 
body temperature and heart rate in hyper- and hypothyroid state  
Male mice showed significantly increased body weight (BW) compared to female 
mice under euthyroid and hyperthyroid conditions (Fig. 2A, B). For euthyroid mice 
highest Δ BW was observed in week 9, m: <16.5% and f: <5.9% (F(17,252)=9.003, 
p<0.0001 for time effect and F(1,252)=67.18, p<0.0001 for sex effect, interaction: 
F(17,252)=4.065, p<0.0001). Similarly, for hyperthyroid mice highest Δ BW was 
observed in week 9, m: <29.6% vs f: <16.5% (F(17,252)=33.43, p<0.0001 for time effect 
and F(1,252)=88.28, p<0.0001 for sex effect, interaction F(17,252)=3.966, p<0.0001). In 
contrast sex-difference in body weight gain disappeared in hypothyroidism except for 
occasional time points in week 3, 5 and 9 (highes tΔ BW m: ~2% at week 9 vs 
f: ~0.7% at week 9, F(17,252)=2.055, p=0.0093 for time effect and F(1,252)=52.98, 
p<0.0001 for sex effect with no interaction F(17,252)=1.614, p=0.0605, Fig. 2C). 
Euthyroid female mice consumed more food (m: ~4.5 vs f: ~5 g/g BW*40g) and water 
(m: ~4.8 vs f: ~6 ml/g BW*40g) than male mice (Fig. 2D, G; food intake: 
F(8,126)=61.77, p<0.0001 for time effect and F(1,126)=121.7, p<0.0001 for sex effect, 
interaction: F(8,126)=3.469, p=0.0012; water intake: F(8,126)=31.92, p<0.0001 for time 
effect and F(1,126)=385.3, p<0.0001 for sex effect, interaction: F(8,126)=3.342, 
p=0.0017). T4 administration enhanced food (m: ~5.5 vs f: ~6.5 g/g BW*40g) and 
water intake (m: ~6 vs f: ~7.5 ml/g BW*40g) in both sexes, again significantly more 
pronounced in female mice (Fig. 2E, H; food intake: F(8,126)=11.56, p<0.0001 for time 
effect and F(1,126)=78.90, p<0.0001 for sex effect, interaction: F(8,126)=5.721, 
p<0.0001, water intake: F(8,126)=7.898, p<0.0001 for time effect and F(1,126)=90.29, 
p<0.0001 for sex effect, interaction: F(8,126)=3.170, p=0.0026). Hypothyroidism 
abolished sex-difference in food intake (m: ~5 vs f: ~4.8 g/g BW*40g, F(8,126)=9.004, 
p<0.0001 for time effect and F(1,126)=15.25, p=0.0002 for sex effect, interaction: 
F(8,126)=9.393, p<0.0001, Fig. 2F) and reversed sex-difference in water consumption 
with female mice showing significantly less water intake (m: ~6.8 vs f: ~4 ml/g 
BW*40g, F(8,126)=13.55, p<0.0001 for time effect and F(1,126)=90.96, p<0.0001 for sex 
effect, interaction: F(8,126)=34.92, p<0.0001 , Fig. 2I). 
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Fig. 2: Body weight change, food and water intake in euthyroid, T4 or LoI/MMI/ClO4- 
treated mice. Time course of the average body weight (BW) of male and female mice over 
an experimental period of 9 weeks under (A) control, (B) T4 and (C) LoI/MMI/ClO4- treatment. 
Average food intake was related to BW during experiment in (D) euthyroid, (E) hyperthyroid 
and (F) hypothyroid conditions in mice of both sexes. After run-in period mice were placed on 
low iodine diet for induction of hypothyroidism, or on control iodine diet by the same supplier 
to adapt the nutritional intake (euthyroid and hyperthyroid groups). Arrows indicate start of 
treatment. Time course of average water intake was monitored over the experimental period 
of 9 weeks under (G) control, (H) TH excess and (I) TH deprivation of male and female mice. 
Data are presented as mean ± SD, N = 8 animals/sex/treatment/time point; 2-way ANOVA 
followed by Bonferroni post-hoc analysis applied for time and sex effects, *p<0.05, **p<0.01, 
***p<0.001 above graph represent multiple-testing results. 
 
Body temperature, measured by a rectal probe, was higher in euthyroid female 
compared to male mice (m: ~37.5 vs f: ~38.2°C, p<0.05). This sex difference 
persisted during T4 administration (m: ~38.1 vs f: ~38.8°C, p<0.05, F(1,28)=21.23, 
p<0.0001 for sex effect, F(1,28)=16.50, p=0.0004 for treatment effect and 
F(1,28)=0.04857, p=0.8272 for interaction) and LoI/MMI/ClO4- treatment (m: ~37.2 vs f: 
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~38.2°C, p<0.01, F(1,28)=25.77, p<0.0001 for sex effect, F(1,28)=0.9667, p=0.3339 for 
treatment effect and F(1,28)=0.7794, p=0.3848 for interaction, Fig. 3A). Interestingly, a 
drop in body temperature was only observed in male but not female hypothyroid mice 
compared to euthyroid controls.  
Non-invasive ECG measurements were performed to investigate the influence of TH 
on heart rate (HR). Euthyroid female animals showed higher HR than male mice (m: 
~704 vs f: ~738 bpm, p<0.05). Sex-difference in HR disappeared with TH excess (m: 
~770 vs f: ~782 bpm, F(1,28)=5.837, p=0.0225 for sex effect, F(1,28)=32.65, p<0.0001 
for treatment effect and F(1,28)=1.306, p=0.2628 for interaction) or deprivation (m: 
~564 vs f: ~577 bpm, F(1,28)=5.586, p=0.0253 for sex effect, F(1,28)=227.2, p<0.0001 
for treatment effect and F(1,28)=1.099, p=0.3034 for interaction, Fig. 3B).  
 
Fig. 3: Influence of sex and change of TH serum concentrations on body temperature 
and heart rate. (A) Body temperature was assessed by rectal temperature measurements 
and (B) non-invasive ECG was performed on conscious mice of both sexes under euthyroid, 
hyperthyroid and hypothyroid conditions. Data are presented as mean ± SD, N= 8 
animals/sex/treatment; 2-way ANOVA followed by Bonferroni post-hoc analysis applied for 
treatment and sex effects, *p<0.05, **p<0.01, ***p<0.001 above bars represent multiple-
testing results.   
 
Male mice show pronounced impairment of muscle function and coordination 
while female mice exhibit increased activity under TH excess 
Muscle strength, tonus and coordination of movements were examined by the 
chimney test. In general, female mice showed better performance in climbing up the 
tube than male mice (m: ~26.57 vs f: ~7.4 sec, Fig. 4A). Hyper- and hypothyroidism 
resulted in decrease of muscle strength and coordination in female, but even more 
strikingly in male mice (m: ~80.13 vs f: ~27.11 sec, p<0.001, F(1,28)=23.94, p<0.0001 
  Chapter 3 
62 
 
for sex effect, F(1,28)=24.66, p<0.0001 for treatment effect and F(1,28)=5.266, p=0.0294 
for interaction (hyper) and m: ~60.71 vs. f: ~9.97 sec, p<0.05, F(1,28)=19.23, p=0.0001 
for sex effect, F(1,28)=5.3, p=0.029 for treatment effect and F(1,28)=3.923, p=0.0575 for 
interaction (hypo)). Of note, performance in the chimney test was more impaired 
under TH excess than TH deprivation.  
To investigate changes in activity and exploration behaviour an open field test was 
used. Overall activity was measured by total distance travelled, while exploration was 
quantified by the frequency of rearing events. Control animals showed no sex 
difference in open field parameters. Interestingly, T4 excess resulted in increased 
activity and exploratory behaviour in only female mice (m: Δ~257.9 cm vs f: 
Δ~1243.2 cm, p<0.001 and m: Δ~8.6 vs f: Δ~16.6 counts, p=0.05), whereas 
LoI/MMI/ClO4- treatment led to a decreased activity in male mice only (m: Δ~ 805.4 
cm, vs f: Δ~227.2 cm, p<0.01, Fig. 4B, C). Sex effect under hyperthyroidism was not 
significant (F(1,28)=3.164, p=0.0861 for activity, F(1,28)=0.6493, p=0.4272 for 
exploratory behaviour) but treatment effect reached statistical significance 
(F(1,28)=7.6, p=0.0102 for activity and F(1,28)=10.60, p=0.0030 for exploratory 
behaviour). Their interaction was significant for activity (F(1,28)=17.64, p=0.0002), but 
not for exploratory behaviour (F(1,28)=1.064, p=0.3112). While under hypothyroidism 
no sex effect was found (F(1,28)=0.9943, p=0.3272 for activity and F(1,28)=0.8467, 
p=0.3654 for exploratory behaviour), treatment effect was significant (F(1,28)=12.86, 
p=0.0013 for activity and F(1,28)=9.231, p=0.0051 for exploratory behaviour). 
Furthermore we found an interaction between sex and treatment on exploratory 
behaviour (F(1,28)=8.406, p=0.0072), but not on activity (F(1,28)=4.033, p=0.0544). 
In contrast to these sex-specific modulations of TH impact on behaviour, no sex 
differences were noted for male and female mice on the rotarod test under eu-, 
hyper- and hypothyroid conditions (Fig. 4D-F).  
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Fig. 4: Behavioural assessment of male and female mice under T4 excess or 
deprivation. The chimney test was used to (A) examine muscle strength, tonus and 
coordination of movements in male and female mice under euthyroid, hyper- or hypothyroid 
conditions. The open field was used to investigate activity and exploration behaviour. (B) 
Total distance travelled was measured to assess activity and (C) frequency of rearings were 
determined to assess exploratory behaviour. The rotarod test was used for an overall 
assessment of coordination and motor function in male and female mice before start of 
treatment (training period) and under sham (D), (E) T4 or (F) LoI/MMI/ClO4- treatment. Data 
are presented as mean ± SD, N= 8 animals/sex/treatment; 2-way ANOVA followed by 
Bonferroni post-hoc analysis applied for sex and treatment effects of A-C and unpaired 
Student´s t-test for sex-effect of D-F,  *p<0.05, **p<0.01, ***p<0.001 represent multiple-
testing or t-test results. 
 
Sex influences on serum thyroid function status in hyperthyroidism and liver 
function in hypothyroidism  
Serum TT4, fT4, fT3 concentrations did not differ between euthyroid male and female 
mice (Fig. 5A-C). TSH serum concentrations of euthyroid male and female mice were 
310 ± 170 mU/l and 290 ± 30 mU/l respectively (±SEM, n=4). T4 treatment resulted in 
marked sex differences in serum T4  and T3 status with 2.3-fold higher TT4 and fT4 
concentrations in hyperthyroid females compared to male mice (Fig. 5A-C) and TSH 
concentrations below detection limit (<10 mU/l) in both sexes. LoI/MMI/ClO4- 
treatment reduced TT4 concentrations below assay detection limit (<0.5 µg/dl) in both 
sexes (Fig. 5A-C) and increased TSH to 6830 ± 1070 mU/l and 7790 ± 1270 mU/l in 
male and female mice respectively (±SEM, n=4). Sex effects on TH serum 
parameters were observed for TT4 and fT4 under hyperthyroidism (TT4: F(1,28)=20.50, 
p=0.0001; fT4: F(1,28)=10.80, p=0.0027) but not for hypothyroidism (TT4: 
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F(1,28)=0.09858, fT4: p=0.7559; F(1,28)=0.2127, p=0.6482) and not for fT3 (hyperthyroid: 
F(1,28)=2.485, p=0.1261; hypothyroid: F(1,28)=0.1553, p=0.6965). Treatment effects had 
an impact on TT4 concentrations (hyperthyroid: F(1,28)=95.74, p<0.0001; hypothyroid: 
F(1,28)=165.8, p<0.0001) and on fT4 and fT3 concentrations under hyperthyroidism 
(fT4: F(1,28)=41.32, p<0.0001; fT3: F(1,28)=5.26, p<0.0001). No treatment impact was 
observed under hypothyroidism for fT4 and fT3 (fT4: F(1,28)=2.316, p=0.1393; fT3: 
F(1,28)=0.1645, p=0.6882). Interaction of TH status and sex was found for TT4 and fT4 
under hyperthyroidism (TT4: F(1,28)=21.26, p<0.0001; fT4: F(1,28)=10.75, p=0.0028) but 
not under hypothyroidism (TT4: F(1,28)=0.1272, p=0.7241; fT4: F(1,28)=0.2350, 
p=0.6316) and not for fT3 (hyperthyroid: F(1,28)=3.658, p=0.0661; hypothyroid: 
F(1,28)=0.8460, p=0.3656). 
To examine the influence of sex on TH dependent liver function, liver parameters 
were analysed in sera collected at the end of treatment. While no changes were 
found in aspartate aminotransferase, creatine kinase, cholinesterase and albumin 
serum concentrations (data not shown) a marked sex-difference was found for total 
cholesterol (CHO) and triglyceride (TG) concentrations. Male mice exhibited higher 
CHO concentrations compared to female mice in the euthyroid state and 
hypothyroidism led to significantly larger increases in serum CHO concentrations in 
male compared to female mice (m: Δ~ 224.6 mg/dl, f: Δ~ 63.9 mg/dl). In contrast, T4 
treatment decreased total CHO concentrations in both sexes (m: Δ~106.9 mg/dl, f: 
Δ~ 63.1 mg/dl). Thus, sex-difference in serum CHO levels disappeared during TH 
excess (F(1,12)=1.530, p=0.2397), while deprivation led to an exaggeration 
(F(1,12)=35.44, p<0.0001) (Fig. 5D). The treatment effect (F(1,12)=57.23, p<0.0001 for 
hyperthyroidism and F(1,12)=54.66, p<0.0001 for hypothyroidism) was considered 
significant and interacted with the sex effect (F(1,12)=3.799, p=0.0075 for 
hyperthyroidism and F(1,12)=16.96, p=0.0014 for hypothyroidism). Serum TG 
concentrations were not different in euthyroid males and females, but increased in 
hyperthyroid female mice only (m: Δ~0.035 mg/ml, f: Δ~0.198 mg/ml, F(1,12)=0.08541, 
p=0.7751). However, a sex-difference appeared by TH modulation and was 
exaggerated by LoI/MMI/ClO4- treatment (m: 0.288 mg/ml vs f: 0.186 mg/ml, p<0.05, 
F(1,12)=15.77, p=0.0019) (Fig. 5E). The treatment effect was considered significant for 
hyperthyroidism (F(1,12)=20.98, p=0.0006) and interacted with sex effect (F(1,12)=10.23, 
p=0.0076), but not for hypothyroidism (F(1,12)=3.983, p=0.0692; F(1,12)=0.3958, 
p=0.5410 for interaction). 
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Fig. 5: Serum TH status in euthyroid controls, T4 or LoI/MMI/ClO4- treated male and 
female mice. (A) Total thyroxine (TT4), (B) free thyroxine (fT4) and (C) free triiodothyronine 
(fT3) concentrations were determined in sera by ELISA after 7 weeks of treatment. (D) Total 
cholesterol and (E) triglyceride serum concentrations were determined by ELISA at the end 
of experiment in sera of euthyroid, hyperthyroid, and hypothyroid mice of both sexes. Data 
are presented as mean ± SD, N= 8 animals/sex/treatment for TH concentrations, 
N=4/sex/treatment animals for total cholesterol concentrations; 2-way ANOVA followed by 
Bonferroni post-hoc analysis applied for sex and treatment effects, *p<0.05, **p<0.01, 
***p<0.001 above bars represent multiple-testing results. 
 
Evidence for a distinct impact of sex on cellular TH effects on gene expression 
in target organs brown adipose tissue, heart and liver  
Expression of TH responsive genes and TH transporters was studied by quantitative 
RT-PCR in BAT, heart and liver of male and female mice under T4 excess, TH 
deprivation and euthyroid condition (Fig. 6A-I). A distinct and organ specific pattern of 
sex-variation in gene expression was observed. In brown adipose tissue marked sex-
specific alterations in Dio2 transcript levels were detected in hyperthyroid 
(upregulation in male, downregulation in female mice) and for Lat2 in hyper- and 
hypothyroid animals (Fig. 6A-B). Additionally, sex-dependent variation was found for 
expression of all investigated target genes and TH transporters in euthyroid mice 
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(Fig. 6C). In contrast to this data very little or no sex-impact was found on target gene 
or TH transporter gene expression in heart neither in euthyroid controls nor in 
response to T4 or LoI/MMI/ClO4- treatment (Fig. 6D-F). In fact, for most investigated 
genes, a distinctly higher expression was found in heart tissue of male mice 
irrespective of thyroid function status. In line with the contribution of liver and BAT to 
metabolic features of thyroid dysfunction, significant sex-specific alterations for e.g. 
Dio1, Tbg and Me1 as well as Mct10 and Lat1 expression were obvious with 
manipulation of thyroid status (Fig. 6G-H), while livers of male and female control 
mice showed little sex-variation in target gene and TH transporter expression (Fig. 
6I). 
 
Fig. 6: TH effects in brown adipose tissue (BAT), heart and liver of male and female 
mice. Fold changes of representative TH responsive genes were measured by quantitative 
RT-PCR in (A) BAT, (D) heart and (G) liver tissue of hyperthyroid or hypothyroid mice of both 
sexes and normalized to euthyroid samples. For BAT Dio2, Ucp1 and PGC1α expression for 
heart Dio2, Myh6 and Hcn4 expression and for liver Dio1, Tbg and Me1 expression were 
quantified. Additionally, mRNA expression of TH transporter genes were analyzed in (B) 
BAT, (E) heart, and (H) liver. For BAT: Mct8, Mct10, Oatp3a1, Lat2, for heart: Mct8, Ntcp, 
Lat1, Lat2 and for liver: Mct8, Mct10, Lat1, Lat2. Furthermore, euthyroid sex comparison was 
analysed in (C) BAT, (F) heart and (I) liver of all genes and female gene expression was 
normalized to male samples. Data are presented as mean ± SD, N= 5-7 
animals/sex/treatment; unpaired Student´s t-test, *p<0.05, **p<0.01, ***p<0.001 represent t-
test results. 
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3.5 Discussion 
The female preponderance of thyroid dysfunction is well-known, however, whether 
gender has an impact on manifestation and outcome of hyper- and hypothyroidism in 
men and women has not been well studied and the molecular mechanisms are still 
unclear. Using a murine model, we found marked sex-differences in functional 
behaviour, metabolic and biochemical parameters in hyper- and hypothyroid mice. 
Sex of mice did not alter the general response of body weight and heart rate to 
manipulation of thyroid status, only the extent of these changes is somewhat 
different. In addition, a distinct sex-variation in cellular TH effects on gene expression 
was observed in BAT, heart and liver on the basis of TH target and TH transporter 
gene expression analysis.  
Sex-difference for water intake reverses during TH deprivation 
A clear sex-difference could be observed for water intake in euthyroid and 
hyperthyroid conditions as females consumed more water than male mice (Fig. 2G, 
H). Strikingly, this is reversed in hypothyroidism and female mice consume 
significantly less water than their male counterparts (Fig. 2I). This observation could 
indicate that female mice taste bitter substances differently due to altered taste 
receptor distributions. However, studies of taste receptors in mice either addressed 
only male mice [18] or observed no sex-differences [19]. Preferences for the primary 
taste qualities sweet, sour, bitter, salty and umami showed no sex-differences for 
C57BL/6 mice [20]. Thus, the supplemented drugs might be recognized not by usual 
taste receptors, but different receptor types in female and male mice. However, 
decreased water consumption did not affect the success of LoI/MMI/ClO4- treatment 
as TT4 serum concentrations were below limit of detection and serum TSH was 
highly elevated to comparable values for both sexes. Sex-difference for water intake 
was reversed under euthyroid and hyperthyroid conditions as females consumed 
more water than male mice (Fig. 2G, H). Therefore, manipulation of TH status might 
also affect hormonal regulation of fluid intake, water and salt homeostasis, an 
observation compatible with altered water metabolism in hypothyroid patients [21, 22] 
and increased hypothalamic vasoactive intestinal polypeptide-immunoreactive 
neuron expression in hypothyroid rats [23]. For other phenotypic traits related to 
manipulation of TH concentration sex-specific differences persisted (e.g. body 
temperature in hyper- and hypothyroidism), were exaggerated (e.g. food intake in 
hyperthyroidism) or disappeared (e.g. BW change in hypothyroidism). 
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TH excess results in distinct exaggeration of behavioural traits in male vs 
female mice 
Behavioural assessment of our mice consisted of measurements of locomotor 
activity, motor function and coordination tests. TH manipulation resulted in increased 
activity and exploratory behaviour during TH excess in female mice only, while 
decreased activity under TH deprivation was present in male mice only (Fig 4B, C). 
Previous studies with adult-onset hypothyroidism in male mice support our 
observation of decreased locomotor activity, with no consistent findings for anxiety 
[24, 25]. Impact of sex and TH excess on locomotor activity have not been addressed 
so far. For euthyroidism a higher locomotor activity as well as increased voluntary 
exercise of females compared to male mice have previously been described [26, 27] 
and was confirmed in our study. The chimney test investigates motor coordination 
and muscular strength and showed higher impairment of performance by T4 
administration than by LoI/MMI/ClO4- treatment for both sexes (Fig. 4A). Male mice 
showed more pronounced affliction of chimney test performance under manipulation 
of TH status. Since the rotarod test evaluating motor coordination and balance in 
movements showed no sex or treatment differences (Fig. 4D-F) we suspect muscle 
function to be responsible for the observed effects in chimney test. To our 
knowledge, our study is the first to assess muscle strength under hyper- and 
hypothyroid condition for mice of both sexes. When assessing behaviour it is 
important to distinguish whether the differences are due to a compromised muscle 
function or neurological impairment. Comparison of mice of both sexes showed 
generally shorter contraction of isolated muscles in male mice [28]. Therefore, it has 
been suggested, that male muscles are generally faster and have a higher maximum 
power output than female muscles. On the other hand, female muscles are generally 
more fatigue resistant, recover faster and show less mechanical damage after 
exercise [28, 29]. As central nervous system and peripheral nervous system 
coordinate muscle function, it is not unreasonable to conclude that both neurological 
and primary muscular factors might contribute to observed sex-differences [30, 31]. 
These aspects remain to be investigated. 
Sex-difference in body temperature persists throughout thyroid dysfunction 
and is reflected by cellular TH effects on gene expression in BAT 
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Persisting sex-differences in eu- and hyperthyroidism between male and female mice 
were found for body temperature with higher values in female mice (Fig. 3A). It has 
been previously described that euthyroid female mice have higher body temperature 
than male mice, but this is not explained by classical TH serum concentrations in 
euthyroid or hyperthyroid animals [26, 32]. As BAT is a TH target organ and involved 
in regulation of body temperature [33], gene expression analysis was performed for 
TH target genes and TH transporter expression. With manipulation of TH status TH-
responsive sex-difference in gene expression was only found for Dio2, which 
increased in BAT of hyperthyroid male mice, but decreased in BAT of hyperthyroid 
female mice (Fig. 6A). However, we cannot extrapolate from transcript concentration 
on enzyme activity, as previous studies showed different regulation of Dio2 under TH 
influence [34]. No sex-difference was found for the investigated TH-responsive genes 
under TH deprivation. This supports the observed persisting sex-differences in body 
temperature, as TH manipulation resulted in little sex-differences of TH responsive 
gene expression in BAT. For TH transporter genes only Lat2 was higher expressed 
in BAT of hyperthyroid male compared to female mice, however Lat2 gene 
expression was also increased in BAT of hypothyroid female compared to male mice 
(Fig. 6B). Lat2 is known to transport not only TH (preferentially diiodothyronines), but 
also small neutral amino acids [35, 36]. Thus, it might reflect sex-different needs for 
amino acid transport in BAT during TH dysfunction.  
For interpretation of cellular TH effects on gene expression in BAT it is important to 
remember that two mechanisms play a role in BAT activation and thermogenesis. 
Firstly, adjustment of body temperature in response to thermal stress which occurs 
due to housing temperature (23°C instead of thermoneutrality at 30°C) and therefore 
chronically augmented metabolism [37]. Secondly, activation of basal energy 
expenditure by TH results in increased thermogenesis [38, 39]. The balance between 
these two mechanisms has been addressed in recent studies under TH deprivation 
and showed that BAT thermogenic program was only down-regulated when 
hypothyroidism was combined with thermoneutrality [40]. In our study mice were not 
kept under thermoneutral condition, hence we expect an overlap between adjustment 
to thermal stress and activation or inactivation of basal energy expenditure by TH 
excess or deprivation, respectively.  
Sex-difference in heart rate disappears with hyper- and hypothyroidism 
  Chapter 3 
70 
 
Euthyroid female mice showed higher HR compared to males, but this sex-difference 
disappeared with a hyper- or hypothyroid state (Fig. 3B). We asked whether these 
changes in sex-impact would also be mirrored by cellular TH effects and hence 
performed gene expression analysis in heart tissue. No sex-difference in the 
expression of investigated TH responsive genes was found. Similarly, for TH 
transporters only Ntcp showed different expression in male and female heart tissues 
irrespective of TH dysfunction (Fig. 6E). Hence, this data does not explain why sex-
difference in HR disappears with manipulation of TH status and it is therefore likely 
that the investigated genes do not reflect the total organ response. Sex-specific 
impact on neuronal regulation of heart rate and function might lead to these changes 
independent from myocardial gene expression [41].  
TH dependent liver function and metabolism is sex-specific 
It is well known that TH influences serum total CHO concentrations [42-45]. A 
correlation with serum TH status was confirmed by changes in CHO serum 
concentrations of our mice. A sex-difference in CHO levels was augmented during 
LoI/MMI/ClO4- treatment and disappeared under T4 administration (Fig. 5D). Since 
male mice showed more pronounced changes than female mice, we suggest that 
CHO metabolism in livers of male mice may be more sensitive to TH manipulation 
compared to female mice. This observation is supported by the known sex-
dependent regulation of Cyp7a1 in transgenic mice, where hyperthyroidism 
decreased Cyp7a1 in male mice, while no regulation could be found in female mice 
[43]. In addition, studies on changes in other functional parameters in liver tissues 
revealed sex-dependent regulation of tight junction proteins, such as claudin-1 and 
claudin-2 in cholangiocytes and hepatocytes of male and female animals under 
hypothyroid conditions. Further experiments including analysis of CHO synthesis 
pathways led to the hypothesis that claudins may be relevant for reversal of sex 
hormone-related susceptibility to gallstone formation in hypothyroidism [6]. On the 
other hand, TG serum concentration increased in hyperthyroid female mice only (Fig. 
5E) and suggest a different TG metabolism response to TH in male and female mice. 
Gene expression profile shows more pronounced TH-dependent regulation in liver of 
female compared to male mice. Thus, a higher expression of TH-responsive genes 
Dio1 and Me1 was noted in hyperthyroidism in female mice liver and Tbg transcripts 
were elevated in hypothyroid female liver compared to male mice. For TH 
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transporters Mct10 gene expression was increased in hyperthyroid female mice and 
for Lat1 a higher expression was observed in hyperthyroid male mice (Fig. 6G, H).  
Possible influence of estrogens on TT4 and fT4 serum concentrations during 
TH excess 
One very obvious sex-specific alteration was the increase in TH serum 
concentrations in female hyperthyroid mice. In fact, 2.3-fold higher TT4 and fT4 serum 
concentrations were measured in female mice after 7 weeks of T4 treatment (Fig. 5A-
C). This is in agreement with previous findings showing a 2-fold increase in TT3 
serum concentrations in female mice under T3 treatment, whereas male mice 
revealed only 50% increase in TT3 serum concentrations [47]. In contrast, under TH 
deprivation no sex-differences in serum TT4, fT4, fT3 and TSH concentrations were 
found in our mice. Sex differences in thyroid function parameters, such as TSH and 
classical thyroid hormones T4 and T3 have also been addressed in epidemiological 
studies, however no consistent findings were reported [48-50]. Other studies using 
murine models have described sex differences in thyroid function parameters at least 
for some strains and indicate that serum TH status needs to be considered when 
studying TH action [7, 51]. Thus, for every genotype TH serum concentrations should 
be measured in a sex-matched manner.  
When studying sex-differences in animal models or humans it is likely that the most 
elaborated differences between male and female individuals are related to gonadal 
hormones. The connection between TH and estrogens has been a subject of 
extensive research. One major effect is an increase in thyroxine-binding globulin 
capacity by estrogens [52, 53]. In our mice study we observed increased TT4 serum 
concentration in hyperthyroid female compared to male mice, which could be 
explained by higher binding capacity of thyroxine-binding globulin. However, this 
does not explain the sex-dependent difference in fT4 concentrations, which were also 
significantly higher in female compared to male mice. Secondly, interactions between 
gonadal and thyroid hormones occur through the hypothalamic-pituitary-thyroid and 
the hypothalamic-pituitary-gonadal axis, thus hyper- and hypothyroidism can interfere 
with the gonadal axis resulting in infertility in particular in the female organism. 
Finally, there was no apparent direct linear correlation between phenotype and 
classical T4/T3 ratio in relation to observed sex-variation in phenotypical traits. Thus 
although higher TT4 and fT4 serum concentrations were present in hyperthyroid 
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female mice, they show exaggeration only in motor activity and exploration while 
other traits of hyperthyroidism are less prominent than in male animals.  
Conclusions 
We showed that sex is an important modifier of TH action resulting in distinct 
phenotypic, metabolic and biochemical traits of hyper- and hypothyroidism in male 
and female mice. Importantly, a direct linear link between TH serum concentrations 
and sex-dependent phenotype was not observed. The wide spectrum of key players 
in TH action, such as distinct circulating TH derivatives and metabolites, tissue-
specific TH transporters, non-genomic TH effects and classical nuclear TH action 
illustrates the complex situation in an intact organism [54]. It seems crucial to 
address possible sex-difference under natural conditions, further analysis of sex-
specific traits will require additional studies using e.g. gonadectomized animals. 
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Supplemental table 1: Oligonucleotides used for amplification of house-keeping genes, TH 
responsive genes and TH transporters by real-time PCR. 
gene Forward primer Reverse primer 
18S CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT 
Ppia CTTGGGCCGCGTCTCCTTCG GCGTGTAAAGTCACCACCCTGGC 
RPL 13a GGGCAGGTTCTGGTATTGGA GGGGTTGGTATTCAATCCGCT 
Gapdh CCTCGTCCCGTAGACAAAATG TGAAGGGGTCGTTGATGGC 
ß-Actin CTGTCGAGTCGCGTCCA TCATCCATGGCGAACTGGTG 
Polr2a CTTTGAGGAAACGGTGGATGTC TCCCTTCATCGGGTCACTCT 
Dio1 GGGCAGGATCTGCTACAAGG CGTGTCTAGGTGGAGTGCAA 
Dio2 GTGACTGGGGAAGCAGAGTG AGTTTAACCTGTTTGTAGGCATC 
Tbg TGGGCATGTGCTATCATCTTCA GAGTGGCATTTTGTTGGGGC 
Me1 TAAGGGTCGTGCATCTCTCAC TGCAGCAACTCCTATGAGGG 
Myh6 CAGACAGAGATTTCTCCAACCCA GCCTCTAGGCGTTCCTTCTC 
Hcn4 CAGCGTCAGAGCGGATACTT CTTCTTGCCTATGCGGTCCA 
Ucp1 GGATGGTGAACCCGACAACT CTTGGATCTGAAGGCGGACT 
PGC1α TCTCAGTAAGGGGCTGGTTG AGCAGCACACTCTATGTCACTC 
Mct8 CTCCTTCACCAGCTCCCTAAG ACTTCCAGCAGATACCACACC 
Mct10 CGTGAGTGTCTTCACGGACA CGATGGAGCTTACAAAAGAACTGG 
Lat1 AGCGTCCCATCAAGGTGAAT GGGCTTGTTCTTCCACCAGA 
Lat2 AACAACACCGCGAAGAACCA GGAGCCAATGATGTTCCCTACAA 
Oatp3a1 CGCTACGGAAACAACTCAGC GAGTCCGTCTGGCATTCACA 
Ntcp GGGGACATGAACCTCAGCATT CCCTATGGCGCAAGGAATGA 
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4.1 Abstract 
Background: Thyroid dysfunction is more common in women and increases with 
age. The precise role of sex hormones in pathogenesis and manifestation of thyroid 
diseases is still not fully understood. Using a murine model, we asked whether sex 
influences phenotypes of hyper- and hypothyroidism at different ages.  
Methods: Hyper- and hypothyroidism were induced by i.p. T4 or MMI/ClO4-/LoI 
treatment over 7 weeks in 12 and 20 months old female and male C57BL/6N mice. 
Control animals underwent PBS treatment (n=7-11 animals/sex/treatment). Animals 
were investigated for impact of sex on body weight, food and water intake, body 
temperature, heart rate, behaviour (locomotor activity, motor coordination and 
strength) and serum thyroid hormone (TH) status. 
Results: Distinct sex impact was found in euthyroid and hyperthyroid mice, while 
phenotypic traits of hypothyroidism were similar in male and female mice, except for 
water intake and this was irrespective of age. T4 treatment resulted in 2-fold higher 
TT4, FT4 and FT3 serum concentrations in adult and old female mice. Contrary to 
male mice, hyperthyroid females gained body weight despite diminished food and 
water intake and higher activity in adult and old ages. Advanced muscle function 
under control conditions decreased under TH excess to a higher extent in female 
than male mice. Higher body temperature in female mice was confirmed in both age 
groups and at all TH conditions, while no sex impact was observed for heart rate in 
adult and old mice. 
Conclusions:  
By comparison of male and female young, adult and old mice with thyroid dysfunction 
we could identify that TH-dependent body weight change, food and water intake, 
muscle function and motor activity are influenced by sex hormones. An impact of sex 
hormones on TH serum concentrations, body temperature and heart rate was less 
apparent and needs further evaluation. In summary, we showed that sex differences 
in phenotypes were modulated by TH excess and less by TH deprivation. 
 
Keywords: thyroid hormone, hyperthyroidism, hypothyroidism, sex-difference, 
thyroid dysfunction, age, mice, phenotype  
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4.2 Introduction 
Thyroid dysfunctions (TDs) are known to occur with 2-9 fold higher prevalence in 
women than men [1]. However, both are affected by similar symptoms such as 
fatigue, cold intolerance, weight gain or bradycardia under hypothyroidism in contrast 
to nervousness, heat intolerance, tachycardia and weight loss, despite increased 
appetite under hyperthyroidism [2, 3]. Interestingly, a recent study highlighted that 
symptom presence or absence are better predictors for overt hypothyroidism in men 
than women, as women report significantly more symptoms after thyroid hormone 
(TH) replacement therapy than men [4]. Moreover, women are prone to be 
overtreated with THs in comparison to men increasing the risk of atrial fibrillation and 
reduced bone mineral density in female patients [5]. Yet the precise molecular 
mechanisms by which sex hormones or genetics may contribute to this female 
preponderance are still unclear.  
Additionally, data on a possible sex difference in thyroid function parameters such as 
the thyroid-stimulating hormone and serum concentrations of classical THs thyroxine 
(T4) and triiodothyronine (T3) in cohort studies are inconclusive, with studies showing 
sex variance of TH function parameters (6-9) whilst others do not [10-12]. These 
contrary findings could have resulted from differences in cohort characteristics (age 
and gender distribution, ethnicity, iodine supply, exclusion of clinically unapparent 
thyroid disease) and assays employed.  
In a previous study we performed a characterization of young mice with thyroid 
dysfunction and identified sex-specific traits of hyper- and hypothyroidism in 
behavioural, functional, metabolic, biochemical and molecular parameters [13]. 
Since the prevalence of TD increases with age we asked whether this may 
differentially impact male vs. female mice systemically. Thus, to understand the 
influence and interplay of sex and age in tissue and organ-specific TH action we set 
up a mouse study.  
Male and female mice were randomized to either euthyroid or chronic hyperthyroid 
and hypothyroid group. First, we assessed mice of young age (5 months, [13]) and 
subsequently adult (12 months) and old (20 months) animals. Mice were 
characterized under chronic hyper- or hypothyroidism for changes in body weight 
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Chronic hyperthyroidism and hypothyroidism were induced as previously described 
[13-16]. Briefly, for hyperthyroidism i.p. injections of 1 μg/g body weight T4 (Sigma-
Aldrich (T2376), USA) were performed every 48h. For induction of chronic 
hypothyroidism, animals were fed a low-iodine diet (LoI; TD.95007, Harlan 
Laboratories, USA) and received drinking water supplemented with 0.02% 
methimazole (MMI, Sigma-Aldrich (301507), USA), 0.5% sodium perchlorate (ClO4-) 
(Sigma-Aldrich (310514), USA) and 0.3% saccharine as sweetener (Sigma-Aldrich 
(240931), USA) (LoI/MMI/ClO4-). In addition, hypothyroid animals received i.p. 
injections of PBS every 48 hours. Control animals were fed a control diet and 
received i.p. injections of PBS every 48 hours. 
Blood sample collection and analysis of serum TH concentrations 
Final blood samples were obtained by heart puncture and stored 30 min on ice 
before clearing by centrifugation. Free triiodothyronine (FT3), free thyroxine (FT4) and 
total T4 (TT4) concentrations in serum of mice were measured using commercial 
ELISA kits according to the manufacturer's instructions (DRG Instruments GmbH, 
Marburg, Germany). Detection ranges were 0.5-25 µg/dL, 0.05-7.5 ng/dL and 0.05-
20 pg/mL for TT4, fT4 and fT3, respectively.  
Monitoring of body weight, food and water intake 
Body weight was measured three times a week by placing mice on a scale. Food 
consumption was determined once a week by measuring the weight of remaining 
food pellets in the metal cage top. Water intake was controlled by weighing of water 
bottles (each, to the nearest 0.1g) weekly (in control and hyperthyroid groups) or 
twice (in hypothyroid groups) per week in control and TH manipulated groups. Male 
mice were caged individually, while female mice were kept in groups of three to four 
animals. Food and water intake of female mice was calculated by dividing the 
measured intake by the number of animals in each cage. 
For each mouse, average daily food and water intake was calculated, and 
adjustments for body weight were derived by dividing average intake by the average 
body weight, and multiplying the result by 40 g (average body weight of mice). 
Measurement of body temperature 
Body temperature of mice was assessed four times using a cream-covered rectal 
probe (RET-3 rectal probe for mice, Kent Scientific Corporation, USA) connected to a 
thermocouple thermometer (Acorn Temp JKT Thermocouple Meter, Kent Scientific 
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Corporation, USA). Mice were placed on the top of the cage and the rectal probe was 
carefully inserted 2 cm into the rectum until a steady temperature was measured, 
which took approximately 8 to 10 sec. 
Measurement of heart rate 
Non-invasive restrained electrocardiography (ECG) recording was performed using 
an in-house protocol [13]. Conscious mice were placed on a platform with their paws 
on silver electrodes and were restrained by a half-tunnel. Signal was derived, 
enhanced and digitalized (Picoscope 2204, Pico Technology, United Kingdom). ECG 
was recorded using Picoscope 6 Software over 60-90 sec and heart rate was 
determined by measurements of RR intervals over 8 sec in a stable steady state. 
Non-invasive restrained ECG was recorded 3 times in all animals. 
Rotarod test 
The rotarod test [13,17] basically consists of five 3 cm diameter cylinders, enabling 
five mice to be tested simultaneously. On the first testing day, mice were allowed to 
acclimate to the rotarod test by letting them walk 6 min on the rotating cylinder with 
constant acceleration from 2-20 rpm. 
For each rotarod session mice were subjected to 4 trials, with a minimum resting time 
interval of 6 min between the trials. Rotation mode was switched to constant 
acceleration from 4-50 rpm within 5 min. Maximum time and speed mastered by the 
animal was recorded. Mice that fell off the rod or attained full speed were placed 
back to their home cages. Every animal was subjected to two rotarod sessions (with 
a suspension period of 7 days) each before and after induction of thyroid dysfunction 
(4 sessions with 16 trials in total). Sessions 2 and 4 were used for statistical analysis.  
Chimney test 
The chimney test is constituted of a plastic tube (length 30 cm, diameter 3 cm). Mice 
were placed inside the tube and allowed to reach the other end. Then the tube was 
turned into a vertical position with mice head upside down. The test consisted of 
determining the time taken by mice to climb up to 25 cm of height. Mice were given 
90 sec of time to pass the test [13,18,19]. 
Open Field 
The open field consisted of a closed square area made of Plexiglas (50 x 50 cm). 
The area was divided in 4 corners, 4 walls and a center region (16 x 16 cm). Animals 
were tested in the dark phase of their dark/light cycle. Mice were placed in the center 
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of the open field and allowed to move freely for 5 min. Movements were monitored 
and digitalized by VideoMot2 software. Software recorded entries in all areas 
including time, frequency, latency and distance. Occurring events of rearing, freezing, 
grooming and jumping were recorded manually by the investigator during the 
experiment. Mice were placed in their home cages after 5 min of exploring the arena. 
Statistical analysis 
All data are shown as means ± standard deviation (SD) or standard error of the mean 
(SEM), as indicated. Statistical analysis using GraphPad Prism 6 Software was 
performed. The effects of hyper- and hypothyroidism are often opposing and 
inclusion of both treatments would therefore always show a significant treatment 
effect. To prevent false positive results statistical analysis of treatment groups were 
performed separately for hyper- and hypothyroid groups. 2-way ANOVA, 1-way 
ANOVA followed Bonferroni post-hoc analysis or unpaired Student´s t-test were 
applied as indicated. Values of *p<0.05, **p<0.01, ***p<0.001 were considered 
statistically significant. 
4.4 Results 
Effect of T4 administration on TH serum concentrations is exaggerated in 
female mice irrespective of age  
To examine TH serum changes with T4 excess or TH deprivation final blood samples 
were collected 24h after last T4 injection or continuous MMI/ClO4-/LoI treatment. 
No significant sex differences were noted in euthyroid adult and old mice for TT4, 
FT4 and FT3 serum concentrations (Fig. 2). Interestingly, T4 treatment resulted in a 
larger increase of TT4, FT4 and FT3 concentrations in sera of female compared to 
male mice in adult and even more in old age (p<0.001, Fig.2, Table 1). On the other 
hand, TH deprivation was marked by TT4 serum concentrations below assay 
detection limit (0.5 µg/dL) in male and female mice of both age groups (Fig. 2 A, D), 
whereas FT4 was not altered except for old female mice showing a reduction of 60% 
(F(1,30)=5.577 for treatment effect, p=0.0249, Fig. 2 E). Moreover, MMI/ClO4-/LoI 
treatment did not result in altered FT3 concentrations in male and female mice of 
both ages (Fig. 2 C, F). 
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Fig. 2: Serum TH status in adult and old male and female mice under TH excess or 
deprivation. TT4, FT4 and FT3 serum concentrations were determined by ELISA at the end 
of T4 or MMI/ClO4-/LoI treatment in sera of (A-C) adult and (D-F) old male and female mice. 
A distinct sex effect on T4 treatment was obvious by higher TH serum concentrations in 
female than male mice. Data are presented as mean ± SD, n= 7-11 animals/sex/treatment, 
2-way ANOVA followed by Bonferroni post hoc analysis for each hyper- and hypothyroid 
conditions, respectively; *p<0.05, **p<0.01, ***p<0.001.  
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Table 1: Statistical analysis of TT4, FT4 and FT3 serum measurements in adult and old 
mice of both sexes. 2-way Anova followed by Bonferronis post hoc analysis was applied. 
Sex dependency was emphasized by illustration of Δ(female-male) values. 
age adult old 
Δ(female-male) 
TT4=10.6 µg/dL 
FT4=3.8 ng/dL 
FT3=7.4 pg/dL 
TT4=13.0 µg/dL 
FT4=5.0 ng/dL 
FT3=8.2 pg/dL 
treatment effect 
TT4: F(1,26)=202.5, p<0.001 
FT4: F(1,26)=92.76, p<0.001 
FT3: F(1,26)=53.67, p<0.001 
TT4: F(1,26)=129.7, p<0.001 
FT4: F(1,26)=44.52, p<0.001 
FT3: F(1,26)=60.42, p<0.001 
sex effect 
TT4: F(1,26)=27.4, p<0.001 
FT4: F(1,26)=31.48, p<0.001 
FT3: F(1,26)=13.45, p=0.0011 
TT4: F(1,26)=28.64 p<0.001 
FT4: F(1,26)=27.76 p<0.001 
FT3: F(1,26)=26.79, p<0.001 
interaction 
TT4: F(1,26)=31.01, p<0.001 
FT4: F(1,26)=26.06, p<0.001 
FT3: F(1,26)=10.6, p=0.0031 
TT4: F(1,26)=41.28, p<0.001 
FT4: F(1,26)=17.83, p<0.001 
FT3: F(1,26)=20.90, p<0.001 
 
Sex-difference in body weight change manifests with T4 treatment and aging 
The impact of thyroid dysfunction on body weight (BW) of male and female mice was 
assessed over the entire experimental procedure and related to the individual body 
weight at start (Suppl. Table 1). Euthyroid male and female adult and old mice had 
comparable BW changes throughout the experiment (Fig. 3 A, D). In contrast, T4 
treatment resulted in a marked sex-difference for BW change. While adult and old 
females gained weight under TH excess, male mice decreased BW at the same age 
(for adult: F(27,371)=15.00 for time, F(1,371)=180.2 for sex effect, F(27,371)=5.726 for 
interaction, p<0.001; for old: F(27,489)=8.01 for time, F(1,489)=353.8 for sex effect, 
F(127,489)=13.13 for interaction, p<0.001 Fig. 3 B, E). No sex-differences for BW 
changes were detected overall in adult and old hypothyroid animals (Fig. 3 C, F).  
Noteworthy, to avoid different nutritional intake, all hypothyroid mouse groups were 
changed to low iodine diet with start of the protocol for induction of hypothyroidism, 
while euthyroid and hyperthyroid mice received an equivalent control diet.  
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Fig. 3: Body weight change of adult and old mice of both sexes in eu-, hyper and 
hypothyroid conditions. BW was related to individual start weight in (A-C) adult and (D-F) 
old male and female mice. Sex differences in euthyroid (A, D), hyperthyroid (B, E) and 
hypothyroid (C, F) conditions were assessed. TH excess resulted in BW gain of females, 
while males lost BW in both ages. No sex difference was observed under TH deprivation. 
Data are presented as mean ± SD, n= 7-11 animals/sex/treatment, 2-way ANOVA followed 
by Bonferroni post hoc analysis, *p<0.05, **p<0.01, ***p<0.001. 
 
Sex impacts food intake in euthyroid animals and is diminished by age and TH 
modulation 
Food intake of all mice groups was measured weekly and calculated to respective 
BW of the individual mouse. Euthyroid control animals showed higher food intake in 
female compared to male mice in adult and old ages, however with larger difference 
in adult compared to old age (for adult: F(8,108)=24.92 for time, F(1,108)=430.6 for sex 
effect, F(8,108)=9.204 for interaction, p<0.001; for old: F(8,134)=15.75 for time, 
F(1,134)=51.5 for sex effect, F(8,134)=1.783 for interaction, p=0.0857; Fig. 4 A, D).  
Both, T4 and MMI/ClO4-/LoI treatment diminished sex difference of food intake in 
adult and old ages with stronger increase of food intake in hyperthyroid males (Fig. 4 
B, E) and stronger decrease in hypothyroid females, irrespective of age (Fig. 4 C, F).  
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Fig. 4: Food intake behaviour during experimental procedure influenced by sex, age 
and TH condition. Food intake was related to BW weekly in (A-C) adult and (D-F) old male 
and female mice. Sex-dependency was noted for euthyroid groups, which disappeared by 
TH excess and deprivation. Data are presented as mean ± SD, n= 7-11 
animals/sex/treatment, 2-way ANOVA followed by Bonferroni post hoc analysis, *p<0.05, 
**p<0.01, ***p<0.001. 
 
Sex-difference of water intake is diminished in hyperthyroid and reversed in 
hypothyroid animals  
Water intake of all mouse groups was measured weekly and calculated to respective 
BW of individual mouse. Adult and old aged female euthyroid mice had higher water 
intake than male mice (for adult: F(8,108)=23.26 for time, F(1,108)=936.2 for sex effect, 
F(8,108)=5.017 for interaction, p<0.001; for old: F(8,134)=16.38 for time, F(1,134)=219.4 for 
sex effect, F(8,134)=1.788 for interaction, p=0.0847, Fig. 5 A, D).  
Sex and age-dependent differences were found for water intake under 
hyperthyroidism. Adult female mice did not change drinking behaviour under T4 
treatment, while male mice increased water intake over time. Thus, compared to the 
euthyroid situation the sex-difference reversed and adult male mice consumed more 
water than female mice (F(8,119)=42.04 for time, F(1,119)=0.1882 for sex effect, 
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F(8,119)=13.24 for interaction, p<0.001 Fig. 5 B). At old age, no sex-difference was 
observed and both male and female mice increased water intake under TH excess 
(Fig. 5 E).  
Hypothyroidism was marked by a reversed sex-difference in drinking behaviour. 
While water intake in male mice did not significantly change by MMI/ClO4-/LoI 
treatment, a dramatic decrease of water intake was observed in female mice, 
irrespective of age (for adult: F(8,126)=15.27 for time, F(1,126)=560.8 for sex effect, 
F(8,126)=73.19 for interaction, p<0.001; for old: F(8,156)=4.373 for time, F(1,156)=106.0 for 
sex effect, F(8,156)=9.991, p<0.001 for interaction; Fig. 5 C, F). 
 
Fig. 5: Water consumption in adult and old groups of male and female mice, under 
control, TH excess or deprivation. Water intake was related to BW weekly in (A-C) adult 
and (D-F) old male and female mice under euthyroid condition, T4, or MMI/ClO4-/LoI 
treatment. Data are presented as mean ± SD, n= 7-11 animals/sex/treatment, 2-way ANOVA 
followed by Bonferroni post hoc analysis, *p<0.05, **p<0.01, ***p<0.001. 
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Body temperature in contrast to heart rate, is strongly sex-dependent 
irrespective of TH status and age 
Sex-dependency was observed throughout all measurements with a higher body 
temperature in female compared to male mice in adult as well as old age and at all 
TH conditions (Fig. 6 A, B, table 2).  
 
Fig. 6: Body temperature and heart rate in adult and old male and female mice with  
eu-, hyper- and hypothyroid state. Rectal body temperature measurements and non-
invasive ECG were performed in (A) adult and (B) old male and female mice to assess body 
temperature and (C, D) to determine changes in heart rate. Under TH excess and deprivation 
persistent higher body temperature of female mice were noted at all TH status and ages, 
whereas no sex impact was noted for heart rate. Data are presented as mean ± SD, n= 7-11 
animals/sex/treatment, 2-way ANOVA followed by Bonferroni post hoc analysis, *p<0.05, 
**p<0.01, ***p<0.001. 
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Table 2: Statistical analysis of body temperature measurements in adult and old mice 
of both sexes. 2-way ANOVA followed by Bonferronis post hoc analysis was applied for 
hyper- and hypothyroid conditions. 
age adult old 
Δ(female-male) 
eu: 0.68°C 
hyper: 0.48°C 
hypo: 0.95°C 
eu: 0.94°C 
hyper: 0.46°C 
hypo: 1.00°C 
treatment effect 
hyper: F(1,25)=28.25, p<0.001 
hypo: F(1,26)=16.48, p<0.001 
hyper: F(1,29)=22.19, p<0.001 
hypo: F(1,31)=0.719, p=0.403 
sex effect 
hyper: F(1,25)=23.43, p<0.001 
hypo: F(1,26)=43.08, p<0.001 
hyper: F(1,29)=20.13 p<0.001 
hypo: F(1,31)=37.18 p<0.001 
interaction 
hyper: F(1,25)=0.707, p=0.408 
hypo: F(1,26)=1.152, p=0.293 
hyper: F(1,29)=2.326, p=0.138 
hypo: F(1,31)=0.0024, p=0.878 
 
Non-invasive ECG measurements were performed to examine the influence of sex 
and TH on heart rate. However, no significant sex differences were found between 
euthyroid, hyperthyroid and hypothyroid mice at adult and old age (Fig. 6 C, D). 
 
Sex difference on muscle strength and motor coordination is diminished by TH 
deprivation and TH excess in adult and old mice 
To investigate the impact of TH disturbances on motor function and muscle strength 
in male and female mice rotarod and chimney tests were performed.  
In particular, the rotarod test examines the ability to balance and walk on a rotating 
cylinder and thereby investigates motor coordination and function. For each mouse a 
training period was implemented in euthyroid state and was compared to the 
performance under hyper-, hypo- or again euthyroid state.  
Euthyroid female mice spend more time on the rod compared to male mice at adult 
and old ages (for adult: F(7,96)=1.680 for time, F(1,96)=279.6 for sex effect, F(7,96)=0.576 
for interaction; for old: F(7,120)=1.972 for time, F(1,120)=80.98 for treatment effect, 
F(7,120)=0.7789 for interaction; Fig. 7 A, D), showing better muscle endurance and 
motor coordination. T4 treatment and TH deprivation resulted in diminished sex 
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differences in adult and old mice with generally poorer performance of hyperthyroid 
adult and old mice and unchanged performance of old hypothyroid mice (Fig. 7 B-C, 
E-F). 
 
Fig. 7: Rotarod performance in all groups in both ages and sexes under control, T4 or 
MMI/ClO4-/LoI treatment. Time spend on the rotating cylinder was determined in (A-C) adult 
and (D-F) old male and female mice. Pronounced sex difference in euthyroid mice was 
diminished by TH excess or deprivation. Data are presented as mean ± SD, n= 7-11 
animals/sex/treatment, unpaired two-tailed student´s t-test, *p<0.05, **p<0.01, ***p<0.001. 
 
To further evaluate muscle strength, tonus and coordination of movements we used 
the chimney test, which measures the required time of mice to climb up in a tube. 
Overall better coordination of movement and muscle strength was observed in 
female compared to male mice (Fig. 8). Thus euthyroid control male mice failed in a 
high percentage to pass the test, while female mice succeeded to climb up the tube. 
This however was impaired under hyper- and hypothyroid conditions with more 
pronounced impairment under TH excess (F(5,39)=10.13, p<0.001, Fig. 8 A). Old male 
mice were not able to pass the Chimney test illustrating the profound effect of age on 
muscle strength and coordination (Fig. 8 B).  
To determine whether activity was different between male and female adult and old 
mice an open field test was used. Sex-differences were observed at all ages and 
varied with TH status. In general higher activity was found in female compared to 
male mice and this was persistent in eu-, hyper- and hypothyroid state irrespective of 
age, either as a trend or on a significant level (adult: F(5,39)=16.42, p<0.001, Fig. 8 C 
and old F(5,50)=10.34, p<0.001, Fig. 8 D).  
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Fig. 8: Chimney test and open field activity of adult and old mice of both sexes under 
eu-, hypo- or hyperthyroid conditions. The Chimney test was performed in (A) adult and 
(B) old male and female mice to assess muscle function, while the open field test was 
performed to assess the activity of mice by measuring the covered distance in (C) adult and 
(D) old age under TH excess, deprivation or euthyroid state. Data are presented as mean ± 
SD, n= 7-11 animals/sex/treatment, One-way ANOVA followed by Bonferroni post hoc 
analysis, *p<0.05, **p<0.01, ***p<0.001. 
 
4.5 Discussion 
Thyroid dysfunction (TD) may occur at any stage of life in women and men, but vary 
in its prevalence and severity of symptoms. Two aspects are relevant in the clinical 
situation. First, TD affects far more often women than men and second, the 
prevalence of TD increases with age, but symptoms are diminished in elderly 
patients while risks for co-morbidities increase. To approach such differences under 
highly standardized conditions we decided to use a rodent model and investigated 
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mice of different ages to define specific traits of TD in male and female mice. In a first 
study we assessed sex-differences in young animals of 5 months [13] and 
subsequently continued with characterization of hyper- or hypothyroidism in adult (12 
months) and old (20 months) male and female mice. Although female mice do not 
undergo a menopause as humans, still the hormonal activity and reproduction 
possibility declines with age [20, 21] and one can hypothesize that sex impact on TH 
action may be reduced in old compared to young female and male mice. Thus, by 
using our aging mice cohorts we were able to extract phenotypical traits to be likely 
sex hormone dependent or not. Traits of TD in young animals which were diminished 
or reversed at old age are suggested to be likely sex hormone dependent, in contrast 
to sex-differences which were consistent in all ages and might be highly controlled in 
terms of genetic background.  
Sex difference in response of TH serum concentration to T4 treatment 
An obvious difference in response to T4 treatment was observed in all age groups. 
Female mice of all ages had higher TT4, FT4 and FT3 serum concentrations if 
subjected to chronic T4 treatment ([13], Figure 2). This has been already observed 
by us in an earlier study [16] and by others using T3 [22], but was not expected to 
appear in older mice. In our aging study female mice had almost two-fold higher TT4 
serum concentrations compared to male mice in young, adult and old age. In fact, 
this could have resulted from increased thyroxin-binding globulin (TBG) capacity by 
estrogen [23, 24], which has been described in human patients. However, for 
euthyroid mice a higher TBG concentration in sera of male in comparison to female 
mice was shown [25], but addressed no TH alteration. Concluding from our 
investigations in young mice, chronic T4 treatment strongly repressed TBG gene 
expression in both sexes [13]. Furthermore, TBG was reported to be the only TH 
responsive transport protein for TH in contrast to transthyretin (TTR) or albumin [26]. 
Thus TTR or albumin might caused the observed sex-dependent effects for TT4 
serum concentrations under TH excess independent of TBG, but were not subjected 
in this study. 
Interestingly, despite of sex influence on TT4 serum concentrations, larger increase 
of FT4 and FT3 serum concentrations were noted in females compared to male mice.  
Sex differences in FT3 serum concentrations in hyperthyroid adult and old mice 
under T4 treatment might have resulted in this chronic approach from sex-dependent 
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T4 to T3 conversion by deiodinase 1 (Dio1), which was previously reported to be 
differently active in young male and female mice. Thus, renal Dio1 was found to be 
more active in female than male mice, while hepatic Dio1 showed higher activity in 
male than female mice [27]. A subsequent study investigating an age effect on 
sexual dimorphism of Dio1 showed no differences in hepatic Dio1 activity at 12 
months of age, but persistent sex difference in renal Dio1 activity [28]. Thus, higher 
renal Dio1 activity might have influenced FT3 serum values in female mice, but was 
not investigated in this study. Furthermore, concluding from TH serum concentrations 
under T4 treatment, one would expect to observe exaggerated symptoms of 
hyperthyroidism in female mice. 
In contrast, TH deprivation induced by combined MMI/ClO4-/LoI treatment, resulted in 
all age groups in very low TT4 and unchanged FT4 and FT3 serum concentrations, 
except for decreased FT4 concentrations in old female mice. However, this 
difference was minor and might be an assay variation with little relevance on further 
evaluation of phenotypical traits. 
Body weight changes sex-dependently under TH excess 
An impact of THs on BW has been demonstrated already for young mice [16, 29, 30]. 
In addition, in our initial study a sex-dependent influence was noted with faster weight 
gain in young hyperthyroid male compared to female mice [13]. In contrast, this sex 
dependency under TH excess reversed with age. Adult and old hyperthyroid female 
mice gained more BW in comparison to male mice. Strikingly and close to the human 
situation, adult and old male mice even lost BW when subjected to T4 excess (Fig. 3 
B, E). Thus, this suggested a more pronounced male sex hormone dependent 
regulation of BW change under TH excess. For young mice an increase of BW has 
been described during shorter induction periods, but no data for old hyperthyroid 
animals were available so far. To our knowledge, this was the first study to 
characterize BW changes in a model of chronic TH excess in mice of both sexes and 
at different ages.  
TH deprivation resulted in stagnation of BW with no sex-differences for BW change in 
all age groups in line with results of TH serum concentrations ([13], Fig. 3 C, F).  
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Sex-differences in nutritional intake disappear with TH excess and deprivation  
As differences in BW change were found especially in hyperthyroid animals, we 
considered nutrient intake as a possible explanation. Higher food intake was noted in 
euthyroid female compared to male mice in all ages, while no sex impact on this 
parameter was found in hypothyroid groups ([13], Fig. 4 A, C-D, F). In contrast, TH 
excess in young animals resulted in higher food intake in females than males [13], a 
sex difference that disappeared in hyperthyroid adult and old mice (Fig. 4 B, E). 
Thus, food intake was not in line with BW change and did not explain BW loss or gain 
in male and female mice across the different age groups. In fact, increased food 
intake was stronger correlated with less BW gain or even with BW loss (e.g. adult 
and old hyperthyroid males). All these observations led us to the hypothesis that at 
least under hyperthyroid conditions BW did not correlate with food intake and that 
these two traits were affected differently by THs. Moreover, regulation of food intake 
is a highly complex process, which can be a direct consequence of treatment or a 
compensatory response regulated by a central mechanism [31]. Thus, either uptake 
of nutrients is different or the metabolism of these nutrients could be differently 
regulated in male and female mice. In addition, it might be a result of several factors 
in which nutrient intake plays a role as food can be used for various functions e.g. 
energy storage in fat pads, increased development of muscles, maintaining body 
temperature or providing enough calories to enable high activity. Moreover, it has 
been shown for several mouse strains, that higher food intake was correlated with 
higher activity [32-34], but none of these studies evaluated different TH conditions.  
As second part of nutrient metabolism we evaluated water intake, which in part 
reflects the activity of mice [35]. Euthyroid female mice consumed more water than 
male mice, irrespective of age ([13], Fig. 5 A, D). T4 treatment at the same time 
influenced drinking behaviour in a sex- and age-dependent manner. Sex-difference 
was diminished and even disappeared at the end of experiment in young mice [13]. 
In adult mice sex difference in water intake was even reversed with consumption in 
male mice, as female mice drinking behaviour did not change under chronic TH 
excess (Fig. 5 B). At the old age no sex difference in this parameter could be 
observed in hyperthyroid mice (Fig. 5 E). These findings suggest a sex hormone 
dependency for water intake and raise the awareness that impact of TH excess may 
be influenced by male and female sex hormones. 
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In contrast TH deprivation resulted in a vanished or even reversed sex-difference 
with higher water intake in young, adult and old male mice ([13], Fig. 5 C, F) and a 
drastic decrease of water intake in hypothyroid female mice. One reason might be 
different taste sensitivity for the drugs MMI or ClO4- or saccharine which was added 
as sweetener to cover bitter taste of these drugs. As the acceptance of these drugs 
was low in female mice throughout all ages, it might be a genetic rather than a 
female sex hormone effect.  
In contrast to heart rate, TH effects on body temperature with aging remain 
sex-dependent 
Rectal body temperature was already different between young male and female mice 
under all TH conditions [13]. However, also adult and old female mice had higher 
body temperature than male mice, irrespective of treatment, suggesting a strong sex-
dependent effect (Fig. 6 A, B). Non-invasive methods of rectal and surface body 
temperature measurements correlate very well with mice core body temperature [36]. 
However, a drawback of these methods is, that only certain time points can be 
measured and might therefore miss differences in small time frames. As reported 
previously in a study investigating the influence of sex hormones on body 
temperature via radiotelemetry [20], sex-differences were most obvious at daytime 
and in the proestrous and estrous period with higher values in 3 months old females 
than males. Ovariectomy in these mice resulted in similar body temperature pattern 
during proestrous and estrous as in male mice, indicating that differences in these 
time frames were regulated by sex hormones. Throughout all other days and nights 
body temperature was comparable between ovariectomized and normal female mice 
suggesting that sex hormones are not the only factors contributing to body 
temperature regulation in female mice. As no influence of THs was addressed in this 
study, we conclude from our measurements, that TH excess and deprivation have 
likely stronger influence on basal body temperature in general, rather than on distinct 
time points during estrous cycle. 
Another very important characterization was the influence of THs and sex on heart 
rate, as tachycardia or bradycardia are well known manifestations of TD with 
increased morbidity in an elderly organism. 
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Sex-difference for heart rate was present in young euthyroid mice but disappeared by 
TH excess or deprivation [13], suggesting that alteration of TH status might mask 
impact of sex hormones. In adult and old mice no sex impact was found for heart 
rate, irrespective of TH status (Fig. 6 C, D). Measurements of heart rate were 
performed in a non-invasive ECG, which although pre-trained to the restrainer 
resulted in an increased stress for all mice and could have masked small differences 
within the measurements. 
In an aged organism TH dysfunction alters muscle function, coordination and 
activity more in females than males  
Muscle function was assessed with two different tests. The chimney test focused on 
muscle strength and coordination of movement, while the rotarod test provided 
information on endurance and motor coordination. 
In our previous study we found that TD impaired performance in young male and 
female mice with diminished sex difference under hyper- and hypothyroid condition 
while euthyroid female mice generally show better results in the rotarod test [13]. In 
adult and old mice the sex difference also disappeared under TH excess or 
deprivation (Fig. 7 A-F). Interestingly, this was caused by either a weaker 
performance of female mice (hyperthyroid) or by a stable performance of females but 
an improvement of endurance and motor coordination in males (hypothyroid).  
As already described for young mice [13], also in adult mice a major sex-difference 
was found in the chimney test in euthyroid, hyperthyroid and hypothyroid mice. 
Female mice had a much higher ability to climb up the tube at all TH conditions, while 
male mice were incapable to pass the chimney test (Fig. 8 A). Thus, this observation 
suggested that female mice had a better movement coordination and muscle 
strength throughout the lifespan than male mice. This was supported by the 
assessment of chimney test in old mice, where except for one male mouse none was 
able to pass the test, while at least eight female mice were still able to climb up the 
tube (Fig. 8 B). A better muscle function in female mice has previously been 
described to result from a better fatigue resistance, recovery and less mechanical 
damage after exercise [37, 38], which is in line with our observations assessed by 
chimney and rotarod test in euthyroid mice. Although an advantage in female 
muscles was noted throughout all age stages suggesting a genetic background, TH 
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modulation had a stronger impact on females than males. Thus, the interplay 
between thyroid and sex-hormones might regulate to some extent muscle and/or 
neurological functions of the central and peripheral nervous system. Therefore, it is 
not unreasonable to conclude that both neurological and primary muscular factors 
might contribute to observed sex-differences [39, 40]. Noteworthy, especially the 
chimney test was influenced by BW and size of the mice. As females are lighter and 
smaller than males at all TH conditions and ages, they are less impaired by their 
body composition than males and are in a favourable position to climb up the tube. 
Thus, assessing motor function beside muscle strength and endurance, BW and size 
are considerable contributing factors. 
Changes in activity were assessed by the open field test and were quantified by 
measuring the total distance travelled in 5 minutes. Significant sex-difference was 
noted with higher activity of female mice at different TH conditions and persisted in 
adult, but decreased with old age ([13], Fig. 8 C, D), which is in line with other studies 
confirming a higher locomotor activity and increased voluntary exercise in female 
mice [20, 41]. Thereby a decrease with age may indicate an influence of sex 
hormones on activity of female mice, irrespective of TH status. 
Conclusion 
Since women are more frequently affected by hyper- and hypothyroidism it is 
important to clarify if and how men and women may differ in manifestation and 
severity of symptoms of TD. To address this question, we have performed mice 
studies in both sexes and at different ages and found sex-specific changes in 
phenotypic traits by TD. Thus, by comparing experimental results of young from adult 
and old mice we could identify BW change, food and water intake, muscle function 
and activity to be likely sex hormone dependent. An impact of sex hormones on TH 
serum concentrations, body temperature and heart rate remains to be further 
investigated. Additionally, we showed that sex differences were modulated by TH 
excess and less so by TH deprivation. 
A very important future next step is the evaluation of organ specific differences to 
approach molecular mechanisms which contribute to the observed phenotypical traits 
and this will be our focus in the following studies. In summary, traits of TD vary with 
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sex at least in mice, and this is sustained for several hyperthyroid signs throughout 
life.  
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Supplemental Material 
Supplemental table 1: Body weight of adult and old, male and female mice at first (start) 
and last (final) day of experiment. 
age sex start final eu  final hyper final hypo 
adult 
males 40.2 ±5.0 45.8 ±3.7 40.1 ±4.1 35.6 ±2.0 
females 28.0 ±1.4 30.5 ±3.1 34.3 ±2.2 27.0 ±1.6 
old 
males 39.0 ±5.2 41.3 ±3.7 36.9 ±5.3 34.0 ±3.1 
females 30.3 ±3.5 32.8 ±3.2 33.7 ±4.4 28.7 ±1.7 
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5.1 Abstract 
Background: Clinically, a diminished bile excretion has been found in hypothyroid 
patients. Disorders of the biliary system are more frequent in women. However, in 
hypothyroidism the prevalence of gallstone diseases is higher in men. In liver the 
tight junction protein claudin-1 plays an important role in bile secretion by maintaining 
the paracellular barrier of bile canaliculi and bile duct. 
Objectives: We hypothesized that hypothyroidism could lead to an altered claudin-1 
expression in the liver. 
Methods: We characterized claudin-1 in liver of euthyroid and hypothyroid male and 
female C57BL/6NTac mice. Claudin-1 mRNA expression was analyzed by real-time 
PCR. In addition, claudin-1 expression and localization was analyzed by Western blot 
and immunofluorescence. 
Results: Claudin-1 is expressed in canalicular regions and the bile ducts of murine 
liver. Livers of female mice showed a lower claudin-1 expression than male livers. In 
hypothyroid mice livers, females revealed an elevated claudin-1 expression whereas 
diminished claudin-1 expression was found in male animals compared to the 
euthyroid status. 
Conclusion: We demonstrate a correlation between claudin-1 expression and 
hypothyroidism in murine liver. Furthermore, a sex-dependent alteration of claudin-1 
expression was found.  
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5.2 Introduction 
Hypothyroidism is a pathophysiological state marked by decreased circulating thyroid 
hormone (TH) concentrations or impaired TH action in target tissues. In clinical 
practice, hypothyroidism is mostly due to afflictions of the thyroid gland per se and is 
defined by elevated thyroid stimulating hormone (TSH) with or without decreased 
free thyroxine (fT4) serum concentrations, termed overt or subclinical hypothyroidism 
respectively. Autoimmune thyroiditis is the most common cause of hypothyroidism in 
humans and a female preponderance in both autoimmune thyroid disease and 
hypothyroidism has long been known [1, 2]. The incidence in developing 
hypothyroidism in Western world is between 0.6 and 3.5 per 1.000 people [3]. In 
Europe women are 1.7-6.8 fold more frequently affected by hypothyroidism than men 
[1, 2]. 
The liver is an important site of TH metabolism and therefore thyroid dysfunction is 
associated with many hepatic alterations, such as a decrease in liver cholesterol 
metabolism, resulting in hypercholesterolemia in hypothyroidism [4] and diminished 
bile secretion from hepatocytes [5]. The reduced bilirubin and bile excretion can lead 
to elevated bilirubin in newborns with congenital hypothyroidism [6]. In addition, 
hypothyroidism increases the risk for gallbladder stones and common bile duct 
stones [7]. Interestingly, women seem to be more affected than men in developing 
common bile duct stones [7], whereas in hypothyroidism the prevalence of gallstone 
diseases is higher in men [8]. 
Tight junction (TJ) proteins like claudin-1 are involved in the regulation of the 
paracellular barrier integrity and paracellular permeability between epithelial and 
endothelial cells by TJ strand formation. Claudin-1 is involved in polarization of 
hepatocytes by formation of basolateral and apical plasma membrane domains [9]. In 
mice liver claudin-1 is expressed in the bile canalicular region of hepatocytes as well 
as in epithelial cells of the bile duct [10]. Biliary diseases in human can be associated 
with altered claudin-1 expression or mutations. For instance, in the neonatal 
ichthyosis-sclerosing cholangitis (NISCH) syndrome claudin-1 gene mutations may 
lead to increased paracellular permeability between bile duct epithelial cells [11]. 
Other examples are familial hypercholanemia with claudin-1 mutations [12], acute 
acalculous cholecystitis with decreased claudin-1 [13] and intrahepatic 
cholangiocarcinoma with elevated claudin-1 expression [14]. 
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Scarce data are so far available on a potential influence of TH on claudin-1. A role of 
TH in TJ dynamics and maintenance in seminiferous epithelia has recently been 
described in rats [15]. Furthermore thyroid hormone receptor (THR) THRα1/THRß-
deficient mice have been shown to exhibit defective wound healing besides impaired 
hair growth [16]. Since claudin-1 is known to be pivotal for an intact skin barrier [17], 
a role of TH receptors and or TH may be suspected. However, transfer of this 
speculation to other tissues or organs has to be handled carefully as TJ are in fact 
functionally similar but structurally quite variable between different tissues or organs 
and the protein composition cannot be compared necessarily. So far a direct 
correlation between TH, THRs and claudin-1 has not yet been studied. 
In this study, we asked whether TH may impact claudin-1 expression in liver tissues 
and which compartments could be affected. We used male and female C57BL/6NTac 
mice with euthyroid and hypothyroid serum TH status to analyze claudin-1 
expression and localization patterns in the liver. 
5.3 Materials and Methods 
Animals 
Eighteen weeks old male and female (n=32) C57BL/6NTac mice (Taconic Europe, 
Denmark) were housed in temperature- (23 ± 1 °C) and light-controlled (inverse 
12:12 hour light-dark cycle) conditions. Food and water were provided ad libitum. All 
animal experiments were performed in accordance with the German regulations for 
Laboratory Animal Science (GVSOLAS) and the European Health Law of the 
Federation of Laboratory Animal Science Associations (FELASA). The protocols for 
animal studies were approved by the Landesamt für Natur, Umwelt und 
Verbraucherschutz Nordrhein-Westfalen (LANUV-NRW), Germany. 
Treatment and collection of mice blood samples and livers 
To establish a hypothyroid state, animals were fed a low-iodine diet (Harlan, USA) 
with an addition of 0.02% methimazole, 0.5% perchlorate and 3 g/l saccharin (Sigma, 
Germany) to drinking water for 7 weeks (n=8 animals/sex). Control groups received 
control diet (Harlan, USA) and regular water over the whole treatment period (n=8 
animals/sex). The non-caloric sweetener saccharin is described to increase water 
consumption, to decrease food consumption and to alter the intestinal microbiota. 
However, changes in body weight in male C57BL/6 mice were not found [18]. 
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Blood samples were collected from the retrobulbar venous plexus with a heparinated 
micropipette at the start and end of the experiment from each animal. Blood samples 
were stored on ice for 30 min for coagulation and serum was obtained by 
centrifugation at 4°C for 10 min at 10.000g. Serum aliquots were stored at -80°C. 
Total thyroxine (TT4) concentrations in serum of mice were measured using ELISA 
kits according to the manufacturer's instructions (DRG Instruments GmbH, 
Germany). Hypothyroidism in the mice was defined by decreased serum TT4 
concentrations (detection limit of 0.5 µg/dL). 
Mice were euthanized and perfused with heparinized saline through a needle placed 
in the left ventricle. Livers were isolated, frozen in liquid nitrogen, and stored at -
80 °C until further processing. 
RNA isolation and cDNA synthesis 
For RNA extraction, tissues were homogenized in 600 µl RLT buffer (Qiagen) by 
4.000 rpm and further treated with proteinase k (Qiagen) based on the 
manufacturers’ protocol. Total RNA from tissue lysates was purified by RNeasy mini 
kit (Qiagen, Germany) and on-column DNase digestion using RNase-Free DNase 
Set (Qiagen, Germany). RNA quantity and quality were determined by NanoDrop 
1000 (Thermo Scientific). 2 µg of RNA was reverse transcribed to cDNA using 
random hexamers and SuperScript III First-Stand Synthesis System for RT-PCR 
according to instruction manuals (Life Technologies, Germany). 
Real-time PCR 
Oligonucleotides of deiodinase 1 (Dio1), malic enzyme 1 (Me1) and claudin-1 genes 
were designed using PrimerBlast (NCBI) and synthesized by eurofins (Eurofins MWG 
Synthesis, Germany). Dio1 forward primer: GGGCAGGATCTGCTACAAGG, Dio1 
reverse primer: CGTGTCTAGGTGGAGTGCAA. Me1 forward primer: CCCACAACA-
GTGTCTACCCAT, Me1 reverse primer: TCATCCAGGAAGGCGTCATA. Claudin-1 
forward primer: CAACCCGAGCCTTGATGGTA, claudin-1 reverse primer: ACTAAT-
GTCGCCAGACCTGA. Quantitative real-time PCR (RT-PCR) was performed using 
LightCycler® DNA Master SYBR Green I and the LightCycler®480 System (Roche, 
Germany). The PCR program consisted of an initial denaturation step (5 min at 
95 °C) and 40 amplification cycles with 15 sec at 95 °C, 10 sec at 60 °C, 20 sec at 
72 °C. For normalization of Dio1, Me1 and claudin-1 expression reference genes 
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18S, Ppia (peptidylprolyl isomerase A, cyclophilin A) and RPL13 a (ribosomal protein 
L13a) were used. Stability of housekeeping genes was determined by calculation of 
the coefficient of variation on the normalized relative quantities and by calculation of 
the geNorm M value. The geNorm value determines the most stable housekeeping 
genes and calculates the gene expression normalization factor based on the 
geometric mean of a housekeeping gene. The genomic average of the “best” three 
housekeeping genes (best keeper index) was calculated by repeated pair-wise 
correlation analysis. Target genes were correlated to the calculated index (best 
keeper index). Fold-changes were calculated by the relative expression software tool 
(REST© (provision of a subsequent statistical test to the analyzed Ct values by a 
pair-wise fixed reallocation randomization test, efficiency corrected ΔΔCt method, 
Ct<35) [19, 20]. 
Western blot 
The following antibodies were used: anti-claudin-1 (1:250, Invitrogen, USA), anti-
GAPDH (1:1.000, Cell Signalling, USA), anti-cytokeratin 19 (1:1.000, Abcam, USA), 
anti-ß-actin (1:2.000, Cell Signalling, USA), anti-mouse/anti-rabbit-IgG (1:2.000, Cell 
Signalling, USA) and anti-mouse IgG DyLight 488 conjugate (1:15.000; Life 
Technologies, USA). Whole protein lysates were extracted by RIPA-buffer (150mM 
sodium chloride, 50mM Tris pH 8.0, 1% NP-40, 0.5% sodiumdeoxycholate, 0.1% 
sodium dodecyl sulfate, 2mM ethylenediaminetetraacetate, 50mM sodium fluoride, 
protease inhibitor, Sigma, Germany). Extracted proteins were quantified by BCA 
protein assay (Pierce, Rockford, USA). Aliquots of proteins (40 µg) were fractionated 
on Any kDTM CriterionTM TGXTM SDS polyacrylamide gels and blotted by wet transfer 
(wet electroblotting by 10 V and 4 °C, overnight) onto PVDF membranes (BioRad, 
USA). Unspecific binding sites were blocked with blocking buffer (5% milk powder in 
phosphate buffered saline, Sigma, Germany) for 1h at room temperature. Claudin-1 
GAPDH, cytokeratin 19 and ß-actin were detected by overnight incubation of the 
respective antibody at 4 °C in blocking buffer. GAPDH and ß-actin were used as 
internal protein loading controls. Both protein loading controls revealed a stable 
protein loading, only GAPDH is shown. Cytokeratin 19 was used to detect the 
amount of cholangiocytes in whole protein lysates [21]. Secondary antibodies were 
incubated at room temperature for 1h. Visualization was done by luminescence using 
the Immun-StarTM WesternCTM Kit (BioRad, USA) as well as fluorescence (VersaDoc 
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System, BioRad, USA). Differences in protein expression levels were quantified by 
densitometry using the Image LabTM Software (BioRad, USA). Relative values of the 
loading controls GAPDH and cytokeratin 19 were calculated. The claudin-1 protein 
values were divided by the calculated relative values of either GAPDH or cytokeratin 
19. The adjusted values were used to calculate the geometric mean of the loading 
controls and claudin-1 followed by calculation of the fold-change of claudin-1 to the 
respective loading controls.  
Immunofluorescence 
The following antibodies were used: anti-claudin-1 (1:100, Invitrogen, USA), 
AlexaFluor® 555 Phalloidin (1:40, Invitrogen, USA), and AlexaFluor® 488 (1:250, 
Invitrogen, USA) secondary antibody. Cryo liver tissues were fixed in 4% 
paraformaldehyde (Sigma, Germany) for 15min at room temperature and 
permeabilized using 0.1% Triton X100 (Sigma, Germany) in phosphate buffered 
saline (PBS) for 10min at room temperature. The pre-incubation in blocking solution 
containing 3% bovine serum albumin (BSA) and 0.3% Triton X100 in PBS was 
performed at room temperature for 30min. Cryo liver tissues were incubated with 
primary antibodies overnight at 4°C in 1%BSA/PBS. Secondary antibody AlexaFluor® 
488 was incubated for 1h at room temperature in 1%BSA/PBS. The F-actin 
cytoskeleton was visualized by incubation of AlexaFluor® 555 Phalloidin for 20min at 
room temperature. The cell nuclei were stained by incubation of Hoechst 33342 
(1:1.000, Invitrogen, USA) for 5min at room temperature. Cover slides were 
embedded by ImmuMount (Thermo Scientific, USA) and viewed on the confocal 
microscope Zeiss ELYRA PS.1 LSM710. 
Statistical analysis 
All data are shown as mean±SEM, as indicated. Statistical analysis was performed 
using GraphPad Prism 5 Software. For ELISA and real-time PCR data 2-way ANOVA 
was applied. Values of *p≤0.05, ***p<0.001, #p<0.0001 were considered statistically 
significant. 
5.4 Results 
To determine successful induction of hypothyroidism in C57BL/6NTac mice TT4 
serum concentrations were determined by ELISA measurement (fig. 1a). Induction of 
hypothyroidism resulted in a significant decrease of TT4 serum concentration in male 
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(1.20±0.56 µg/dL vs. 2.86±0.21 µg/dL) and female mice (0.35±0.33 µg/dL vs. 
3.01±0.77 µg/dL). TT4 serum concentration of female hypothyroid mice is below the 
detection limit of the applied assay (0.5 µg/dL) and therefore carefully to construe. 
To ensure a hypothyroid state in mice livers, the mRNA levels of the two positively 
regulated TH responsive genes Dio1 and Me1 were analyzed (fig. 1b). Induction of 
hypothyroidism significantly decreased Dio1 mRNA levels in male and female mice 
as compared to euthyroid mice (0.01±0.001 vs. 1.07±0.08 for males and 0.01±0.001 
vs. 1.02±0.03 for females, respectively). Me1 mRNA levels revealed also a significant 
decrease in hypothyroid mice as compared to euthyroid mice of both sexes 
(0.24±0.02 vs. 1.07±0.06 for males and 0.42±0.03 vs. 1.02±0.06 for females, 
respectively).  
Claudin-1 mRNA level was investigated in male and female C57BL/6NTac mice liver 
with normal thyroid function and under chronic hypothyroidism (fig. 1c). Claudin-1 
mRNA level was not altered in hypothyroid male mice as compared to euthyroid male 
mice (0.86±0.06 vs. 1.12±0.09). Conversely, the induction of hypothyroidism in 
female mice led to a significant increase of claudin-1 mRNA level as compared to 
euthyroid control mice (1.98±0.26 vs. 0.97±0.15). Comparing male to female mice 
with normal thyroid function, a significantly lower claudin-1 mRNA level was observed 
in female mice (0.66±0.07 vs. 0.97±0.15). 
 
Figure 1: Serum concentration of total thyroxine (TT4) in male and female eu- and hypothyroid 
mice. Fold-changes of deiodinase 1, malic enzyme 1 and claudin-1 mRNA expression in 
euthyroid and hypothyroid male and female mice liver by quantitative real-time PCR. a TT4 
serum concentration is significantly lower in male mice after induction of hypothyroidism than 
euthyroid male control mice. TT4 serum concentration of hypothyroid female mice is significantly lower 
as compared to the euthyroid female control group. TT4 was determined in mice serum by ELISA at 
the start and end of 7 weeks (wks) treatment. Assay detection limit of 0.5 µg/dL. Data are represented 
as mean±SEM, n=16 for start, n=8 for end groups, 2-way ANOVA, ns= not significant, *p<0.05, 
#p<0.0001. b Deiodinase 1 (Dio1) and malic enzyme 1 (Me1) mRNA levels are significantly decreased 
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in hypothyroid mice as compared to euthyroid mice for both sexes. c Claudin-1 mRNA level is not 
altered in hypothyroid male mice as compared to euthyroid male mice. Claudin-1 mRNA level is 
significantly up-regulated in female mice under hypothyroidism. Claudin-1 mRNA level of euthyroid 
female mice normalized to euthyroid male mice shows a significantly lower claudin-1 mRNA level in 
female animals. 18S, Ppia (peptidylprolyl isomerase A, cyclophilin A) and Rpl13 a (ribosomal protein 
L13a) were used as reference genes. Data are represented as mean±SEM, n=8, efficiency corrected 
ΔΔCt method, 2-way ANOVA, ns= not significant, *p<0.05, **p<0.01, #p<0.0001. 
To investigate, if differences in mRNA expression were also reflected on the protein 
level, claudin-1 expression was studied by Western blot analysis in euthyroid and 
hypothyroid livers of male and female mice followed by quantification (fig. 2a,b). 
Hypothyroid male mice showed a lower claudin-1 protein level than the euthyroid 
control group. In addition, mRNA results of a significantly lower claudin-1 level in 
euthyroid female than male mice could be confirmed on protein level. Moreover, an 
increased claudin-1 protein level was shown after induction of hypothyroidism in 
female mice. Equal amounts of cytokeratin 19 protein (protein marker of 
cholangiocytes [21]) in male and female mice liver with normal thyroid function and 
under hypothyroidism were observed. 
 
Figure 2: Claudin-1 protein expression and quantification in euthyroid and 
hypothyroid male and female mice liver. a/b Whole protein lysates were used. Lower 
claudin-1 (18 kDa) protein level in hypothyroid male mice liver than euthyroid male mice liver. 
Elevated claudin-1 protein level in hypothyroid female mice liver as compared to euthyroid 
female mice liver. Euthyroid female mice show lower claudin-1 protein amount than euthyroid 
male mice liver. As loading controls GAPDH (37 kDa) and cytokeratin 19 (40 kDa) as marker 
of cholangiocytes were used. Quantification was performed by densitometry and 
normalization of claudin-1 protein amount to the respective loading controls. Representative 
examples are shown (n=8). 
To determine the localization pattern of claudin-1, immunofluorescence analysis of 
euthyroid and hypothyroid mice liver of both sexes was performed (fig. 3). Claudin-1 
protein was found to be located in the canalicular regions of hepatocytes as well as in 
epithelial cells of bile ducts. In addition, a homogeneous decrease of claudin-1 
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protein level was observed in hypothyroid male mice liver vs. euthyroid male controls 
(fig 3a,b). In hypothyroid female mice liver claudin-1 level increased mainly in bile 
duct regions as compared to euthyroid female controls (fig. 3c,d). 
 
Figure 3: Immunofluorescence of claudin-1 in euthyroid and hypothyroid male and 
female mice liver. a Euthyroid male liver with claudin-1 (green) staining in canalicular region 
of liver and the bile duct. Central vein (CV), Bile duct (B) and hepatocytes (H). b Hypothyroid 
male liver with lower claudin-1 level than euthyroid male liver. c Euthyroid female liver with 
low claudin-1 level. d Hypothyroid female liver with distinct claudin-1 expression in 
cholangiocytes and/or epithelial cells of the bile duct. Grey scale images show only claudin-1 
channel. F-actin cytoskeleton has been stained by AlexaFluor® 555 Phalloidin (red). Nuclei 
were stained by Hoechst 33342 (cyan). Magnification of 63x. Confocal microscope Zeiss 
ELYRA PS.1 LSM710. Representative examples are shown (n=4). 
5.5 Discussion 
Here we show that the TJ protein claudin-1 reveals sex-dependent liver expression 
and is distinctly altered by induction of hypothyroidism in male and female mice liver. 
Expression differences were found on mRNA and protein level. In euthyroid mouse 
liver, claudin-1 is higher expressed in males than females and seems to be localized 
mainly in canalicular regions of liver, cholangiocytes and epithelial cells of the bile 
duct, hence the biliary system. Our data contrast with a previous study, reporting 
elevated claudin-1 expression in female compared to male mouse livers by 
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immunohistochemistry [22]. However, differences could be explained by different 
methods used to detect claudin-1 expression and/or the investigated C57BL/6 
substrain. 
When comparing hypothyroid to euthyroid mice liver we found differences in claudin-
1 expression between both sexes. In male mouse liver, induction of hypothyroidism 
decreases claudin-1 protein whereas in females an increase in claudin-1 expression 
could be detected. Total T4 serum concentrations of mice suggest a more 
hypothyroid state of females than male mice which could impact claudin-1 
expression. However, if female mice are more hypothyroid than male mice it would 
be suspected that claudin-1 expression results in a more pronounced decrease in 
female than male mice liver. Furthermore, due to TH responsive gene levels in mice 
livers a comparable hepatic hypothyroid state of male and female mice could be 
speculated. 
Hypothyroidism can lead to a disturbed bile transporting system in rat liver [23]. A 
reduced bile excretion in liver of hypothyroid mice could also be related to an altered 
expression of claudin-1 due to its localization within the bile duct and canalicular 
region. However, if claudin-1 is TH-dependently regulated by THRß, the most 
prevalent thyroid hormone receptor in liver [24], has to be investigated in further 
studies. 
Hypothyroidism could indirectly affect claudin-1 expression in liver due to altered 
cholesterol content. In the blood-testis barrier of rabbits fed a 2% cholesterol 
enriched diet increased occludin and zonula occludens protein 1 (ZO-1) expression 
levels as well as a pronounced endosomal distribution of these TJ proteins have 
been observed [25]. Depletion of cell cholesterol in a human kidney cell line (Caco-2) 
leads to a loss of membrane localization of claudin-3, -4, -7 and occludin resulting in 
a diminished paracellular integrity and an increased paracellular permeability [26, 
27]. However, claudin-1 distribution was not altered in Caco-2 cells under cholesterol 
depletion [26]. In contrast, Madin-Darby canine kidney cells (MDCK) reveal that the 
paracellular integrity develops more rapidly and reaches higher values of integrity the 
lower the cell cholesterol content is [28]. 
It could be speculated that the decreased claudin-1 expression in liver of hypothyroid 
male mice might contribute to an altered paracellular pathway of the hepatocellular 
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tract. In addition increased claudin-1 expression in hypothyroid female liver could 
result in pronounced paracellular integrity of the canalicular region and bile duct.  
Very little is known about the functional consequences of altered claudin-1 
expression and the regulation of claudin-1 in the bile duct epithelium. Claudin-1 
deficient mice do not show biliary diseases, probably because these mice died at 
birth due to an impaired skin barrier [17]. It seems likely, that sex hormones are 
involved. Previous in vitro studies have shown that progesterone and estradiol are 
influencing TJ expression in a concentration dependent manner in human vascular 
endothelial and human endometrial epithelial cells [6, 29]. However, most animal 
studies concentrated on TJ proteins like occludin or ZO-1 and data of claudin-1 are 
almost missing [3]. It is thought that claudin-1 could be regulated via different signal 
transduction pathways like MAPkinase or PI3kinase [9], but the data are not 
consistent and it will be interesting to consider these pathways in the context of non-
genomic TH action. 
It should not disregard that a possible interaction between estradiol and TH could be 
involved in the sex-specific differences of claudin-1 expression as both receptors, 
THRs and estrogen receptors, belong to the superfamily of nuclear receptors and 
share similarities in TH responsive element structures [30]. It has been shown that 
molecular interactions between THRs and estrogen receptors are sufficient to 
mediate environmental effect on estrogen-controlled reproductive behavior [30]. 
Recently an overlapping effect of TH and estradiol on glutathione S-transferase-α 
gene expression in mice kidney has been observed [31]. However, if claudin-1 
expression is also influenced in an estradiol-dependent manner can be investigated 
by using e.g. an ovariectomized mouse model. 
In liver also other TJ proteins like occludin, claudin-2 and claudin-3 are expressed 
[10]. If these TJ proteins are equally affected by TH has to be determined in further 
studies. 
However, absence or mutations of claudin-1 have been associated with distinct 
human biliary diseases [11-13]. It is supposed that women are more affected in 
developing common bile duct stones than men [32]. It could be speculated that the 
low claudin-1 expression in euthyroid female mice liver could prefer the formation of 
biliary diseases due to a less-sufficient paracellular barrier. Otherwise, there seems 
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to be a sex-dependent relation between hypothyroidism and gallstone diseases with 
a higher prevalence for men [8]. The diminished hepatic claudin-1 expression in 
hypothyroid male mice and an increased risk for biliary disease with low claudin-1 
expression [11-13] could explain why gallstone diseases are more frequent in 
hypothyroid men. 
The molecular mechanisms that account for the observed sex-dependent pattern of 
claudin-1 expression and their functional consequences have to be investigated in 
further studies. In summary this study shows that the TJ protein claudin-1 is altered 
by hypothyroidism and differs between sexes in a mice model. 
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Chapter 6: Discussion 
Thyroid hormones (THs) control various physiological functions, such as heart rate, 
bone development, lipid metabolism, body temperature (BT) and body weight (BW), 
as well as brain maturation and function (Yen, 2001). Thus, an untreated dysbalance 
of THs causes severe symptoms. Thyroid dysfunctions (TDs) resulting from an over- 
or underproduction of THs are known as hyper- and hypothyroidism, respectively and 
are frequent in the general population. Moreover, TDs show a female preponderance 
with women more often affected by hyper- and hypothyroidism, thyroid autoimmunity, 
as well as thyroid cancer (Vanderpump et al., 1995; Hollowell et al., 2002; Leese et 
al., 2008).  
Interestingly, little is known whether TDs have different consequences or morbidity in 
male or female organism.  
To clarify whether TDs have sex-specific symptoms and traits the characterization of 
a mouse model is an important tool, in particular since it allows comprehensive 
analysis of behaviour, dissection of organ-specific effects and tissue-specific analysis 
of TH signalling. Thus, using male and female C57Bl/6 wildtype mice it is possible to 
mimic the clinical situation of a hyper- or hypothyroid state and to study the influence 
of sex on phenotypical traits of TDs.  
As the onset of TDs varies in the human population a further important issue is to 
include mice of different ages. Thus, hyper- or hypothyroidism may have different 
outcomes at young, adult or old life stage. From the clinical point of view symptoms 
of TDs are often diminished in the elderly population although the prevalence of TD 
increases and are often masked by complaints about impairments related to aging 
(Rehman et al., 2005). Furthermore, an additional advantage of using especially 
older female mice is the possibility to exclude influence of circulating sex hormones. 
Although mice do not undergo a menopause as women do (Wise, 2006), 
measurements of estrogen concentration in sera of old female mice showed 
comparable values as for ovariectomized female mice (Cai et al., 2014). Thus, by 
using young and old female mice one can distinguish between differences, which are 
likely sex-hormone dependent or due to genetic background and by this approach 
assess the influence of circulating female sex hormones. 
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6.1 Induction of chronic hyper- and hypothyroidism in a mouse model 
Various methods are used in the literature by different groups for an induction of 
hyper- and hypothyroidism in rodents (Bianco et al., 2014; Reed et al., 2000; Ferreira 
et al., 2007; Wilcoxon et al., 2007; Fabian et al., 2015). However, TD induction 
protocols used in our studies had to meet certain criteria. First, well tolerated by mice 
in general; second, usable as long-term treatment and third, successful in induction 
of TD in both sexes. Prior literature research revealed more studies on rat than on 
mice, as well as only few studies comprising both sexes. Furthermore, to clarify the 
influence of sex on symptoms of TDs a treatment of several weeks is needed, an 
aspect which has not been addressed so far.  
 
Methods for deprivation of TH concentrations in mice 
Hypothyroidism defined as TH deficiency, can be induced by using antithyroidal 
drugs, which are administered via food, water or direct injection. Another more 
invasive procedure to induce TH deprivation is thyroidectomy, which however 
requires high experimental expertise and results in a considerable burden for the 
animals. Antithyroidal drugs are known to be well tolerated in humans, as well as in 
rodents (De Leo et al., 2016). Most common used drugs include propylthiouracil 
(PTU), methimazole (MMI) and perchlorate (ClO4-) and are in rodent studies, if 
applied by drinking water, combined with a sweetener as saccharine or sweet syrup. 
PTU can be administered via food pellets and reduces TH serum concentrations by 
blocking thyroid peroxidase (TPO) as well as by inhibiting Dio1 (Shiroozu et al.,1983; 
Bianco and Kim, 2006). Thus, not only the production of THs is blocked, but also the 
conversion of T4 to T3 in peripheral organs is reduced. MMI supplied by drinking 
water inhibits only TPO, and is not sufficient to decrease TH production completely 
(Shiroozu et al., 1983). By adding ClO4-, an inhibitor of the sodium-iodide-symporter 
(mediates iodide uptake in follicular cells of the thyroid gland for TH synthesis; Leung 
et al., 2010), and in combination with a low-iodine diet a successful TH deprivation is 
achieved (Hönes et al., unpublished). However, PTU administration is not well 
tolerated in long-term experiments in mice, therefore combined MMI/ClO4- treatment 
in drinking water, in addition to a low-iodine diet was preferred, which achieved TT4 
serum concentrations below assay detection limit after 3 weeks (Hönes et al., 
unpublished).  
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Protocols to induce TH excess in mice and establishment of i.p. and oral T4 
treatment 
For induction of hyperthyroidism, besides species differences, different administration 
routes for T4 or T3, as well as a combination of both are described in the literature. 
However, in this work T4 was the preferred drug, as on the one hand L-thyroxine is 
mainly used for TH substitution in patients and on the other hand investigating the 
conversion of T4 to T3 was part of this study. The dosage of T4 administered via i.p. 
injections in the literature ranged from low (e.g. 0.6 µg/g BW for 30 days; Klecha et 
al., 2006) to high (10 µg/g BW for 8 days; Reed et al., 2000) concentrations. To 
prevent severe thyrotoxicosis in a long-term treatment a dosage of 1 µg/g BW T4 
was used every 48 hours. In addition, the required time to achieve stable tissue 
thyrotoxicosis was unknown, hence induction of hyperthyroidism was conducted over 
a period of at least 5 weeks. Using the oral T4 supply route, ranges of 2 µg T4/mL to 
12 µg T4/mL were reported (Ferreira et al., 2007; Wilcoxon et al., 2007; Messarah et 
al., 2010). At the beginning of the experiment, a dosage of 5 µg T4/mL was used and 
enabled comparison of the efficacy of i.p. vs oral T4 supply for induction of chronic 
hyperthyroidism in mice.  
Both i.p. and oral T4 administration resulted in elevated TH serum concentrations of 
TT4, FT4 and FT3 after 2-3 weeks of treatment, which remained high throughout 
experimental time (Chapter 2, Fig. 2, 3). Thereby, the oral dosage of 5 µg T4/mL 
resulted in much higher TH serum concentrations than expected and caused severe 
thyrotoxicosis in mice. Thus, the oral group was divided and one part received 
1 µg/mL T4 continuously while in the other group, treatment of mice was stopped for 
1 week to monitor if TH serum concentrations recover to normal ranges. One week 
was sufficient to obtain normal TH serum concentrations (Chapter 2, Fig. 3) and 
hence T4 treatment was continued in this group with 1 µg T4/mL. Lower oral dosage 
resulted in a rapid and proportional adjustment of TH serum concentrations and thus 
being then comparable in both methods, 1 µg/g BW T4 i.p. or 1 µg/mL T4 in drinking 
water.  
In this context, a sex difference in TH serum state after exogenous i.p. T4 supply was 
found with much higher TT4 and FT4 serum concentrations in female compared to 
male mice (Chapter 2, Fig. 2). Since no differences were found in sham treated 
control male and female mice, the response to T4 administration and its metabolism 
is suggested to be estrogen-dependent. Previous studies by others support this 
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observations and reported a sex-dependent response to exogenous T3 supply with 
higher T3 serum concentrations in female compared to male mice (da Silveira et al., 
2014). However, further evaluation and testing in subsequent studies in 
gonadectomised mice are necessary to obtain detailed information about sex-
dependent response to TH metabolism in mice sera.  
 
Time-dependent tissue response to TH excess in mice 
The next important issue of this study was to evaluate if chosen treatment timing is 
sufficient to maintain a hyperthyroid state over a long-term period and at the end of 
experiment on tissue level. Thus, liver and heart of mice sacrificed 24h, 48h, 72h and 
144h after last i.p. or oral T4 administration were analysed via quantitative real-time 
polymerase chain reaction (qRT-PCR) for known TH-responsive gene expression. 
For i.p. T4 treatment a 24h or 48h dosing interval was sufficient to maintain a 
thyrotoxic organ state. Moreover, an extended dosing interval resulted in a transient 
hypothyroid organ state, most likely due to sustained suppressed HPT axis under 
chronic thyrotoxicosis.  
Furthermore, comparison of gene expression changes between i.p. and oral T4 
treated mice at the same time points showed that transcript changes in organs of oral 
T4 treated mice were less pronounced compared to i.p. treated animals most likely 
due to altered kinetics and/or dosage of altered TH exposure. Thus, an injection 
resulted in a rapid increase of serum TH concentrations, while oral treatment ensured 
continuous, but low dosages of T4. Therefore, a discontinuation of oral T4 supply 
should not be implemented prior to sacrifice and organ collection.  
Finally, although i.p. and oral T4 administration were reliable methods to induce 
hyperthyroidism in mice, for subsequent studies i.p. over oral treatment was 
preferred due to the possibility of a better control of dosage in each individual mouse. 
A treatment time of 3 weeks was required to achieve stable steady state of TH serum 
concentrations and was therefore set as an induction period, prior to phenotypical 
characterization of mice. 
Thus, in the following studies of young (5 months), adult (12 months) and old (20 
months) male and female mice hypothyroidism was induced by 0.02% MMI, 
0.5% ClO4- and 0.3% saccharine in drinking water combined with low iodine diet, 
while hyperthyroidism was induced by i.p. injections of 1 µg/g BW T4 every 48h.  
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6.2 Distinct sex impact on TH serum concentrations under TH excess  
As already described in the previous section, a difference in response to T4 
treatment was noted with higher TH serum concentrations in female compared to 
male mice. Subsequent studies of young, adult and old mice confirmed the same 
sex-dependent distribution for TT4, FT4 and FT3 serum concentrations (Chapter 3, 
Fig. 5 a-c, Chapter 4, Fig. 2). As the degree of difference (Δ=female-male) between 
young, adult and old animals was similar (~2-fold), this could have not resulted from 
female sex-hormone influence only.  
Differences in TT4 concentrations can be related to increased estrogen-dependent 
binding to thyroxine-binding globulin (TBG) (Engbring and Engström, 1958; Tahboub 
and Arafah, 2009). Thus, estrogen replacement in postmenopausal women often 
results in increased TT4, but decreased FT4 concentrations due to a shift of higher 
thyroxine binding (Abdalla et al., 1984; Mazer, 2004). However, this is not 
transferable to this mouse studies, as high dosages of T4 were used, which might 
have resulted in an oversaturation of TBG and thereby higher FT4 concentrations.  
Assuming a decrease of estrogen concentration in female mice with aging, additional 
studies are needed to evaluate further contributing factors as e.g. sex-dependent T4 
uptake from peritoneum. Whether this is mediated via lymphatic or non-lymphatic 
absorption and if sex plays a role has not been described yet (Nagy et al., 1992). 
Furthermore, many pathways are involved in TH metabolism as degradation and 
detoxification of TH excess, which can be sex-dependently altered. A single-injection 
of T4 is excreted to ~90% within 48h in similar parts by feces and urine in young 
male mice (Schneider et al., 2006). Although not included in this work, one can 
assume a change of excretion in a long-term treatment being additionally influenced 
by age and sex, a hypothesis which should be assessed in future studies. 
Sex-different response to T4 treatment was also noted for FT3 serum concentrations 
and is most likely a result of higher FT4 and TT4 concentrations in female mice, as 
more available T4 molecules can be converted to T3. In fact, a higher sex-dependent 
enzymatic Dio1 activity in female mice was described not only for young (2 months; 
Riese et al., 2006), but also adult mice (12 months; Schomburg et al., 2007) and 
supports this hypothesis. Thus higher renal Dio1 activity in young female compared 
to male mice was noted, while hepatic Dio1 was more active in males than female 
mice (Riese et al., 2006). Aging was accompanied by persistent sex-difference in 
renal Dio1 activity, while no sex-difference was noted in livers of 12 months old mice 
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(Schomburg et al., 2007). Renal Dio1 activity might contribute to the observed sex-
differences in serum FT3 of hyperthyroid mice, but was not addressed in our studies 
so far.  
TH deprivation resulted in TT4 serum concentrations below assay detection limit, in 
all age groups and in male and female mice confirming successful induction of 
hypothyroidism, independent of age and sex.  
 
6.3 Sex-dependent influence of THs on body weight and nutrient uptake 
Alterations of body weight are influenced by age, sex and TH 
Patients diagnosed of TDs often complain about changes in BW. Hyperthyroidism is 
associated with weight loss, while hypothyroidism goes along with BW gain (Fox et 
al., 2008). In this context one of the obvious phenotypical changes was expected for 
BW in our mice.  
The influence of TH excess on BW of rodents has been addressed in previous 
studies. BW gain or no alterations of BW have been described for young mice under 
thyrotoxic conditions (de Luise and Harker, 1989; da Silveira et al., 2014; Cordeiro et 
al., 2013; Tancevski et al., 2008), while BW loss was found only with short intra-
cerebral administration of T3 (Alvarez-Crespo et al., 2016) in mice. In the 
establishment of chronic hyperthyroidism BW gain was observed under T4 treatment 
in male and female mice at 10 weeks, sex-dependently more pronounced in females 
(Chapter 2, Fig. 4). Using young mice (5 months) BW gain could be confirmed with 
TH excess, but this time sex-dependently more pronounced in male mice (Chapter 3, 
Fig. 2 b). One very likely reason for this discrepancy is the difference in age at 
beginning of experiment and therefore different stages of development.  
Furthermore, hyperthyroidism and aging was accompanied by a strong sex-
difference in BW, observed in adult (12 months) and old (20 months) mice. T4 
treated female mice gained BW to a similar amount in adult and old age as in young 
(5 months), while T4 treated male mice started to loose BW after 2-3 weeks of 
treatment in adult and directly from the start of treatment in old age (Chapter 4, Fig. 3 
b, e). As this strong effect was male mice specific, BW regulation under hyperthyroid 
conditions could be influenced by male sex-hormones.  
The ATA guidelines for investigations of thyroid hormone economy and action in 
rodents (Bianco et al., 2014) described in 2014 a plateau in BW change to be 
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characteristic under systemic hypothyroidism. This was confirmed for young (5 
months) male and female mice (Chapter 3, Fig. 2 c) while with increasing age adult 
and old mice of both sexes very slowly lost weight during experimental time (Chapter 
4, Fig. 3 c, f). Thus, an aging organism might be less able to compensate TH 
deprivation compared to a young organism. Sex-dependency was observed only for 
certain time points in young and at some time points in old mice with lower BW of 
males compared to females. This might indicate a better tolerance of TH deficiency in 
female than male mice. 
Sham treated control animals did not show sex-difference in BW change in adult and 
old age, however young male mice gained weight faster than females. This is in line 
with the suppliers information of juvenile male mice gaining weight over a longer time 
period during development compared to female mice (Taconic Biosciences, USA) 
and has also been reported by other studies (Samuel et al., 2013). However, BW and 
fat content is regulated by several factors in rodents and is not dependent on THs 
only, as shown in a recent study. A stringent selection of high and low BW mice was 
used to generate over 50 generations two BW-specific lines out of the same 
background and strain. Interestingly, TH deprivation in both thus newly created 
mouse strains resulted in a decrease of BW and fat mass, but could not equalize 
high BW mice to low BW mice. Even after depletion of thyroid and growth hormones, 
BW of both mice strains were not equal, suggesting that further genetic factors 
contribute to BW regulation (Bünger et al., 1998). 
 
TH-dependent food and water intake is differently regulated in female and male mice 
As a useful addition to changes in BW, monitoring of food and water intake was 
implemented to assess influences of TDs on nutrient uptake and body composition. 
In patients hypothyroidism can be accompanied by loss of appetite (ATA booklet 
Hypothyroidism, 2013) while hyperthyroidism is usually associated with increased 
appetite (ATA brochure Hyperthyroidism, 2014).  
TH excess resulted in a sex-difference in food and water consumption in young 
animals, which decreased in adult and even disappeared at old age. While no 
difference was noted for food intake between male and female mice in all age groups 
under TH deprivation, water intake was reversed and young, adult and old male mice 
consumed more water than females. Food and water intake of mice in euthyroid 
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conditions was sex-dependent at all ages with higher food intake in female than male 
mice (Chapter 3, Fig. 2 d; Chapter 4, Fig. 4 a, d, Fig. 5 a, d). 
Surprisingly, a reversed drinking behaviour of hypothyroid mice was noted in young, 
adult and old ages, as female mice, despite of addition of saccharine, consumed less 
MMI/ClO4- water. It remains speculative whether this is related to sex-dependent 
preference of some substances (MMI/ClO4-), as taste receptor distribution in mice 
has been shown to be sex-unspecific (Zhang et al., 2008; Tordoff et al., 2007). 
Alternatively, this could have resulted from altered hormonal regulation of fluid intake 
which has been described in hypothyroid patients (Sahún et al., 2001; Karmisholt et 
al., 2011), but was not addressed in mice so far. Thus, a TH influence on thirst 
regulation might be sex-specific in mice or rodents in general. 
Both food and water intake seemed to be similarly regulated, with respect to age and 
sex under euthyroid and hyperthyroid conditions. Altered food intake did not explain 
observed differences in BW change. Moreover, increased food intake was even 
related to BW loss instead of gain e.g. in adult and old hyperthyroid males. In fact, 
this reflects the clinical situation of hyperthyroid patients of a BW loss despite of 
increased appetite. Thus, understanding the regulation of food intake and weight 
during hyperthyroidism in older male mice might help to apply the findings on human 
situation. 
Food intake in general is known to regulate metabolic functions in mice, but is 
regulated itself by similar metabolic events as described in this work under TH 
alterations. Mice spend at least half of their energy intake for maintenance of body 
temperature, a critical factor which they cannot afford if food is scarce. Thus, food 
restriction in mice results in a fast response of metabolic changes including lowering 
of BT, reduction of thyroid activity, growth and reproduction and thereby reducing 
energy expenditure (Martinez-Sanchez et al., 2014; Himms-Hagen, 1999). It has 
been shown in mice that thyroidal activity and serum T3 levels decrease during 
fasting or severe caloric restriction, but increase again fast when food becomes 
available (Cordeiro et al., 2013; Lartey et al., 2015). Other groups confirmed these 
findings of an increase of food intake in different types of TH excess, or decrease 
under TH deprivation (Cordeiro et al., 2013; Kong et al., 2004; Groba et al., 2013). 
Thus, these data clearly show a highly regulated interplay between nutrient intake 
and thyroidal activity, which is not only different in female and male mice, but 
suggests an influence of sex hormones.  
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6.4 Sex influence on heart rate and body temperature in thyroid dysfunctions 
Sex does not alter TH-dependent heart rate 
Besides TH influence on body composition other functions of an organism are 
affected if THs are in a dysbalance. Hyperthyroidism is often attended by tachycardia 
and heat intolerance, while hypothyroidism goes along with bradycardia and cold 
intolerance in patients (Bahn et al., 2011; Garber et al., 2012). Thus, in all mice we 
determined heart rate in a non-invasive electrocardiography (ECG) system and 
measured BT via rectal probe to identify a possible sex-dependent influence.  
Interestingly, the only sex-difference for heart rate was found for euthyroid young 
male and female mice. Females had a higher heart rate than male mice, a difference 
which disappeared by TH modulation (Chapter 3, Fig. 3 b). No sex difference was 
noted for adult and old mice under any TH conditions (Chapter 4, Fig. 6 c, d). Of 
note, in all age groups and sexes, TH deprivation resulted in a decrease of heart 
rate, while an increase in heart rate under TH excess was found only in young male 
and female mice. ECG measurements were performed in conscious mice after 
training to the restrainer. However, every experiment increased the stress level 
resulting in an increase of basal heart rate and BT. Thus, sex-differences might be 
masked and not distinguishable due to a high stress response. An option to exclude 
stress during measurements is the implantation of a telemetric probe. Using these 
probes long-term measurements are possible without further manipulation. But this in 
turn would increase the physical burden of mice in a much higher value as an 
operation is needed and was therefore not performed.  
 
Body temperature is sex and TH-dependent  
The aspect of a stress response to experiments and handling needs to be considered 
in the influence on BT as well. In fact, the results of rectal temperature 
measurements are considered to be consistent as they were shown to correlate well 
with core body temperature (Newsom et al., 2004). Throughout all age groups and 
TH conditions female mice had a higher BT than male mice (Chapter 3, Fig. 3 a; 
Chapter 4, Fig. 6 a, b) suggesting less influence of circulating female sex hormones. 
A study assessing sex-dependency of BT by radio telemetry over several days 
recorded BT changes in cycling sham-treated and ovariectomized female mice, as 
well as in orchidectomized and sham-treated males. Two important findings were 
noted in this study. First, higher BT in sham-treated female mice during resting and 
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activity phases compared to male mice. And second, higher BT in sham-treated 
female mice during estrous and proestrous cycle in comparison to ovariectomized 
female mice. Thereby, an estrous-associated higher BT in sham-treated female mice 
was always correlated with higher activity in comparison to ovariectomized females. 
Fewer differences were noted for resting BT of these mice, suggesting an influence 
of circulating female sex hormones on activity, which in turn results in increase of BT. 
Thus, at least two factors contribute to the observed sex-differences in BT of male 
and female mice. First, female sex hormones are responsible for elevated BT by 
increasing the activity estrous-dependently and second, increased resting 
temperature of female mice regulated sex hormone-independently (Sanchez-Alavez 
et al., 2011).  
As sex-dependency for BT was measured in all TH conditions and ages TH 
modulation might have less impact on sex-dependency but more on general BT 
regulation, as BT measurements were performed on certain days in the active state 
without consideration of estrous cycle in these mice.  
 
6.5 Activity and muscle function are sex- and TH-dependent 
Fatigue, as well as hyperactivity are symptoms of hypo- and hyperthyroidism in 
human patients, respectively. Moreover, an influence of THs on motoric and muscle 
function are known for a long time (Bahn et al., 2011; Garber et al., 2012; Bianco et 
al., 2014). Thus, an assessment of locomotor activity and muscle function in female 
and male mice under TH modulation was included. Evaluation of activity in young, 
adult and old mice was determined by an open field test, whereas two different 
muscle test were performed. To assess muscle endurance and motor coordination, 
mice were exposed to walk on an accelerating, rotating cylinder (Rotarod), while 
muscle strength and coordination was evaluated by the ability to climb up a tube in a 
certain time frame (Chimney test). 
 
TH independently females show higher locomotor activity in open field than male 
mice 
The open field test reveals an individual response to a novel environment and is 
known to predict a disposition to neuropsychiatric disorders as increased anxiety and 
depression rather than representing the normal acitivity of mice (Carreira et al., 
2017). Although the calculation of open field activity did not always reached 
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significance, a higher locomotor activity of female compared to male mice was 
observed for eu-, hyper- and hypothyroid conditions in young animals. These sex-
differences persisted in adult, but were diminished in old mice (Chapter 3, Fig. 4 b, 
Chaper 4, Fig. 8 c, d). Thus, female mice responded stronger to a novel environment 
than male mice, irrespective of age and TH condititon. Higher locomotor activity and 
increased voluntary exercise of female mice has already been described in euthyroid 
animals (Sanchez-Alavez et al., 2011; Konhilas et al., 2004). However, the possible 
influence of THs and aging on sex-dependent activity has not been addressed so far. 
As sex differences were noted at all ages, but diminished in old mice, this suggests a 
TH-independent, most likely sex hormone-dependent influence. 
 
Muscle function is improved age-dependently in female mice 
In general, muscle endurance was better in female than male mice, displayed by an 
improved performance of female mice in euthyroid controls in young, adult and old 
age. Sex difference was most pronounced in adult mice and decreased in old age. 
This was due to a decline in muscle function of male mice already obvious at 12 
months in control animals, while no age effect was noted in females between 5 and 
12 months of age. Only at 20 months, muscle function of female mice had declined, 
however their performance was still improved compared to 20 months old male mice. 
Under TH excess and deprivation, sex difference disappeared in young, adult and old 
mice (Chapter 3, Fig. 4 d-f, Chapter 4, Fig. 7). Hence muscle function in female mice 
had declined under TH excess especially in adult and old age, while male 
performance was already reduced per se. On the contrary, under TH deprivation 
female mice showed a comparable ability as euthyroid females, while male mice 
even improved e.g. in adult age (Chapter 4, Fig. 7 c).  
These findings from the rotarod test were also in line with results of the chimney test, 
showing a correlation between muscle coordination and strength. Euthyroid female 
mice showed a better performance at all ages and needed less time to climb up the 
tube compared to males. While male mice showed a drastic decline in muscle 
strength already at 12 months of age, with a high failure rate little difference in 
performance was noted between 5 and 12 months old female mice. In addition, 
muscle strength declined with TH modulation in male and female mice, more under 
TH excess compared to TH deprivation, but sex effect was still persistent in young 
and adult age. However, for old mice the chimney test was not applicable, as only 
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one male and eight female mice were able to climb up the tube, and therefore neither 
a sex- nor a TH-effect could have been addressed properly (Chapter 4, Fig. 8 a, b).  
 
Suggested mechanisms of TH and sex hormone influence on muscle function 
Thyroid and sex hormones are likely to be involved in central mediated and direct 
effects on muscle coordination and function. An early study describing the influence 
of age, sex and TH on the energy metabolism of muscles investigated oxygen 
consumption of isolated soleus muscles. Mice of both sexes, different ages (5-35 
weeks) and with or without T3 treatment were included. Hyperthyroidism increased 
oxygen consumption compared to controls; however, a sex or age effect was 
addressed in euthyroid mice only. Aging resulted in a reduction of oxygen 
consumption and thereby decreased muscle metabolic rate in male and female mice. 
Moreover, female compared to age-matched male mice had advanced oxygen 
consumption (de Luise and Harker, 1989). In addition it has been reported, that 
isolated male muscles contract shorter than female muscles, resulting in a higher 
output (Glenmark et al., 2004). In contrast, female muscles are more fatigue 
resistant, recover faster and show less mechanical damage after exercise (Glenmark 
et al., 2004; Burnes et al., 2008). Thus, ex vivo investigations confirmed age and sex, 
as well as TH-dependent effects on muscle metabolism and function, which was 
observed in motoric tests in this work in vivo. Interestingly, deiodinase 2 (Dio2) 
deficient mice, which are characterized by a disrupted HPT-axis with normal T3, but 
elevated T4 and TSH serum concentrations (Schneider et al., 2001) show an 
impairment in motor coordination and function in adult (6 months) but not young (3 
months) male mice. However, if this was a central or direct effect is not 
distinguishable. At 3 and at 6 months altered T3 and T4 concentrations were noted in 
cerebellum and cortex of Dio2 deficient mice, while TH content of muscles was 
measured only at 6 months of age, showing decreased intramuscular T3 
concentrations (Bárez-López et al., 2014). Most likely both, central nervous system 
and muscle effects are responsible for disturbance of motor function in organisms 
with altered TH status. 
  
6.6 Sex hormone influence on TH action in target organs 
Phenotypical changes due to TH modulation in mice of different sexes and ages are 
caused by alterations in underlying molecular mechanisms on transcriptional and 
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translational level. First, gene regulations were investigated by qRT-PCR to quantify 
expression changes due to TH excess or deprivation in young male and female mice. 
As classical symptoms of TD are, amongst others, changes in heart rate, heat or cold 
intolerance and lipid serum profile, investigation of TH-responsive genes and 
transporters focused on heart, brown adipose tissue (BAT) and liver (Chapter 3, Fig. 
6). 
 
Little sex effect was noted for TH-dependent cardiac gene expression   
Sex-difference observed for heart rate in young euthyroid mice disappeared with TH 
modulation. Thus, it was interesting, whether this was reflected in sex-dependent 
gene expression changes in heart tissues of these mice. However, sodium-
taurocholate co-transporting polypeptide (Ntcp) was the only gene, which was 
differently regulated in male and female mice, suggesting that all other genes 
analysed were not representative for whole organ response (Chapter 3, Fig. 6 d-f). 
Moreover, heart rate might have been influenced by indirect alterations of 
sympathetic system, rather than resulting from a direct effect of TH excess or 
deprivation, but was not addressed in these studies so far.  
 
BAT gene expression was strongly sex-dependent in euthyroid mice 
Contrary to heart rate, a persistent sex-difference in BT was noted in eu-, hyper- and 
hypothyroid conditions. Higher expression of all investigated TH responsive and TH 
transporter genes were found in BAT of euthyroid female compared to male mice. TH 
excess resulted in a sex-different response of Dio2 and L-type amino acid transporter 
2 (Lat2) expression, while for hypothyroidism only Lat2 was sex-dependently altered. 
These data suggest a stronger sex-dependency of BAT genes in euthyroid and less 
in hyper- or hypothyroid state. BAT has been shown to be crucial for maintaining BT 
under cold conditions as an important regulator by enabling non-shivering 
thermogenesis through mitochondrial uncoupling protein 1 (Ucp1) (Golozoubuva et 
al., 2001). Moreover, BAT is highly responsive for TH, as well as cold conditions by 
stimulating β-adrenergic signalling centrally and directly (Silva 2006; Alvarez-Crespo 
et al., 2016; Weiner et al., 2017). Thereby, an important note is to consider the 
housing conditions of mice during experimental time at ~23°C, which results in a 
regular exposition to a cold challenge and activated BAT. In contrast thermoneutrality 
in mice is achieved at 30°C. Thus, to evaluate a TH effect only, one should perform 
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mice experiments in a thermoneutral environment. Using this approach TH excess 
has been suggested to cause a fever-like state, rather than an overproduction of heat 
(Alvarez-Crespo et al., 2016). Hypothyroidism in turn inactivated BAT activity only at 
thermoneutrality (Ueta et al., 2011). Therefore, an overlap of activating or inactivating 
signalling due to TH modulation and adjustment to thermal stress due to lowered 
housing temperatures, were expected in mice experiments of this work. In fact, these 
compensatory mechanisms most likely contribute to altered gene expression 
regulation, and one cannot easily distinguish between both effects. However, a sex 
effect has not been addressed on BAT activity and regulation so far, as either male 
or female samples were studied, but not both sexes at once (Weiner et al., 2016; 
Alvarez-Crespo et al., 2016; Sellayah and Sikder, 2014) and will be in focus in future 
investigations. 
 
Hepatic gene alterations are sex and TH-dependent 
Another important TH target organ is the liver which was studied in more detail to 
evaluate if sex has an impact on TH-dependent gene regulation. Among the 
investigated genes in livers of young male and female mice, sex-dependent gene 
expression was noted for both TH conditions hyper- and hypothyroidism. Under 
hyperthyroidism Dio1, malic enzyme (Me1), monocarboxylate transporter 10 (Mct10) 
and L-type amino acid transporter 1 (Lat1) were differently expressed, with higher 
transcriptional levels in female mice except for Lat1. Under hypothyroidism increase 
of Tbg expression was higher in female than in male mice, while no differences were 
noted for other TH responsive genes and transporters. Comparison of liver tissues of 
euthyroid control mice showed a lower basal Tbg, but higher Lat1 gene expression in 
female compared to male mice (Chapter 3, Fig. 6 i). One could speculate that a more 
pronounced response of altered gene expression in female mice under 
hyperthyroidism could be a consequence of sex-difference in serum TH 
concentrations. This hypothesis cannot be rejected, but considering the gene 
expression profiles of hyperthyroid female and male mice in three different target 
organs (heart, BAT, liver) at least in young animals, a consistent gene regulation 
pattern in organs of females compared to male mice could not have been observed. 
Thus, TH serum concentrations may not entirely reflect the organ-specific TH 
concentrations and hence it is not possible to conclude on organ-specific response.  
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6.7 Focus on interplay of TH and sex in liver function and lipid metabolism 
TH-influence on triglyceride and cholesterol serum concentrations is stronger in male 
than female mice 
Another important question was, if the observed sex-dependent hepatic gene 
expression changes are relevant for liver function. Hence, triglyceride and cholesterol 
serum concentrations were determined first, as lipid metabolism is one of the main 
functions of the liver and is known to be altered during hyper- and hypothyroidism 
(Bahn et al., 2011; Garber et al., 2012; Bianco et al., 2014). Surprisingly and in 
contrast to sex-dependent phenotypes under TH excess, a sex difference for both 
lipid parameters could not be detected under TH deprivation with lower serum 
triglyceride and cholesterol concentrations in female compared to male mice 
(Chapter 3, Fig. 5 d, e). Additionally, euthyroid control females had lower cholesterol 
concentrations compared to euthyroid male mice. Thus, sex-difference in cholesterol 
serum concentrations disappeared with TH excess and was pronounced under TH 
deprivation. Moreover, cholesterol metabolism of male mice is suggested to be more 
sensitive for TH modulation than of female mice, as magnitudes of alterations were 
higher in male than female mice. Changes in lipid serum composition might have not 
resulted from metabolic changes in the liver only, but most likely influenced 
additionally by TH responses from other organs as brown and white adipose tissue 
as well as muscles.  
Previous studies have reported a sex-dependent regulation of Cyp7a1 (cholesterol-7-
αhydroxylase, promotes first step of bile acid synthesis) under TH excess, with 
increased expression in male than in female mice (Jonas et al., 2015). Moreover, in 
this work other pathways were identified, which might contribute to sex-specific 
alteration of lipid metabolism. 
 
Role of Claudin-1 in sex and TH-dependent alterations of hepatic function 
Tight junctions are important in the formation of a paracellular barrier integrity 
between epithelial and endothelial cells, e.g. of the bile duct and hepatocytes. 
Claudin-1, one of many tight junction proteins, is expressed in the bile canalicular 
region of hepatocytes and is known to be involved in formation of basolateral and 
apical plasma membrane domains to promote polarization (Kojima et al., 2003, 
Kojima et al., 2009). A functional relevance of this protein in hepatocytes is proven by 
patients with altered claudin-1 expression or claudin-1 mutations, who suffer from 
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biliary diseases (Carlton et al., 2003; Laurila et al., 2007; Nemeth et al., 2009; Grosse 
et al., 2012). Moreover, a TH-dependent change in sex-dependent prevalence of 
biliary diseases, e.g. gallstone formation, has been described. Women are more 
prone to develop gallstones in euthyroid conditions than men, however the 
prevalence changes if patients are TH deprived since hypothyroid men are more 
frequently affected by gallstones than women (Volzke et al., 2005; Laukkarinen et al., 
2010). Thus, the possible influence of sex and hypothyroidism on hepatic Claudin-1 
expression was assessed in young male and female mice. Claudin-1 was lower 
expressed in livers of euthyroid female compared to male mice. TH deprivation 
increased Claudin-1 gene expression in livers of females, but not in male mice 
(Chapter 5, Fig. 1 c). Moreover, these findings were confirmed on protein level by 
immunoblot and fluorescence microscopy, as again livers of euthyroid male mice had 
higher protein expression level of Claudin-1 than female mice, but this reversed 
under hypothyroidism in decreased and elevated expression level in male and female 
mice, respectively (Chapter 5, Fig. 2). Using fluorescence microscopy, the 
localization of Claudin-1 was visualized in canalicular region of liver and the bile duct 
(Chapter 5, Fig. 3). Thus, a clear TH and sex-dependent alteration of Claudin-1 was 
shown on transcriptional and translational level with a putative influence on 
paracellular pathway. Increased Claudin-1 expression might promote paracellular 
integrity of the canalicular region and bile duct, while decreased expression could 
lead to impairment. Ongoing studies using a mouse model susceptible to gallstone 
formation will help to unravel the role of Claudin-1 and other tight junction proteins, 
as well as enzymes of cholesterol and bile acid metabolism, in the sex-dependent 
prevalence especially in euthyroid and hypothyroid conditions. 
 
6.8 Conclusion and outlook 
In summary, for the first time the clinical situation of a sex- and age-dependent 
difference of hyper- and hypothyroidism was addressed in an in vivo model to enable 
not only the analysis of phenotypical traits but provide the ability to investigate the 
underlying mechanisms on a molecular level. Nutrient intake, BW, BT, heart rate and 
motoric and behaviour changes due to TH modulation were assessed. A complex 
pattern of age-dependent or independent traits under hyper- or hypothyroid 
conditions were found and created new hypotheses, which will be further 
investigated. Interesting sex-difference in TH excess on TH serum concentrations, 
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BW, nutrient intake and muscle function indicated an influence of sex hormones. 
Surprisingly little effects were noted for heart rate, while BT was persistently different 
in male and female mice. First molecular investigations confirmed sex- and organ-
specific response on transcriptional level in heart, BAT and liver. Moreover, first hints 
for a clinical relevance of sex-dependency on cholesterol metabolism were found and 
related to sex- and TH-specific regulation of hepatic tight junction protein Claudin-1.  
 
Future perspectives of studies on clinically relevant sex-dependent TH action  
Claudin-1 regulation represents an interesting example of a different outcome of TD 
between women and men warranting further studies in rodents. To prove sex and 
TH-dependency in biliary diseases, especially as proposed for gallstone formation, a 
gallstone susceptible mouse strain of both sexes could be used, which in 
combination of a lithogenic diet results in gallstone formation (Hillebrandt et al., 2003; 
Liu et al., 2008). By additional modulation of TH status in these mice, both 
contributing factors sex and TH can be assessed. Moreover, the alterations in 
cholesterol and lipid concentrations in serum and bile can be evaluated by the 
underlying hepatic mechanisms and will improve the understanding of sex-
dependency in gallstone formation. 
Another interesting sex-dependent effect of THs is well known on bone maintenance 
in the adulthood. Thus, bone turnover is known to be increased in women but not 
men under hyperthyroidism (Bassett and Williams, 2016), which is associated with an 
increased risk of fractures especially in postmenopausal women (Bauer et al., 2001, 
Blum et al., 2015). Reduced bone mineral density was found in hyperthyroid post-, 
but not premenopausal women or men (Uzzan et al., 1996). Thus, in translation to 
the clinical situation bone samples of mice at different ages and both sexes have 
been collected during experimental time and are currently under investigation. This 
will help to gain a deeper insight of sex and age-dependent TH action on bones.  
 
Extending the understanding of sex effects on muscle function  
Another interesting finding during phenotypical characterization of TDs in mice 
appeared for striking sex-difference in neuromuscular function. Female mice seemed 
to maintain their advanced muscle function for a much longer time than male mice. 
Thus, to further confirm and evaluate if this is related to improved muscle strength, 
additional functional tests are possible, as well as the determination of muscle size, 
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fibre type and the excitation-contraction process. Forelimb grip strength can be used 
to evaluate in vivo neuromuscular performance. Improved performance indicates 
increased muscle strength, whereas a decrease in grip strength indicate weakness 
and augmented fatigability (Bonetto et al., 2015). In addition, the four limb-hanging 
test is a method to assess muscle strength of all four limbs and determines the 
general condition over time, but although easy to perform this method needs to be 
evaluated in context of other tests and consideration of BW of mice (Bonetto et al., 
2015). Furthermore, molecular analysis of skeletal muscle force production can be 
measured in isolated whole-muscle or single myofiber preparations of extensor 
digitorum longus (fast-switch) and soleus (slow-switch) muscles. Thus, electrical 
stimulation of repeated contraction and recovery phases can be used to determine 
mechanisms of fatigue, whereas quantification of specific force is helpful to evaluate 
muscle strength (Bonetto et al., 2015). Taken all these experiments together a TH 
and sex-effect on muscle function could be studied in detail. 
 
Organ-specific response to TH excess in male and female mice 
Surprisingly, continuous sex-dependency was noted for TH excess, resulting in a 
stronger increase of all TH serum concentrations in female mice. Hence, it will be 
interesting if this distribution is also representative within organs. Measurements of 
TH concentrations in different tissues would further clarify, if such a sex-difference is 
mirrored on organ level and would help to interpret gene expression alterations. 
Moreover, this could reveal or discard the hypothesis of a sex and organ-specificity in 
TH uptake and indicate why sex-difference appears in lipid metabolism and hepatic 
function or why no sex-difference was noted for heart rate and cardiac gene 
expression.  
 
Elimination of circulating sex hormones to unravel dependency on TH action 
A very important and well established tool for studying and assessing sex-hormone 
influence is to apply experiments on ovariectomized and orchidectomised female and 
male mice, respectively. With this the influence of circulating sex hormones can be 
dissected. Moreover, applications of individual sex hormones as estrogen or 
testosterone to ovariectomized or orchidectomised mice can reveal a direct effect of 
these components.  
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This approach has been addressed in the past on euthyroid mice and a variety of 
topics (Riese et al., 2006; Walf and Frye 2010; Sanchez-Alavez et al., 2011; Faustino 
et al., 2012). Moreover, first studies related to TH action have been performed in 
young euthyroid, gonadectomized male and female mice and focused on organ-
specific Dio1 activity and expression. Thus, orchidectomy did not changed mRNA or 
activity of Dio1, whereas ovariectomy increased hepatic Dio1 activity and decreased 
renal Dio1 gene expression, suggesting an influence of estrogen on Dio1 stability 
and efficiency (Riese et al., 2006). However, a modulation of TH in combination with 
gonadectomy has not been performed so far and will be a focus in future studies to 
improve the understanding of sex-dependent TH action. 
 
The awareness of extending the research to both sexes in animal studies has been 
published in 2014 by the US National Institutes of Health in Nature (Clayton and 
Collins, 2014) and was further encouraged in the same year by emphasizing sex as 
an important modifier in research studies (Hammes 2014). Thus, although an 
increasing amount of groups pay now more attention on the clear difference between 
female and male rodents, still comprehensive studies on both sexes are scarce.  
Thereby, efforts of basic scientists need to be further increased to improve the 
applicability to human situation. Even more important, TDs as common women 
diseases are in need for a better understanding of female-specific differences, the 
leading causes and the underlying mechanisms. 
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Chapter 7: Appendix 
I Abbrevations and Acronyms   
AITD autoimmune thyroid disease 
ATA American Thyroid 
Association 
BAT brown adipose tissue 
BT body temperature 
BW body weight 
CAPNS2 calpain, small subunit 2 
ClO4- perchlorate 
CYP7A1 cholesterol-7-αhydroxylase 
DIO1 deiodinase 1 
DIO2 deiodinase 2 
DIO3 deiodinase 3 
ECG electrocardiography 
ERK1/2 extracellular signal-
regulated kinases 1/2 
FT3 free triiodothyronine 
FT4 free thyroxine 
HPT hypothalamic-pituitary-
thyroid  
i.p. intraperitoneal injection 
LAT1 L-type amino acid 
transporter 1 
LAT2 L-type amino acid 
transporter 2 
LT4 levothyroxine 
MCT10 monocarboxylate 
transporter 10 
MCT8 monocarboxylate 
transporter 8 
ME1 malic enzyme 
MMI methimazole 
NTCP sodium-taurocholate co-
transporting polypeptide 
  
  
  
  
OATP1C1 organic anion transporter 
protein 1 C 1 
PDE8 phosphodiesterase type 8b 
Pi3K phosphoinositide 3 kinase 
PTU propylthiouracil 
qRT-PCR quantitative real-time 
polymerase chain reaction 
rT3 3,3´,5´-reverse 
triiodothyronine 
RXR retinoid x receptor 
T2 3,3´-diiodothyronine 
T3 3,3´,5´-triiodothyronine 
T4 thyroxine 
TBG thyroxine binding globulin 
TD thyroid dysfunction 
TGAb thyroglobulin antibodies 
TH thyroid hormone 
TPO thyroid peroxidase 
TPOAb thyroid peroxidase 
antibodies 
TR thyroid hormone receptor 
TRE thyroid hormone responsive 
element 
TRH thyreotropin-releasing 
hormone 
TSH thyroid-stimulating hormone 
TSHRAb TSH receptor antibodies 
TT4 total thyroxine 
TTR transthyretin 
UCP1 uncoupling protein 1 
  Appendix 
160 
 
II List of Figures 
Chapter 1 
Fig. 1: Hypothalamic-pituitary-thyroid axis regulated by a negative feedback loop..12 
Fig. 2: Overview of possible TH action within a cell……………………………………14 
Fig. 3: Overview of TH activation and inactivation by deiodinases…………………..15 
 
Chapter 2 
Fig. 1: Schematic illustration of the approach for comparison of ip and oral T4 supply 
and analysis of the sustainability of chronic T4 treatment on organ thyroid state….34 
Fig. 2: Serum concentrations of thyroid hormones TT4, FT4 and FT3 in male and 
female mice with ip T4 treatment compared to sham treated controls……………...35 
Fig. 3: Serum concentrations of thyroid hormones TT4, FT4 and FT3 in male mice 
with oral T4 treatment……………………………………………………………………...36 
Fig. 4: Change in body weight in mice with ip and oral T4 treatment…………..……37 
Fig. 5: Timing of T4 injection to animal sacrifice and its impact on TH responsive 
gene expression in (a) liver and (b) heart……………………………………………....39 
Fig.6: Timing of oral T4 administration and animal sacrifice and its impact on TH 
responsive gene expression in (a) liver and (b) heart……………………………...…40 
 
Chapter 3 
Fig. 1: Study design for phenotypic characterization of hyper- and hypothyroidism in 
female and male mice……………………………………………………………………..53 
Fig. 2: Body weight change, food and water intake in euthyroid, T4 or LoI/MMI/ClO4- 
treated mice…………………………………………………………………………………60 
Fig. 3: Influence of sex and change of TH serum concentrations on body temperature 
and heart rate……………………………………………………………………………….61 
Fig. 4: Behavioural assessment of male and female mice under T4 excess or 
deprivation………………………………………………………………………………….63 
Fig. 5: Serum TH status in euthyroid controls, T4 or LoI/MMI/ClO4- treated male and 
female mice…………………………………………………………………………………65 
Fig. 6: TH effects in brown adipose tissue (BAT), heart and liver of male and female 
mice………………………………………………………………………………………….66 
 
  Appendix 
161 
 
Chapter 4 
Figure 1: Study design of an approach to identify sex-differences of phenotypical 
traits in thyroid diseases………………………………………………………………….82 
Fig. 2: Serum TH status in adult and old male and female mice under TH excess or 
deprivation…………………………………………………………………………………..86 
Fig. 3: Body weight change of adult and old mice of both sexes in eu-, hyper and 
hypothyroid conditions…………………………………………………………………....88 
Fig. 4: Food intake behaviour during experimental procedure influenced by sex, age 
and TH condition…………….………………………………………………………….....89 
Fig. 5: Water consumption in adult and old groups of male and female mice, under 
control, TH excess or deprivation…………………………………………………….....90 
Fig. 6: Body temperature and heart rate in adult and old male and female mice with 
eu-, hyper- and hypothyroid state.……………………………………………………….91 
Fig. 7: Rotarod performance in all groups in both ages and sexes under control, T4 or 
MMI/ClO4-/LoI treatment…………………………………………………………………...93 
Fig. 8: Chimney test and open field activity of adult and old mice of both sexes under 
eu-, hypo- or hyperthyroid conditions…………………………………………………...94 
 
Chapter 5 
Fig. 1: Serum concentration of total thyroxine (TT4) in male and female eu- and 
hypothyroid mice. Fold-changes of deiodinase 1, malic enzyme 1 and claudin-1 
mRNA expression in euthyroid and hypothyroid male and female mice liver by 
quantitative real-time PCR……………………………………………………………….114 
Fig. 2: Claudin-1 protein expression and quantification in euthyroid and hypothyroid 
male and female mice liver………………………………………………………………115 
Fig. 3: Immunofluorescence of claudin-1 in euthyroid and hypothyroid male and 
female mice liver…………………………………………………………………………..116 
 
 
  Appendix 
162 
 
III List of Tables 
Chapter 1 
Table 1: Symptoms and signs of hypothyroidism and hyperthyroidism………………17 
Table 2: The most prominent morbidities of hyperthyroid and hypothyroid patients..18 
Table 3: Prevalence of hypothyroidism and gender distribution reported in studies in 
different countries and continents………………………………………………………...21 
Table 4: Prevalence of hyperthyroidism and gender distribution reported in studies in 
different countries and continents………………………………………………………...22 
 
Chapter 2 
Supplemental Table 1. Mean body weight (BW) in g of ip groups at start of 
experiments (BW start) and after six weeks of T4 or control treatment (BW final)….47 
Supplemental Table 2. Oligonucleotides used for amplification of house-keeping 
genes and putative TH responsive genes in RT-PCR………………………………….48 
Supplemental Table 3. Changes in mRNA expression of putative TH responsive 
genes in liver and heart tissues of animals receiving ip T4 treatment compared to 
controls………………………………………………………………………………………49 
Supplemental Table 4. Changes in mRNA expression of putative TH responsive 
genes in liver and heart tissues of male or female mice with ip T4 treatment (1 µg/g 
BW T4 every 48h over 6 weeks) compared to male or female controls (ip PBS 
injections every 48h over 6 weeks)………………………………………………………50 
 
Chapter 3 
Supplemental table 1: Oligonucleotides used for amplification of house-keeping 
genes, TH responsive genes and TH transporters by real-time PCR………………...78 
 
Chapter 4 
Table 1: Statistical analysis of TT4, FT4 and FT3 serum measurements in adult and 
old mice of both sexes……………………………………………………………………..87 
Table 2: Statistical analysis of body temperature measurements in adult and old mice 
of both sexes…………………………………………………………………………….….92 
Supplemental table 1: Body weight of adult and old, male and female mice at first 
(start) and last (final) day of experiment………………………………………………..106 
  Appendix 
163 
 
IV Bestätigung Betreuerin 
 
Bestätigung: 
Hiermit bestätige ich die Darstellung zu den Anteilen von Frau Rakov an Konzeption, 
Durchführung und Abfassung jeder Publikation (Chapter 2-5) gemäß der 
Promotionsordnung der Fakultät für Biologie zur Erlangung des Dr. rer. nat. 
 
 
Essen, den __________________ ____________________________________ 
      Prof. Dr. Dr. Dagmar Führer-Sakel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Appendix 
164 
 
V Eidesstattliche Erklärungen 
 
Erklärung:  
Hiermit erkläre ich, gem. § 6 Abs. 2, g der Promotionsordnung der Fakultät für 
Biologie zur Erlangung der Dr. rer. nat., dass ich das Arbeitsgebiet, dem das Thema 
„Phenotypical characterization of sex-dependent traits in mice models of 
hyperthyroidism and hypothyroidism“ zuzuordnen ist, in Forschung und Lehre 
vertrete und den Antrag von (Helena Rakov) befürworte.  
 
Essen, den________ ____________________________________ 
     Prof. Dr. Dr. Dagmar Führer-Sakel 
 
Erklärung:  
Hiermit erkläre ich, gem. § 7 Abs. 2, d und f der Promotionsordnung der Fakultät für 
Biologie zur Erlangung des Dr. rer. nat., dass ich die vorliegende Dissertation 
selbständig verfasst und mich keiner anderen als der angegebenen Hilfsmittel 
bedient habe und alle wörtlich oder inhaltlich übernommenen Stellen als solche 
gekennzeichnet habe.  
 
Essen, den _________________ ______________________________  
       Helena Rakov 
 
 
 
Erklärung:  
Hiermit erkläre ich, gem. § 7 Abs. 2, e und g der Promotionsordnung der Fakultät für 
Biologie zur Erlangung des Dr. rer. nat., dass ich keine anderen Promotionen bzw. 
Promotionsversuche in der Vergangenheit durchgeführt habe, dass diese Arbeit von 
keiner anderen Fakultät abgelehnt worden ist, und dass ich die Dissertation nur in 
diesem Verfahren einreiche. 
 
Essen, den _________________ ______________________________  
Helena Rakov 
  Appendix 
165 
 
VI Curriculum Vitae 
 
Der Lebenslauf ist in der Online-Version aus Gründen des Datenschutzes nicht 
enthalten. 
 
  Appendix 
166 
 
VII Acknowledgement 
First, and foremost I would like to express my deepest gratitude to my supervisor 
Prof. Dr. Dr. Dagmar Führer-Sakel for giving me the opportunity to work at this 
extremely interesting topic. Your immense knowledge, enthusiasm and motivation 
has been inspiring for me and I deeply appreciate your continued support, 
encouragement and guidance throughout my PhD time. Thank you for always taking 
time for me, your trust, helpful ideas and our many productive and stimulating 
discussions. 
I would also like to thank the Thyroid Trans Act (TTA) members Prof. Dr. Josef 
Köhrle (Charite, Berlin), PD Dr. Lars Möller and my TTA mentor Prof. Dr. Klaudia Brix 
(Jacobs University, Bremen) for constructive comments and suggestions on my 
project, which always helped me to improve my work.  
A special thank goes to Denise, for your uncountable advices, for proofreading of 
many manuscripts, abstracts, my PhD thesis and an always great and enjoyable time 
at work and off work.  
Furthermore, I would like to take the opportunity to thank each team member during 
my PhD journey who made my lab life so much easier. Kathrin, Sebastian, Julia, 
Judith, Eugi, Sören, Daniela, Janina, Steffi, Andrea, Julius, Kathrin and Sabrina. You 
all contributed to our great team spirit, helped me when I needed a third hand or 
when plan A didn´t worked. I particularly thank Kathrin, for being a great team partner 
and spending hours and hours at the dark side of IG1 with me for more than a year. 
Everything you did was with heart and mind. Thank you, Sebastian for your always 
appreciated feedback on my manuscripts, my thesis and our daily discussions as you 
always know how to solve a problem. Thanks to Julia and Judith for our great talks 
and laughs, Steffi for your incredible experimental knowledge, I can´t remember you 
ever saying „No, I never did it before“. Thank you everyone for your support, helpful 
advices and a great time! Thanks to the whole ZTL team, for answering me every 
question about mice and mouse experiments and a good care of our animals. 
I am infinitely grateful to my parents, who travelled thousands of kilometers to make it 
possible for me to be here and do what I love. Who always believe in me, support me 
and encourage me to reach my goals. Thank you to my brother and his little family 
  Appendix 
167 
 
for being my sunshine and brightening my life. Lastly, I would like to thank my best 
friend and my second half. Thank you for being by my side for so many years and 
sharing my life, for enduring my moods and making me always laugh. 
